id	sid	tid	token	lemma	pos
dpc-3506	1	1	dermatology	dermatology	NOUN
dpc-3506	1	2	:	:	PUNCT
dpc-3506	1	3	practical	practical	ADJ
dpc-3506	1	4	and	and	CCONJ
dpc-3506	1	5	conceptual	conceptual	ADJ
dpc-3506	1	6	original	original	ADJ
dpc-3506	1	7	article	article	NOUN
dpc-3506	1	8	|	|	ADV
dpc-3506	1	9	dermatol	dermatol	ADJ
dpc-3506	1	10	pract	pract	NOUN
dpc-3506	1	11	concept	concept	NOUN
dpc-3506	1	12	.	.	PUNCT
dpc-3506	2	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	2	2	1	1	NUM
dpc-3506	2	3	a	a	DET
dpc-3506	2	4	comparison	comparison	NOUN
dpc-3506	2	5	of	of	ADP
dpc-3506	2	6	clinical	clinical	ADJ
dpc-3506	2	7	,	,	PUNCT
dpc-3506	2	8	demographic	demographic	ADJ
dpc-3506	2	9	and	and	CCONJ
dpc-3506	2	10	 	 	SPACE
dpc-3506	2	11	treatment	treatment	NOUN
dpc-3506	2	12	characteristics	characteristic	NOUN
dpc-3506	2	13	of	of	ADP
dpc-3506	2	14	pediatric	pediatric	NOUN
dpc-3506	2	15	-	-	PUNCT
dpc-3506	2	16	onset	onset	NOUN
dpc-3506	2	17	and	and	CCONJ
dpc-3506	2	18	adult	adult	NOUN
dpc-3506	2	19	-	-	PUNCT
dpc-3506	2	20	onset	onset	NOUN
dpc-3506	2	21	patients	patient	NOUN
dpc-3506	2	22	diagnosed	diagnose	VERB
dpc-3506	2	23	with	with	ADP
dpc-3506	2	24	localized	localized	ADJ
dpc-3506	2	25	scleroderma	scleroderma	NOUN
dpc-3506	2	26	ayşe	ayşe	PROPN
dpc-3506	2	27	akbaş1	akbaş1	PROPN
dpc-3506	2	28	,	,	PUNCT
dpc-3506	2	29	fadime	fadime	NOUN
dpc-3506	2	30	kılınç1	kılınç1	PROPN
dpc-3506	2	31	,	,	PUNCT
dpc-3506	2	32	yıldız	yıldız	PROPN
dpc-3506	2	33	hayran1	hayran1	PROPN
dpc-3506	2	34	1	1	NUM
dpc-3506	2	35	ankara	ankara	PROPN
dpc-3506	2	36	city	city	NOUN
dpc-3506	2	37	hospital	hospital	NOUN
dpc-3506	2	38	,	,	PUNCT
dpc-3506	2	39	dermatology	dermatology	NOUN
dpc-3506	2	40	,	,	PUNCT
dpc-3506	2	41	ankara	ankara	PROPN
dpc-3506	2	42	,	,	PUNCT
dpc-3506	2	43	turkey	turkey	PROPN
dpc-3506	2	44	key	key	ADJ
dpc-3506	2	45	words	word	NOUN
dpc-3506	2	46	:	:	PUNCT
dpc-3506	2	47	adult	adult	NOUN
dpc-3506	2	48	,	,	PUNCT
dpc-3506	2	49	child	child	NOUN
dpc-3506	2	50	,	,	PUNCT
dpc-3506	2	51	epidemiology	epidemiology	NOUN
dpc-3506	2	52	,	,	PUNCT
dpc-3506	2	53	localized	localized	ADJ
dpc-3506	2	54	scleroderma	scleroderma	NOUN
dpc-3506	2	55	,	,	PUNCT
dpc-3506	2	56	morphea	morphea	NOUN
dpc-3506	2	57	citation	citation	NOUN
dpc-3506	2	58	:	:	PUNCT
dpc-3506	2	59	akbaş	akbaş	PROPN
dpc-3506	2	60	a	a	DET
dpc-3506	2	61	,	,	PUNCT
dpc-3506	2	62	kılınç	kılınç	PROPN
dpc-3506	2	63	f	f	PROPN
dpc-3506	2	64	,	,	PUNCT
dpc-3506	2	65	hayran	hayran	NOUN
dpc-3506	2	66	y.	y.	PROPN
dpc-3506	2	67	a	a	DET
dpc-3506	2	68	comparison	comparison	NOUN
dpc-3506	2	69	of	of	ADP
dpc-3506	2	70	clinical	clinical	ADJ
dpc-3506	2	71	,	,	PUNCT
dpc-3506	2	72	demographic	demographic	ADJ
dpc-3506	2	73	and	and	CCONJ
dpc-3506	2	74	treatment	treatment	NOUN
dpc-3506	2	75	characteristics	characteristic	NOUN
dpc-3506	2	76	of	of	ADP
dpc-3506	2	77	pediatric	pediatric	NOUN
dpc-3506	2	78	-	-	PUNCT
dpc-3506	2	79	onset	onset	NOUN
dpc-3506	2	80	and	and	CCONJ
dpc-3506	2	81	adult	adult	NOUN
dpc-3506	2	82	-	-	PUNCT
dpc-3506	2	83	onset	onset	NOUN
dpc-3506	2	84	patients	patient	NOUN
dpc-3506	2	85	diagnosed	diagnose	VERB
dpc-3506	2	86	with	with	ADP
dpc-3506	2	87	localized	localized	ADJ
dpc-3506	2	88	scleroderma	scleroderma	NOUN
dpc-3506	2	89	.	.	PUNCT
dpc-3506	3	1	dermatol	dermatol	NOUN
dpc-3506	3	2	pract	pract	PROPN
dpc-3506	3	3	concept	concept	NOUN
dpc-3506	3	4	.	.	PUNCT
dpc-3506	4	1	2024;14(1):e2024023	2024;14(1):e2024023	X
dpc-3506	4	2	.	.	PUNCT
dpc-3506	5	1	doi	doi	NOUN
dpc-3506	5	2	:	:	PUNCT
dpc-3506	5	3	https://doi	https://doi	PROPN
dpc-3506	5	4	.	.	PUNCT
dpc-3506	5	5	org/10.5826	org/10.5826	NUM
dpc-3506	5	6	/	/	SYM
dpc-3506	5	7	dpc.1401a23	dpc.1401a23	NOUN
dpc-3506	5	8	accepted	accept	VERB
dpc-3506	5	9	:	:	PUNCT
dpc-3506	5	10	july	july	PROPN
dpc-3506	5	11	15	15	NUM
dpc-3506	5	12	,	,	PUNCT
dpc-3506	5	13	2023	2023	NUM
dpc-3506	5	14	;	;	PUNCT
dpc-3506	5	15	published	publish	VERB
dpc-3506	5	16	:	:	PUNCT
dpc-3506	5	17	january	january	PROPN
dpc-3506	5	18	2024	2024	NUM
dpc-3506	6	1	copyright	copyright	NOUN
dpc-3506	6	2	:	:	PUNCT
dpc-3506	6	3	©	©	PROPN
dpc-3506	6	4	2024	2024	NUM
dpc-3506	6	5	akbaş	akbaş	PROPN
dpc-3506	6	6	et	et	PROPN
dpc-3506	6	7	al	al	PROPN
dpc-3506	6	8	.	.	PUNCT
dpc-3506	7	1	this	this	PRON
dpc-3506	7	2	is	be	AUX
dpc-3506	7	3	an	an	DET
dpc-3506	7	4	open	open	ADJ
dpc-3506	7	5	-	-	PUNCT
dpc-3506	7	6	access	access	NOUN
dpc-3506	7	7	article	article	NOUN
dpc-3506	7	8	distributed	distribute	VERB
dpc-3506	7	9	under	under	ADP
dpc-3506	7	10	the	the	DET
dpc-3506	7	11	terms	term	NOUN
dpc-3506	7	12	of	of	ADP
dpc-3506	7	13	the	the	DET
dpc-3506	7	14	creative	creative	ADJ
dpc-3506	7	15	commons	common	NOUN
dpc-3506	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3506	7	17	license	license	NOUN
dpc-3506	7	18	(	(	PUNCT
dpc-3506	7	19	by	by	ADP
dpc-3506	7	20	-	-	PUNCT
dpc-3506	7	21	nc-4.0	nc-4.0	NOUN
dpc-3506	7	22	)	)	PUNCT
dpc-3506	7	23	,	,	PUNCT
dpc-3506	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3506	7	25	,	,	PUNCT
dpc-3506	7	26	which	which	PRON
dpc-3506	7	27	permits	permit	VERB
dpc-3506	7	28	unrestricted	unrestricted	ADJ
dpc-3506	7	29	noncommercial	noncommercial	ADJ
dpc-3506	7	30	use	use	NOUN
dpc-3506	7	31	,	,	PUNCT
dpc-3506	7	32	distribution	distribution	NOUN
dpc-3506	7	33	,	,	PUNCT
dpc-3506	7	34	and	and	CCONJ
dpc-3506	7	35	reproduction	reproduction	NOUN
dpc-3506	7	36	in	in	ADP
dpc-3506	7	37	any	any	DET
dpc-3506	7	38	medium	medium	NOUN
dpc-3506	7	39	,	,	PUNCT
dpc-3506	7	40	provided	provide	VERB
dpc-3506	7	41	the	the	DET
dpc-3506	7	42	original	original	ADJ
dpc-3506	7	43	authors	author	NOUN
dpc-3506	7	44	and	and	CCONJ
dpc-3506	7	45	source	source	NOUN
dpc-3506	7	46	are	be	AUX
dpc-3506	7	47	credited	credit	VERB
dpc-3506	7	48	.	.	PUNCT
dpc-3506	8	1	funding	funding	NOUN
dpc-3506	8	2	:	:	PUNCT
dpc-3506	8	3	none	none	NOUN
dpc-3506	8	4	.	.	PUNCT
dpc-3506	9	1	competing	compete	VERB
dpc-3506	9	2	interests	interest	NOUN
dpc-3506	9	3	:	:	PUNCT
dpc-3506	9	4	none	none	NOUN
dpc-3506	9	5	.	.	PUNCT
dpc-3506	10	1	authorship	authorship	NOUN
dpc-3506	10	2	:	:	PUNCT
dpc-3506	10	3	all	all	DET
dpc-3506	10	4	authors	author	NOUN
dpc-3506	10	5	have	have	AUX
dpc-3506	10	6	contributed	contribute	VERB
dpc-3506	10	7	significantly	significantly	ADV
dpc-3506	10	8	to	to	ADP
dpc-3506	10	9	this	this	DET
dpc-3506	10	10	publication	publication	NOUN
dpc-3506	10	11	.	.	PUNCT
dpc-3506	11	1	corresponding	correspond	VERB
dpc-3506	11	2	author	author	NOUN
dpc-3506	11	3	:	:	PUNCT
dpc-3506	11	4	fadime	fadime	NOUN
dpc-3506	11	5	kılınç	kılınç	PROPN
dpc-3506	11	6	,	,	PUNCT
dpc-3506	11	7	md	md	PROPN
dpc-3506	11	8	,	,	PUNCT
dpc-3506	11	9	associate	associate	NOUN
dpc-3506	11	10	professor	professor	NOUN
dpc-3506	11	11	,	,	PUNCT
dpc-3506	11	12	ankara	ankara	PROPN
dpc-3506	11	13	city	city	PROPN
dpc-3506	11	14	hospital	hospital	PROPN
dpc-3506	11	15	,	,	PUNCT
dpc-3506	11	16	dermatology	dermatology	NOUN
dpc-3506	11	17	,	,	PUNCT
dpc-3506	11	18	ankara	ankara	PROPN
dpc-3506	11	19	,	,	PUNCT
dpc-3506	11	20	turkey	turkey	NOUN
dpc-3506	11	21	.	.	PUNCT
dpc-3506	12	1	tel:+905056842806	tel:+905056842806	NOUN
dpc-3506	12	2	e-mail:fykilinc@yahoo.com	e-mail:fykilinc@yahoo.com	PUNCT
dpc-3506	13	1	introduction	introduction	NOUN
dpc-3506	13	2	:	:	PUNCT
dpc-3506	13	3	morphea	morphea	ADJ
dpc-3506	13	4	localized	localized	ADJ
dpc-3506	13	5	scleroderma	scleroderma	NOUN
dpc-3506	13	6	(	(	PUNCT
dpc-3506	13	7	ls	ls	PROPN
dpc-3506	13	8	)	)	PUNCT
dpc-3506	13	9	is	be	AUX
dpc-3506	13	10	a	a	DET
dpc-3506	13	11	rare	rare	ADJ
dpc-3506	13	12	skin	skin	NOUN
dpc-3506	13	13	disease	disease	NOUN
dpc-3506	13	14	with	with	ADP
dpc-3506	13	15	unknown	unknown	ADJ
dpc-3506	13	16	pathogenesis	pathogenesis	NOUN
dpc-3506	13	17	,	,	PUNCT
dpc-3506	13	18	which	which	PRON
dpc-3506	13	19	causes	cause	VERB
dpc-3506	13	20	sclerosis	sclerosis	NOUN
dpc-3506	13	21	of	of	ADP
dpc-3506	13	22	the	the	DET
dpc-3506	13	23	dermis	dermis	NOUN
dpc-3506	13	24	and	and	CCONJ
dpc-3506	13	25	subcutaneous	subcutaneous	ADJ
dpc-3506	13	26	tissue	tissue	NOUN
dpc-3506	13	27	.	.	PUNCT
dpc-3506	14	1	objectives	objective	NOUN
dpc-3506	14	2	:	:	PUNCT
dpc-3506	14	3	it	it	PRON
dpc-3506	14	4	was	be	AUX
dpc-3506	14	5	aimed	aim	VERB
dpc-3506	14	6	to	to	PART
dpc-3506	14	7	compare	compare	VERB
dpc-3506	14	8	the	the	DET
dpc-3506	14	9	characteristics	characteristic	NOUN
dpc-3506	14	10	of	of	ADP
dpc-3506	14	11	patients	patient	NOUN
dpc-3506	14	12	with	with	ADP
dpc-3506	14	13	pediatric	pediatric	ADJ
dpc-3506	14	14	and	and	CCONJ
dpc-3506	14	15	adult	adult	NOUN
dpc-3506	14	16	-	-	PUNCT
dpc-3506	14	17	onset	onset	NOUN
dpc-3506	14	18	morphea	morphea	NOUN
dpc-3506	14	19	.	.	PUNCT
dpc-3506	15	1	methods	method	NOUN
dpc-3506	15	2	:	:	PUNCT
dpc-3506	15	3	a	a	DET
dpc-3506	15	4	retrospective	retrospective	ADJ
dpc-3506	15	5	analysis	analysis	NOUN
dpc-3506	15	6	was	be	AUX
dpc-3506	15	7	performed	perform	VERB
dpc-3506	15	8	on	on	ADP
dpc-3506	15	9	  	  	SPACE
dpc-3506	15	10	the	the	DET
dpc-3506	15	11	records	record	NOUN
dpc-3506	15	12	of	of	ADP
dpc-3506	15	13	183	183	NUM
dpc-3506	15	14	adult	adult	NOUN
dpc-3506	15	15	morphea	morphea	NOUN
dpc-3506	15	16	patients	patient	NOUN
dpc-3506	15	17	.	.	PUNCT
dpc-3506	16	1	the	the	DET
dpc-3506	16	2	demographics	demographic	NOUN
dpc-3506	16	3	,	,	PUNCT
dpc-3506	16	4	clinical	clinical	ADJ
dpc-3506	16	5	and	and	CCONJ
dpc-3506	16	6	laboratory	laboratory	NOUN
dpc-3506	16	7	characteristics	characteristic	NOUN
dpc-3506	16	8	,	,	PUNCT
dpc-3506	16	9	and	and	CCONJ
dpc-3506	16	10	treatment	treatment	NOUN
dpc-3506	16	11	options	option	NOUN
dpc-3506	16	12	of	of	ADP
dpc-3506	16	13	the	the	DET
dpc-3506	16	14	patients	patient	NOUN
dpc-3506	16	15	were	be	AUX
dpc-3506	16	16	recorded	record	VERB
dpc-3506	16	17	.	.	PUNCT
dpc-3506	17	1	adult	adult	NOUN
dpc-3506	17	2	patients	patient	NOUN
dpc-3506	17	3	with	with	ADP
dpc-3506	17	4	morphea	morphea	PROPN
dpc-3506	17	5	over	over	ADP
dpc-3506	17	6	the	the	DET
dpc-3506	17	7	age	age	NOUN
dpc-3506	17	8	of	of	ADP
dpc-3506	17	9	18	18	NUM
dpc-3506	17	10	were	be	AUX
dpc-3506	17	11	divided	divide	VERB
dpc-3506	17	12	into	into	ADP
dpc-3506	17	13	two	two	NUM
dpc-3506	17	14	groups	group	NOUN
dpc-3506	17	15	according	accord	VERB
dpc-3506	17	16	to	to	ADP
dpc-3506	17	17	the	the	DET
dpc-3506	17	18	age	age	NOUN
dpc-3506	17	19	of	of	ADP
dpc-3506	17	20	onset	onset	NOUN
dpc-3506	17	21	and	and	CCONJ
dpc-3506	17	22	compared	compare	VERB
dpc-3506	17	23	.	.	PUNCT
dpc-3506	18	1	results	result	NOUN
dpc-3506	18	2	:	:	PUNCT
dpc-3506	18	3	twenty	twenty	NUM
dpc-3506	18	4	-	-	PUNCT
dpc-3506	18	5	two	two	NUM
dpc-3506	18	6	percent	percent	NOUN
dpc-3506	18	7	(	(	PUNCT
dpc-3506	18	8	n	n	NOUN
dpc-3506	18	9	=	=	SYM
dpc-3506	18	10	41	41	NUM
dpc-3506	18	11	)	)	PUNCT
dpc-3506	18	12	of	of	ADP
dpc-3506	18	13	the	the	DET
dpc-3506	18	14	patients	patient	NOUN
dpc-3506	18	15	had	have	VERB
dpc-3506	18	16	pediatric	pediatric	ADJ
dpc-3506	18	17	-	-	PUNCT
dpc-3506	18	18	onset	onset	NOUN
dpc-3506	18	19	morphea	morphea	NOUN
dpc-3506	18	20	(	(	PUNCT
dpc-3506	18	21	pols	pol	NOUN
dpc-3506	18	22	)	)	PUNCT
dpc-3506	18	23	and	and	CCONJ
dpc-3506	18	24	77.6	77.6	NUM
dpc-3506	18	25	%	%	NOUN
dpc-3506	18	26	(	(	PUNCT
dpc-3506	18	27	n=142	n=142	PROPN
dpc-3506	18	28	)	)	PUNCT
dpc-3506	18	29	had	have	VERB
dpc-3506	18	30	adult	adult	NOUN
dpc-3506	18	31	-	-	PUNCT
dpc-3506	18	32	onset	onset	NOUN
dpc-3506	18	33	morphea	morphea	NOUN
dpc-3506	18	34	(	(	PUNCT
dpc-3506	18	35	aols	aol	NOUN
dpc-3506	18	36	)	)	PUNCT
dpc-3506	18	37	.	.	PUNCT
dpc-3506	19	1	while	while	SCONJ
dpc-3506	19	2	pols	pol	NOUN
dpc-3506	19	3	had	have	VERB
dpc-3506	19	4	a	a	DET
dpc-3506	19	5	higher	high	ADJ
dpc-3506	19	6	head	head	NOUN
dpc-3506	19	7	-	-	PUNCT
dpc-3506	19	8	neck	neck	NOUN
dpc-3506	19	9	involvement	involvement	NOUN
dpc-3506	19	10	,	,	PUNCT
dpc-3506	19	11	aols	aol	NOUN
dpc-3506	19	12	had	have	VERB
dpc-3506	19	13	a	a	DET
dpc-3506	19	14	higher	high	ADJ
dpc-3506	19	15	breast	breast	NOUN
dpc-3506	19	16	involvement	involvement	NOUN
dpc-3506	19	17	(	(	PUNCT
dpc-3506	19	18	p	p	X
dpc-3506	19	19	<	<	X
dpc-3506	19	20	0.001	0.001	NUM
dpc-3506	19	21	and	and	CCONJ
dpc-3506	19	22	p	p	NOUN
dpc-3506	19	23	=	=	NOUN
dpc-3506	19	24	0.043	0.043	NUM
dpc-3506	19	25	)	)	PUNCT
dpc-3506	19	26	.	.	PUNCT
dpc-3506	20	1	patients	patient	NOUN
dpc-3506	20	2	with	with	ADP
dpc-3506	20	3	linear	linear	PROPN
dpc-3506	20	4	morphea	morphea	PROPN
dpc-3506	20	5	were	be	AUX
dpc-3506	20	6	younger	young	ADJ
dpc-3506	20	7	,	,	PUNCT
dpc-3506	20	8	and	and	CCONJ
dpc-3506	20	9	more	more	ADV
dpc-3506	20	10	frequently	frequently	ADV
dpc-3506	20	11	had	have	VERB
dpc-3506	20	12	at	at	ADV
dpc-3506	20	13	least	least	ADV
dpc-3506	20	14	one	one	NUM
dpc-3506	20	15	laboratory	laboratory	NOUN
dpc-3506	20	16	anomaly	anomaly	NOUN
dpc-3506	20	17	(	(	PUNCT
dpc-3506	20	18	p	p	X
dpc-3506	20	19	=	=	NOUN
dpc-3506	20	20	0.016	0.016	NUM
dpc-3506	20	21	versus	versus	ADP
dpc-3506	20	22	0.024	0.024	NUM
dpc-3506	20	23	)	)	PUNCT
dpc-3506	20	24	.	.	PUNCT
dpc-3506	21	1	anti	anti	ADJ
dpc-3506	21	2	-	-	ADJ
dpc-3506	21	3	dsdna	dsdna	ADJ
dpc-3506	21	4	positivity	positivity	NOUN
dpc-3506	21	5	and	and	CCONJ
dpc-3506	21	6	low	low	ADJ
dpc-3506	21	7	hemoglobin	hemoglobin	NOUN
dpc-3506	21	8	(	(	PUNCT
dpc-3506	21	9	hb	hb	X
dpc-3506	21	10	)	)	PUNCT
dpc-3506	21	11	were	be	AUX
dpc-3506	21	12	observed	observe	VERB
dpc-3506	21	13	more	more	ADV
dpc-3506	21	14	frequently	frequently	ADV
dpc-3506	21	15	in	in	ADP
dpc-3506	21	16	patients	patient	NOUN
dpc-3506	21	17	with	with	ADP
dpc-3506	21	18	breast	breast	NOUN
dpc-3506	21	19	involvement	involvement	NOUN
dpc-3506	21	20	.	.	PUNCT
dpc-3506	22	1	patients	patient	NOUN
dpc-3506	22	2	with	with	ADP
dpc-3506	22	3	inguinal	inguinal	ADJ
dpc-3506	22	4	involvement	involvement	NOUN
dpc-3506	22	5	,	,	PUNCT
dpc-3506	22	6	on	on	ADP
dpc-3506	22	7	the	the	DET
dpc-3506	22	8	other	other	ADJ
dpc-3506	22	9	hand	hand	NOUN
dpc-3506	22	10	,	,	PUNCT
dpc-3506	22	11	had	have	VERB
dpc-3506	22	12	lower	low	ADJ
dpc-3506	22	13	hb	hb	NOUN
dpc-3506	22	14	and	and	CCONJ
dpc-3506	22	15	a	a	DET
dpc-3506	22	16	higher	high	ADJ
dpc-3506	22	17	rate	rate	NOUN
dpc-3506	22	18	of	of	ADP
dpc-3506	22	19	diabetes	diabetes	NOUN
dpc-3506	22	20	,	,	PUNCT
dpc-3506	22	21	and	and	CCONJ
dpc-3506	22	22	those	those	DET
dpc-3506	22	23	patients	patient	NOUN
dpc-3506	22	24	were	be	AUX
dpc-3506	22	25	older	old	ADJ
dpc-3506	22	26	(	(	PUNCT
dpc-3506	22	27	p	p	X
dpc-3506	22	28	=	=	NOUN
dpc-3506	22	29	0.042	0.042	NUM
dpc-3506	22	30	,	,	PUNCT
dpc-3506	22	31	0.040	0.040	NUM
dpc-3506	22	32	,	,	PUNCT
dpc-3506	22	33	and	and	CCONJ
dpc-3506	22	34	0.012	0.012	NUM
dpc-3506	22	35	,	,	PUNCT
dpc-3506	22	36	respectively	respectively	ADV
dpc-3506	22	37	)	)	PUNCT
dpc-3506	22	38	.	.	PUNCT
dpc-3506	23	1	conclusions	conclusion	NOUN
dpc-3506	23	2	:	:	PUNCT
dpc-3506	23	3	clinical	clinical	ADJ
dpc-3506	23	4	characteristics	characteristic	NOUN
dpc-3506	23	5	and	and	CCONJ
dpc-3506	23	6	accompanying	accompany	VERB
dpc-3506	23	7	laboratory	laboratory	NOUN
dpc-3506	23	8	anomalies	anomaly	NOUN
dpc-3506	23	9	of	of	ADP
dpc-3506	23	10	the	the	DET
dpc-3506	23	11	patients	patient	NOUN
dpc-3506	23	12	with	with	ADP
dpc-3506	23	13	morphea	morphea	PROPN
dpc-3506	23	14	depend	depend	VERB
dpc-3506	23	15	on	on	ADP
dpc-3506	23	16	the	the	DET
dpc-3506	23	17	age	age	NOUN
dpc-3506	23	18	of	of	ADP
dpc-3506	23	19	onset	onset	NOUN
dpc-3506	23	20	,	,	PUNCT
dpc-3506	23	21	involvement	involvement	NOUN
dpc-3506	23	22	areas	area	NOUN
dpc-3506	23	23	and	and	CCONJ
dpc-3506	23	24	the	the	DET
dpc-3506	23	25	types	type	NOUN
dpc-3506	23	26	of	of	ADP
dpc-3506	23	27	morphea	morphea	PROPN
dpc-3506	23	28	,	,	PUNCT
dpc-3506	23	29	having	have	VERB
dpc-3506	23	30	such	such	ADJ
dpc-3506	23	31	data	datum	NOUN
dpc-3506	23	32	readily	readily	ADV
dpc-3506	23	33	available	available	ADJ
dpc-3506	23	34	should	should	AUX
dpc-3506	23	35	guide	guide	VERB
dpc-3506	23	36	the	the	DET
dpc-3506	23	37	holistic	holistic	ADJ
dpc-3506	23	38	approach	approach	NOUN
dpc-3506	23	39	for	for	ADP
dpc-3506	23	40	,	,	PUNCT
dpc-3506	23	41	and	and	CCONJ
dpc-3506	23	42	the	the	DET
dpc-3506	23	43	monitoring	monitoring	NOUN
dpc-3506	23	44	process	process	NOUN
dpc-3506	23	45	of	of	ADP
dpc-3506	23	46	,	,	PUNCT
dpc-3506	23	47	the	the	DET
dpc-3506	23	48	disease	disease	NOUN
dpc-3506	23	49	.	.	PUNCT
dpc-3506	24	1	abstract	abstract	ADJ
dpc-3506	24	2	2	2	NUM
dpc-3506	24	3	original	original	ADJ
dpc-3506	24	4	article	article	NOUN
dpc-3506	24	5	|	|	ADV
dpc-3506	24	6	dermatol	dermatol	ADJ
dpc-3506	24	7	pract	pract	NOUN
dpc-3506	24	8	concept	concept	NOUN
dpc-3506	24	9	.	.	PUNCT
dpc-3506	25	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	25	2	introduction	introduction	NOUN
dpc-3506	25	3	morphea	morphea	NOUN
dpc-3506	25	4	localized	localized	ADJ
dpc-3506	25	5	scleroderma	scleroderma	NOUN
dpc-3506	25	6	(	(	PUNCT
dpc-3506	25	7	ls	ls	PROPN
dpc-3506	25	8	)	)	PUNCT
dpc-3506	25	9	is	be	AUX
dpc-3506	25	10	an	an	DET
dpc-3506	25	11	uncommon	uncommon	ADJ
dpc-3506	25	12	inflammatory	inflammatory	ADJ
dpc-3506	25	13	skin	skin	NOUN
dpc-3506	25	14	disease	disease	NOUN
dpc-3506	25	15	which	which	PRON
dpc-3506	25	16	causes	cause	VERB
dpc-3506	25	17	sclerosis	sclerosis	NOUN
dpc-3506	25	18	on	on	ADP
dpc-3506	25	19	the	the	DET
dpc-3506	25	20	dermis	dermis	NOUN
dpc-3506	25	21	and	and	CCONJ
dpc-3506	25	22	subcutaneous	subcutaneous	ADJ
dpc-3506	25	23	tissue	tissue	NOUN
dpc-3506	25	24	.	.	PUNCT
dpc-3506	26	1	the	the	DET
dpc-3506	26	2	pathogenesis	pathogenesis	NOUN
dpc-3506	26	3	of	of	ADP
dpc-3506	26	4	morphea	morphea	PROPN
dpc-3506	26	5	is	be	AUX
dpc-3506	26	6	unknown	unknown	ADJ
dpc-3506	26	7	.	.	PUNCT
dpc-3506	27	1	numerous	numerous	ADJ
dpc-3506	27	2	factors	factor	NOUN
dpc-3506	27	3	can	can	AUX
dpc-3506	27	4	contribute	contribute	VERB
dpc-3506	27	5	to	to	ADP
dpc-3506	27	6	its	its	PRON
dpc-3506	27	7	etiology	etiology	NOUN
dpc-3506	27	8	,	,	PUNCT
dpc-3506	27	9	including	include	VERB
dpc-3506	27	10	trauma	trauma	NOUN
dpc-3506	27	11	,	,	PUNCT
dpc-3506	27	12	environmental	environmental	ADJ
dpc-3506	27	13	factors	factor	NOUN
dpc-3506	27	14	like	like	ADP
dpc-3506	27	15	radiation	radiation	NOUN
dpc-3506	27	16	,	,	PUNCT
dpc-3506	27	17	drugs	drug	NOUN
dpc-3506	27	18	and	and	CCONJ
dpc-3506	27	19	chemicals	chemical	NOUN
dpc-3506	27	20	,	,	PUNCT
dpc-3506	27	21	infections	infection	NOUN
dpc-3506	27	22	,	,	PUNCT
dpc-3506	27	23	vascular	vascular	ADJ
dpc-3506	27	24	dysregulation	dysregulation	NOUN
dpc-3506	27	25	,	,	PUNCT
dpc-3506	27	26	and	and	CCONJ
dpc-3506	27	27	autoimmunity	autoimmunity	NOUN
dpc-3506	27	28	[	[	X
dpc-3506	27	29	1	1	NUM
dpc-3506	27	30	-	-	SYM
dpc-3506	27	31	3	3	NUM
dpc-3506	27	32	]	]	PUNCT
dpc-3506	27	33	.	.	PUNCT
dpc-3506	28	1	these	these	DET
dpc-3506	28	2	stimuli	stimulus	NOUN
dpc-3506	28	3	are	be	AUX
dpc-3506	28	4	thought	think	VERB
dpc-3506	28	5	to	to	PART
dpc-3506	28	6	cause	cause	VERB
dpc-3506	28	7	the	the	DET
dpc-3506	28	8	release	release	NOUN
dpc-3506	28	9	of	of	ADP
dpc-3506	28	10	adhesion	adhesion	NOUN
dpc-3506	28	11	molecules	molecule	NOUN
dpc-3506	28	12	and	and	CCONJ
dpc-3506	28	13	microvascular	microvascular	ADJ
dpc-3506	28	14	injuries	injury	NOUN
dpc-3506	28	15	.	.	PUNCT
dpc-3506	29	1	vascular	vascular	ADJ
dpc-3506	29	2	cell	cell	NOUN
dpc-3506	29	3	adhesion	adhesion	NOUN
dpc-3506	29	4	molecule-1	molecule-1	PROPN
dpc-3506	29	5	,	,	PUNCT
dpc-3506	29	6	intercellular	intercellular	ADJ
dpc-3506	29	7	adhesion	adhesion	NOUN
dpc-3506	29	8	molecule-1	molecule-1	PROPN
dpc-3506	29	9	and	and	CCONJ
dpc-3506	29	10	e	e	NOUN
dpc-3506	29	11	-	-	NOUN
dpc-3506	29	12	selectin	selectin	ADJ
dpc-3506	29	13	can	can	AUX
dpc-3506	29	14	induce	induce	VERB
dpc-3506	29	15	t	t	NOUN
dpc-3506	29	16	-	-	PUNCT
dpc-3506	29	17	cells	cell	NOUN
dpc-3506	29	18	and	and	CCONJ
dpc-3506	29	19	cause	cause	VERB
dpc-3506	29	20	the	the	DET
dpc-3506	29	21	release	release	NOUN
dpc-3506	29	22	of	of	ADP
dpc-3506	29	23	transforming	transform	VERB
dpc-3506	29	24	growth	growth	NOUN
dpc-3506	29	25	factor	factor	NOUN
dpc-3506	29	26	-	-	PUNCT
dpc-3506	29	27	beta	beta	NOUN
dpc-3506	29	28	(	(	PUNCT
dpc-3506	29	29	tgfβ	tgfβ	ADJ
dpc-3506	29	30	)	)	PUNCT
dpc-3506	29	31	and	and	CCONJ
dpc-3506	29	32	profibrotic	profibrotic	ADJ
dpc-3506	29	33	cytokines	cytokine	NOUN
dpc-3506	29	34	such	such	ADJ
dpc-3506	29	35	as	as	ADP
dpc-3506	29	36	interleukin	interleukin	NOUN
dpc-3506	29	37	(	(	PUNCT
dpc-3506	29	38	il	il	PROPN
dpc-3506	29	39	)	)	PUNCT
dpc-3506	29	40	4	4	NUM
dpc-3506	29	41	and	and	CCONJ
dpc-3506	29	42	il-6	il-6	PRON
dpc-3506	29	43	.	.	PUNCT
dpc-3506	30	1	as	as	ADP
dpc-3506	30	2	a	a	DET
dpc-3506	30	3	result	result	NOUN
dpc-3506	30	4	,	,	PUNCT
dpc-3506	30	5	excessive	excessive	ADJ
dpc-3506	30	6	collagen	collagen	NOUN
dpc-3506	30	7	production	production	NOUN
dpc-3506	30	8	and	and	CCONJ
dpc-3506	30	9	decreased	decrease	VERB
dpc-3506	30	10	matrix	matrix	NOUN
dpc-3506	30	11	metalloproteinases	metalloproteinase	NOUN
dpc-3506	30	12	contribute	contribute	VERB
dpc-3506	30	13	to	to	ADP
dpc-3506	30	14	the	the	DET
dpc-3506	30	15	development	development	NOUN
dpc-3506	30	16	of	of	ADP
dpc-3506	30	17	the	the	DET
dpc-3506	30	18	disease	disease	NOUN
dpc-3506	30	19	[	[	X
dpc-3506	30	20	2	2	NUM
dpc-3506	30	21	]	]	PUNCT
dpc-3506	30	22	.	.	PUNCT
dpc-3506	31	1	it	it	PRON
dpc-3506	31	2	is	be	AUX
dpc-3506	31	3	more	more	ADV
dpc-3506	31	4	common	common	ADJ
dpc-3506	31	5	in	in	ADP
dpc-3506	31	6	women	woman	NOUN
dpc-3506	31	7	.	.	PUNCT
dpc-3506	32	1	the	the	DET
dpc-3506	32	2	incidence	incidence	NOUN
dpc-3506	32	3	of	of	ADP
dpc-3506	32	4	morphea	morphea	PROPN
dpc-3506	32	5	ranges	range	VERB
dpc-3506	32	6	from	from	ADP
dpc-3506	32	7	0.4	0.4	NUM
dpc-3506	32	8	to	to	ADP
dpc-3506	32	9	2.7	2.7	NUM
dpc-3506	32	10	per	per	ADP
dpc-3506	32	11	100,000	100,000	NUM
dpc-3506	32	12	people	people	NOUN
dpc-3506	32	13	and	and	CCONJ
dpc-3506	32	14	it	it	PRON
dpc-3506	32	15	is	be	AUX
dpc-3506	32	16	similar	similar	ADJ
dpc-3506	32	17	in	in	ADP
dpc-3506	32	18	children	child	NOUN
dpc-3506	32	19	and	and	CCONJ
dpc-3506	32	20	adults	adult	NOUN
dpc-3506	32	21	.	.	PUNCT
dpc-3506	33	1	[	[	X
dpc-3506	33	2	2	2	NUM
dpc-3506	33	3	-	-	SYM
dpc-3506	33	4	5	5	NUM
dpc-3506	33	5	]	]	PUNCT
dpc-3506	33	6	.	.	PUNCT
dpc-3506	34	1	in	in	ADP
dpc-3506	34	2	children	child	NOUN
dpc-3506	34	3	with	with	ADP
dpc-3506	34	4	morphea	morphea	PROPN
dpc-3506	34	5	it	it	PRON
dpc-3506	34	6	is	be	AUX
dpc-3506	34	7	mostly	mostly	ADV
dpc-3506	34	8	seen	see	VERB
dpc-3506	34	9	between	between	ADP
dpc-3506	34	10	ages	age	NOUN
dpc-3506	34	11	of	of	ADP
dpc-3506	34	12	2	2	NUM
dpc-3506	34	13	and	and	CCONJ
dpc-3506	34	14	14	14	NUM
dpc-3506	34	15	and	and	CCONJ
dpc-3506	34	16	in	in	ADP
dpc-3506	34	17	adults	adult	NOUN
dpc-3506	34	18	with	with	ADP
dpc-3506	34	19	morphea	morphea	NOUN
dpc-3506	34	20	it	it	PRON
dpc-3506	34	21	is	be	AUX
dpc-3506	34	22	mostly	mostly	ADV
dpc-3506	34	23	seen	see	VERB
dpc-3506	34	24	in	in	ADP
dpc-3506	34	25	middle	middle	ADJ
dpc-3506	34	26	ages	age	NOUN
dpc-3506	35	1	[	[	X
dpc-3506	35	2	6	6	NUM
dpc-3506	35	3	]	]	PUNCT
dpc-3506	35	4	.	.	PUNCT
dpc-3506	36	1	it	it	PRON
dpc-3506	36	2	can	can	AUX
dpc-3506	36	3	lead	lead	VERB
dpc-3506	36	4	to	to	ADP
dpc-3506	36	5	functional	functional	ADJ
dpc-3506	36	6	and	and	CCONJ
dpc-3506	36	7	cosmetic	cosmetic	ADJ
dpc-3506	36	8	issues	issue	NOUN
dpc-3506	36	9	.	.	PUNCT
dpc-3506	37	1	in	in	ADP
dpc-3506	37	2	the	the	DET
dpc-3506	37	3	inflammatory	inflammatory	ADJ
dpc-3506	37	4	phase	phase	NOUN
dpc-3506	37	5	,	,	PUNCT
dpc-3506	37	6	erythematous	erythematous	ADJ
dpc-3506	37	7	purple	purple	ADJ
dpc-3506	37	8	-	-	PUNCT
dpc-3506	37	9	colored	color	VERB
dpc-3506	37	10	patches	patch	NOUN
dpc-3506	37	11	and	and	CCONJ
dpc-3506	37	12	plaques	plaque	NOUN
dpc-3506	37	13	are	be	AUX
dpc-3506	37	14	observed	observe	VERB
dpc-3506	37	15	,	,	PUNCT
dpc-3506	37	16	which	which	PRON
dpc-3506	37	17	gradually	gradually	ADV
dpc-3506	37	18	transform	transform	VERB
dpc-3506	37	19	into	into	ADP
dpc-3506	37	20	white	white	ADJ
dpc-3506	37	21	,	,	PUNCT
dpc-3506	37	22	sclerotic	sclerotic	ADJ
dpc-3506	37	23	lesions	lesion	NOUN
dpc-3506	37	24	that	that	PRON
dpc-3506	37	25	are	be	AUX
dpc-3506	37	26	surrounded	surround	VERB
dpc-3506	37	27	by	by	ADP
dpc-3506	37	28	violet	violet	ADJ
dpc-3506	37	29	halos	halo	NOUN
dpc-3506	37	30	.	.	PUNCT
dpc-3506	38	1	as	as	SCONJ
dpc-3506	38	2	lesions	lesion	NOUN
dpc-3506	38	3	heal	heal	NOUN
dpc-3506	38	4	,	,	PUNCT
dpc-3506	38	5	post	post	ADJ
dpc-3506	38	6	-	-	ADJ
dpc-3506	38	7	inflammatory	inflammatory	ADJ
dpc-3506	38	8	hyperpigmentation	hyperpigmentation	NOUN
dpc-3506	38	9	occurs	occur	VERB
dpc-3506	38	10	[	[	X
dpc-3506	38	11	1,7	1,7	NUM
dpc-3506	38	12	]	]	PUNCT
dpc-3506	38	13	.	.	PUNCT
dpc-3506	39	1	laxer	laxer	PROPN
dpc-3506	39	2	et	et	PROPN
dpc-3506	39	3	al	al	PROPN
dpc-3506	39	4	.	.	PROPN
dpc-3506	39	5	classified	classified	PROPN
dpc-3506	39	6	morphea	morphea	PROPN
dpc-3506	39	7	into	into	ADP
dpc-3506	39	8	the	the	DET
dpc-3506	39	9	following	follow	VERB
dpc-3506	39	10	five	five	NUM
dpc-3506	39	11	types	type	NOUN
dpc-3506	39	12	:	:	PUNCT
dpc-3506	39	13	plaque	plaque	NOUN
dpc-3506	39	14	,	,	PUNCT
dpc-3506	39	15	generalized	generalize	VERB
dpc-3506	39	16	,	,	PUNCT
dpc-3506	39	17	linear	linear	ADJ
dpc-3506	39	18	,	,	PUNCT
dpc-3506	39	19	pansclerotic	pansclerotic	ADJ
dpc-3506	39	20	,	,	PUNCT
dpc-3506	39	21	and	and	CCONJ
dpc-3506	39	22	mixed	mix	VERB
dpc-3506	39	23	[	[	X
dpc-3506	39	24	8	8	NUM
dpc-3506	39	25	]	]	PUNCT
dpc-3506	39	26	.	.	PUNCT
dpc-3506	40	1	there	there	PRON
dpc-3506	40	2	are	be	VERB
dpc-3506	40	3	few	few	ADJ
dpc-3506	40	4	studies	study	NOUN
dpc-3506	40	5	compare	compare	VERB
dpc-3506	40	6	pediatric	pediatric	ADJ
dpc-3506	40	7	-	-	PUNCT
dpc-3506	40	8	onset	onset	NOUN
dpc-3506	40	9	morphea	morphea	NOUN
dpc-3506	40	10	(	(	PUNCT
dpc-3506	40	11	pols	pol	NOUN
dpc-3506	40	12	)	)	PUNCT
dpc-3506	40	13	and	and	CCONJ
dpc-3506	40	14	adult	adult	NOUN
dpc-3506	40	15	-	-	PUNCT
dpc-3506	40	16	onset	onset	NOUN
dpc-3506	40	17	morphea	morphea	NOUN
dpc-3506	40	18	(	(	PUNCT
dpc-3506	40	19	aols	aol	NOUN
dpc-3506	40	20	)	)	PUNCT
dpc-3506	40	21	with	with	ADP
dpc-3506	40	22	variable	variable	ADJ
dpc-3506	40	23	results	result	NOUN
dpc-3506	40	24	[	[	X
dpc-3506	40	25	9,10	9,10	NUM
dpc-3506	40	26	]	]	X
dpc-3506	40	27	.	.	PUNCT
dpc-3506	41	1	objectives	objective	VERB
dpc-3506	41	2	the	the	DET
dpc-3506	41	3	aim	aim	NOUN
dpc-3506	41	4	of	of	ADP
dpc-3506	41	5	this	this	DET
dpc-3506	41	6	study	study	NOUN
dpc-3506	41	7	was	be	AUX
dpc-3506	41	8	to	to	PART
dpc-3506	41	9	investigate	investigate	VERB
dpc-3506	41	10	the	the	DET
dpc-3506	41	11	clinical	clinical	ADJ
dpc-3506	41	12	and	and	CCONJ
dpc-3506	41	13	demographic	demographic	ADJ
dpc-3506	41	14	characteristics	characteristic	NOUN
dpc-3506	41	15	of	of	ADP
dpc-3506	41	16	both	both	DET
dpc-3506	41	17	pols	pol	NOUN
dpc-3506	41	18	and	and	CCONJ
dpc-3506	41	19	aols	aol	NOUN
dpc-3506	41	20	patients	patient	NOUN
dpc-3506	41	21	who	who	PRON
dpc-3506	41	22	were	be	AUX
dpc-3506	41	23	followed	follow	VERB
dpc-3506	41	24	up	up	ADP
dpc-3506	41	25	with	with	ADP
dpc-3506	41	26	the	the	DET
dpc-3506	41	27	diagnosis	diagnosis	NOUN
dpc-3506	41	28	of	of	ADP
dpc-3506	41	29	morphea	morphea	NOUN
dpc-3506	41	30	in	in	ADP
dpc-3506	41	31	our	our	PRON
dpc-3506	41	32	clinic	clinic	NOUN
dpc-3506	41	33	,	,	PUNCT
dpc-3506	41	34	evaluate	evaluate	VERB
dpc-3506	41	35	the	the	DET
dpc-3506	41	36	results	result	NOUN
dpc-3506	41	37	,	,	PUNCT
dpc-3506	41	38	examine	examine	VERB
dpc-3506	41	39	the	the	DET
dpc-3506	41	40	clinical	clinical	ADJ
dpc-3506	41	41	pattern	pattern	NOUN
dpc-3506	41	42	and	and	CCONJ
dpc-3506	41	43	laboratory	laboratory	NOUN
dpc-3506	41	44	findings	finding	NOUN
dpc-3506	41	45	,	,	PUNCT
dpc-3506	41	46	and	and	CCONJ
dpc-3506	41	47	compare	compare	VERB
dpc-3506	41	48	the	the	DET
dpc-3506	41	49	treatment	treatment	NOUN
dpc-3506	41	50	options	option	NOUN
dpc-3506	41	51	with	with	ADP
dpc-3506	41	52	each	each	DET
dpc-3506	41	53	other	other	ADJ
dpc-3506	41	54	in	in	ADP
dpc-3506	41	55	the	the	DET
dpc-3506	41	56	light	light	NOUN
dpc-3506	41	57	of	of	ADP
dpc-3506	41	58	the	the	DET
dpc-3506	41	59	literature	literature	NOUN
dpc-3506	41	60	data	data	PROPN
dpc-3506	41	61	.	.	PUNCT
dpc-3506	42	1	methods	method	NOUN
dpc-3506	42	2	retrospective	retrospective	ADJ
dpc-3506	42	3	data	datum	NOUN
dpc-3506	42	4	analysis	analysis	NOUN
dpc-3506	42	5	was	be	AUX
dpc-3506	42	6	performed	perform	VERB
dpc-3506	42	7	on	on	ADP
dpc-3506	42	8	the	the	DET
dpc-3506	42	9	records	record	NOUN
dpc-3506	42	10	of	of	ADP
dpc-3506	42	11	patients	patient	NOUN
dpc-3506	42	12	who	who	PRON
dpc-3506	42	13	were	be	AUX
dpc-3506	42	14	clinically	clinically	ADV
dpc-3506	42	15	and	and	CCONJ
dpc-3506	42	16	histopathologically	histopathologically	ADV
dpc-3506	42	17	diagnosed	diagnose	VERB
dpc-3506	42	18	with	with	ADP
dpc-3506	42	19	morphea	morphea	NOUN
dpc-3506	42	20	between	between	ADP
dpc-3506	42	21	2016	2016	NUM
dpc-3506	42	22	and	and	CCONJ
dpc-3506	42	23	2022	2022	NUM
dpc-3506	42	24	.	.	PUNCT
dpc-3506	43	1	the	the	DET
dpc-3506	43	2	inclusion	inclusion	NOUN
dpc-3506	43	3	criterion	criterion	NOUN
dpc-3506	43	4	for	for	ADP
dpc-3506	43	5	the	the	DET
dpc-3506	43	6	study	study	NOUN
dpc-3506	43	7	was	be	AUX
dpc-3506	43	8	that	that	SCONJ
dpc-3506	43	9	the	the	DET
dpc-3506	43	10	patients	patient	NOUN
dpc-3506	43	11	be	be	VERB
dpc-3506	43	12	at	at	ADV
dpc-3506	43	13	least	least	ADV
dpc-3506	43	14	18	18	NUM
dpc-3506	43	15	years	year	NOUN
dpc-3506	43	16	old	old	ADJ
dpc-3506	43	17	at	at	ADP
dpc-3506	43	18	the	the	DET
dpc-3506	43	19	time	time	NOUN
dpc-3506	43	20	of	of	ADP
dpc-3506	43	21	diagnosis	diagnosis	NOUN
dpc-3506	43	22	.	.	PUNCT
dpc-3506	44	1	children	child	NOUN
dpc-3506	44	2	under	under	ADP
dpc-3506	44	3	the	the	DET
dpc-3506	44	4	age	age	NOUN
dpc-3506	44	5	of	of	ADP
dpc-3506	44	6	18	18	NUM
dpc-3506	44	7	were	be	AUX
dpc-3506	44	8	excluded	exclude	VERB
dpc-3506	44	9	in	in	ADP
dpc-3506	44	10	the	the	DET
dpc-3506	44	11	study	study	NOUN
dpc-3506	44	12	.	.	PUNCT
dpc-3506	45	1	morphea	morphea	ADJ
dpc-3506	45	2	patients	patient	NOUN
dpc-3506	45	3	who	who	PRON
dpc-3506	45	4	were	be	AUX
dpc-3506	45	5	18	18	NUM
dpc-3506	45	6	years	year	NOUN
dpc-3506	45	7	of	of	ADP
dpc-3506	45	8	age	age	NOUN
dpc-3506	45	9	or	or	CCONJ
dpc-3506	45	10	older	old	ADJ
dpc-3506	45	11	were	be	AUX
dpc-3506	45	12	divided	divide	VERB
dpc-3506	45	13	into	into	ADP
dpc-3506	45	14	two	two	NUM
dpc-3506	45	15	categories	category	NOUN
dpc-3506	45	16	:	:	PUNCT
dpc-3506	45	17	aols	aol	NOUN
dpc-3506	45	18	and	and	CCONJ
dpc-3506	45	19	pols	pol	NOUN
dpc-3506	45	20	.	.	PUNCT
dpc-3506	46	1	those	those	PRON
dpc-3506	46	2	with	with	ADP
dpc-3506	46	3	onset	onset	NOUN
dpc-3506	46	4	of	of	ADP
dpc-3506	46	5	morphea	morphea	NOUN
dpc-3506	46	6	before	before	ADP
dpc-3506	46	7	the	the	DET
dpc-3506	46	8	age	age	NOUN
dpc-3506	46	9	of	of	ADP
dpc-3506	46	10	18	18	NUM
dpc-3506	46	11	were	be	AUX
dpc-3506	46	12	considered	consider	VERB
dpc-3506	46	13	as	as	ADP
dpc-3506	46	14	aols	aol	NOUN
dpc-3506	46	15	,	,	PUNCT
dpc-3506	46	16	and	and	CCONJ
dpc-3506	46	17	those	those	PRON
dpc-3506	46	18	with	with	ADP
dpc-3506	46	19	onset	onset	NOUN
dpc-3506	46	20	of	of	ADP
dpc-3506	46	21	morphea	morphea	NOUN
dpc-3506	46	22	after	after	ADP
dpc-3506	46	23	the	the	DET
dpc-3506	46	24	age	age	NOUN
dpc-3506	46	25	of	of	ADP
dpc-3506	46	26	18	18	NUM
dpc-3506	46	27	were	be	AUX
dpc-3506	46	28	considered	consider	VERB
dpc-3506	46	29	as	as	ADP
dpc-3506	46	30	pols	pol	NOUN
dpc-3506	46	31	.	.	PUNCT
dpc-3506	47	1	demographics	demographic	NOUN
dpc-3506	47	2	such	such	ADJ
dpc-3506	47	3	as	as	ADP
dpc-3506	47	4	the	the	DET
dpc-3506	47	5	age	age	NOUN
dpc-3506	47	6	of	of	ADP
dpc-3506	47	7	onset	onset	NOUN
dpc-3506	47	8	of	of	ADP
dpc-3506	47	9	the	the	DET
dpc-3506	47	10	disease	disease	NOUN
dpc-3506	47	11	,	,	PUNCT
dpc-3506	47	12	its	its	PRON
dpc-3506	47	13	duration	duration	NOUN
dpc-3506	47	14	,	,	PUNCT
dpc-3506	47	15	patient	patient	ADJ
dpc-3506	47	16	gender	gender	NOUN
dpc-3506	47	17	,	,	PUNCT
dpc-3506	47	18	the	the	DET
dpc-3506	47	19	clinical	clinical	ADJ
dpc-3506	47	20	type	type	NOUN
dpc-3506	47	21	,	,	PUNCT
dpc-3506	47	22	dermatological	dermatological	ADJ
dpc-3506	47	23	examination	examination	NOUN
dpc-3506	47	24	results	result	NOUN
dpc-3506	47	25	such	such	ADJ
dpc-3506	47	26	as	as	ADP
dpc-3506	47	27	the	the	DET
dpc-3506	47	28	anatomical	anatomical	ADJ
dpc-3506	47	29	region	region	NOUN
dpc-3506	47	30	involved	involve	VERB
dpc-3506	47	31	,	,	PUNCT
dpc-3506	47	32	extracutaneous	extracutaneous	ADJ
dpc-3506	47	33	signs	sign	NOUN
dpc-3506	47	34	,	,	PUNCT
dpc-3506	47	35	accompanying	accompany	VERB
dpc-3506	47	36	systemic	systemic	ADJ
dpc-3506	47	37	findings	finding	NOUN
dpc-3506	47	38	and	and	CCONJ
dpc-3506	47	39	symptoms	symptom	NOUN
dpc-3506	47	40	,	,	PUNCT
dpc-3506	47	41	triggering	trigger	VERB
dpc-3506	47	42	factors	factor	NOUN
dpc-3506	47	43	,	,	PUNCT
dpc-3506	47	44	laboratory	laboratory	NOUN
dpc-3506	47	45	findings	finding	NOUN
dpc-3506	47	46	,	,	PUNCT
dpc-3506	47	47	additional	additional	ADJ
dpc-3506	47	48	comorbid	comorbid	NOUN
dpc-3506	47	49	disease	disease	NOUN
dpc-3506	47	50	,	,	PUNCT
dpc-3506	47	51	history	history	NOUN
dpc-3506	47	52	of	of	ADP
dpc-3506	47	53	autoimmune	autoimmune	ADJ
dpc-3506	47	54	disease	disease	NOUN
dpc-3506	47	55	,	,	PUNCT
dpc-3506	47	56	and	and	CCONJ
dpc-3506	47	57	the	the	DET
dpc-3506	47	58	administered	administer	VERB
dpc-3506	47	59	treatment	treatment	NOUN
dpc-3506	47	60	option	option	NOUN
dpc-3506	47	61	were	be	AUX
dpc-3506	47	62	recorded	record	VERB
dpc-3506	47	63	.	.	PUNCT
dpc-3506	48	1	the	the	DET
dpc-3506	48	2	first	first	ADJ
dpc-3506	48	3	examination	examination	NOUN
dpc-3506	48	4	data	datum	NOUN
dpc-3506	48	5	was	be	AUX
dpc-3506	48	6	used	use	VERB
dpc-3506	48	7	in	in	ADP
dpc-3506	48	8	the	the	DET
dpc-3506	48	9	analysis	analysis	NOUN
dpc-3506	48	10	.	.	PUNCT
dpc-3506	49	1	disease	disease	NOUN
dpc-3506	49	2	subtyping	subtype	VERB
dpc-3506	49	3	was	be	AUX
dpc-3506	49	4	done	do	VERB
dpc-3506	49	5	according	accord	VERB
dpc-3506	49	6	to	to	ADP
dpc-3506	49	7	the	the	DET
dpc-3506	49	8	laxer	laxer	PROPN
dpc-3506	49	9	classification	classification	NOUN
dpc-3506	50	1	[	[	X
dpc-3506	50	2	8	8	NUM
dpc-3506	50	3	]	]	PUNCT
dpc-3506	50	4	.	.	PUNCT
dpc-3506	51	1	anatomical	anatomical	ADJ
dpc-3506	51	2	localization	localization	NOUN
dpc-3506	51	3	was	be	AUX
dpc-3506	51	4	classified	classify	VERB
dpc-3506	51	5	as	as	ADP
dpc-3506	51	6	involving	involve	VERB
dpc-3506	51	7	the	the	DET
dpc-3506	51	8	head	head	NOUN
dpc-3506	51	9	,	,	PUNCT
dpc-3506	51	10	neck	neck	NOUN
dpc-3506	51	11	,	,	PUNCT
dpc-3506	51	12	extremities	extremity	NOUN
dpc-3506	51	13	,	,	PUNCT
dpc-3506	51	14	body	body	NOUN
dpc-3506	51	15	and/or	and/or	CCONJ
dpc-3506	51	16	multiple	multiple	ADJ
dpc-3506	51	17	areas	area	NOUN
dpc-3506	51	18	of	of	ADP
dpc-3506	51	19	involvement	involvement	NOUN
dpc-3506	51	20	.	.	PUNCT
dpc-3506	52	1	the	the	DET
dpc-3506	52	2	presence	presence	NOUN
dpc-3506	52	3	of	of	ADP
dpc-3506	52	4	sclerosis	sclerosis	NOUN
dpc-3506	52	5	(	(	PUNCT
dpc-3506	52	6	skin	skin	NOUN
dpc-3506	52	7	fibrosis	fibrosis	NOUN
dpc-3506	52	8	)	)	PUNCT
dpc-3506	52	9	and	and	CCONJ
dpc-3506	52	10	pigmentation	pigmentation	NOUN
dpc-3506	52	11	on	on	ADP
dpc-3506	52	12	the	the	DET
dpc-3506	52	13	skin	skin	NOUN
dpc-3506	52	14	were	be	AUX
dpc-3506	52	15	examined	examine	VERB
dpc-3506	52	16	.	.	PUNCT
dpc-3506	53	1	statistical	statistical	ADJ
dpc-3506	53	2	analysis	analysis	NOUN
dpc-3506	53	3	spss	spss	PROPN
dpc-3506	53	4	/	/	SYM
dpc-3506	53	5	ibm	ibm	PROPN
dpc-3506	53	6	for	for	ADP
dpc-3506	53	7	windows	window	NOUN
dpc-3506	53	8	21.0	21.0	NUM
dpc-3506	53	9	was	be	AUX
dpc-3506	53	10	used	use	VERB
dpc-3506	53	11	to	to	PART
dpc-3506	53	12	analyze	analyze	VERB
dpc-3506	53	13	the	the	DET
dpc-3506	53	14	data	datum	NOUN
dpc-3506	53	15	.	.	PUNCT
dpc-3506	54	1	the	the	DET
dpc-3506	54	2	sample	sample	NOUN
dpc-3506	54	3	was	be	AUX
dpc-3506	54	4	defined	define	VERB
dpc-3506	54	5	using	use	VERB
dpc-3506	54	6	descriptive	descriptive	ADJ
dpc-3506	54	7	statistics	statistic	NOUN
dpc-3506	54	8	such	such	ADJ
dpc-3506	54	9	as	as	ADP
dpc-3506	54	10	percentage	percentage	NOUN
dpc-3506	54	11	,	,	PUNCT
dpc-3506	54	12	mean	mean	ADJ
dpc-3506	54	13	,	,	PUNCT
dpc-3506	54	14	median	median	ADJ
dpc-3506	54	15	,	,	PUNCT
dpc-3506	54	16	standard	standard	ADJ
dpc-3506	54	17	deviation	deviation	NOUN
dpc-3506	54	18	,	,	PUNCT
dpc-3506	54	19	and	and	CCONJ
dpc-3506	54	20	interquartile	interquartile	ADJ
dpc-3506	54	21	range	range	NOUN
dpc-3506	54	22	(	(	PUNCT
dpc-3506	54	23	iqr	iqr	NOUN
dpc-3506	54	24	)	)	PUNCT
dpc-3506	54	25	.	.	PUNCT
dpc-3506	54	26	  	  	SPACE
dpc-3506	55	1	the	the	DET
dpc-3506	55	2	chi	chi	ADJ
dpc-3506	55	3	-	-	PUNCT
dpc-3506	55	4	square	square	ADJ
dpc-3506	55	5	significance	significance	NOUN
dpc-3506	55	6	test	test	NOUN
dpc-3506	55	7	or	or	CCONJ
dpc-3506	55	8	fisher	fisher	PROPN
dpc-3506	55	9	exact	exact	ADJ
dpc-3506	55	10	test	test	NOUN
dpc-3506	55	11	was	be	AUX
dpc-3506	55	12	used	use	VERB
dpc-3506	55	13	to	to	PART
dpc-3506	55	14	examine	examine	VERB
dpc-3506	55	15	categorical	categorical	ADJ
dpc-3506	55	16	data	datum	NOUN
dpc-3506	55	17	,	,	PUNCT
dpc-3506	55	18	and	and	CCONJ
dpc-3506	55	19	the	the	DET
dpc-3506	55	20	student	student	NOUN
dpc-3506	55	21	t	t	PROPN
dpc-3506	55	22	test	test	NOUN
dpc-3506	55	23	or	or	CCONJ
dpc-3506	55	24	mann	mann	PROPN
dpc-3506	55	25	-	-	PUNCT
dpc-3506	55	26	whitney	whitney	PROPN
dpc-3506	55	27	u	u	PROPN
dpc-3506	55	28	test	test	NOUN
dpc-3506	55	29	was	be	AUX
dpc-3506	55	30	used	use	VERB
dpc-3506	55	31	to	to	PART
dpc-3506	55	32	examine	examine	VERB
dpc-3506	55	33	numerical	numerical	ADJ
dpc-3506	55	34	variables	variable	NOUN
dpc-3506	55	35	.	.	PUNCT
dpc-3506	55	36	 	 	SPACE
dpc-3506	56	1	a	a	DET
dpc-3506	56	2	95	95	NUM
dpc-3506	56	3	%	%	NOUN
dpc-3506	56	4	significance	significance	NOUN
dpc-3506	56	5	level	level	NOUN
dpc-3506	56	6	(	(	PUNCT
dpc-3506	56	7	or	or	CCONJ
dpc-3506	56	8	α=0.05	α=0.05	NOUN
dpc-3506	56	9	error	error	NOUN
dpc-3506	56	10	margin	margin	NOUN
dpc-3506	56	11	)	)	PUNCT
dpc-3506	56	12	was	be	AUX
dpc-3506	56	13	used	use	VERB
dpc-3506	56	14	to	to	PART
dpc-3506	56	15	identify	identify	VERB
dpc-3506	56	16	differences	difference	NOUN
dpc-3506	56	17	in	in	ADP
dpc-3506	56	18	the	the	DET
dpc-3506	56	19	analyses	analysis	NOUN
dpc-3506	56	20	.	.	PUNCT
dpc-3506	57	1	results	result	VERB
dpc-3506	57	2	one	one	NUM
dpc-3506	57	3	hundred	hundred	NUM
dpc-3506	57	4	eighty	eighty	NUM
dpc-3506	57	5	-	-	PUNCT
dpc-3506	57	6	three	three	NUM
dpc-3506	57	7	adult	adult	NOUN
dpc-3506	57	8	patients	patient	NOUN
dpc-3506	57	9	were	be	AUX
dpc-3506	57	10	included	include	VERB
dpc-3506	57	11	in	in	ADP
dpc-3506	57	12	the	the	DET
dpc-3506	57	13	study	study	NOUN
dpc-3506	57	14	.	.	PUNCT
dpc-3506	58	1	the	the	DET
dpc-3506	58	2	female	female	ADJ
dpc-3506	58	3	/	/	SYM
dpc-3506	58	4	male	male	NOUN
dpc-3506	58	5	ratio	ratio	NOUN
dpc-3506	58	6	was	be	AUX
dpc-3506	58	7	5.1:1	5.1:1	NUM
dpc-3506	58	8	.	.	PUNCT
dpc-3506	59	1	the	the	DET
dpc-3506	59	2	demographic	demographic	ADJ
dpc-3506	59	3	data	datum	NOUN
dpc-3506	59	4	of	of	ADP
dpc-3506	59	5	the	the	DET
dpc-3506	59	6	patients	patient	NOUN
dpc-3506	59	7	are	be	AUX
dpc-3506	59	8	shown	show	VERB
dpc-3506	59	9	in	in	ADP
dpc-3506	59	10	table	table	NOUN
dpc-3506	59	11	1	1	NUM
dpc-3506	59	12	.	.	PUNCT
dpc-3506	60	1	the	the	DET
dpc-3506	60	2	most	most	ADV
dpc-3506	60	3	common	common	ADJ
dpc-3506	60	4	type	type	NOUN
dpc-3506	60	5	of	of	ADP
dpc-3506	60	6	morphea	morphea	NOUN
dpc-3506	60	7	was	be	AUX
dpc-3506	60	8	the	the	DET
dpc-3506	60	9	plaque	plaque	NOUN
dpc-3506	60	10	type	type	NOUN
dpc-3506	60	11	(	(	PUNCT
dpc-3506	60	12	figures	figure	NOUN
dpc-3506	60	13	1	1	NUM
dpc-3506	60	14	-	-	SYM
dpc-3506	60	15	3	3	NUM
dpc-3506	60	16	)	)	PUNCT
dpc-3506	60	17	.	.	PUNCT
dpc-3506	61	1	morphea	morphea	ADJ
dpc-3506	61	2	types	type	NOUN
dpc-3506	61	3	were	be	AUX
dpc-3506	61	4	similar	similar	ADJ
dpc-3506	61	5	in	in	ADP
dpc-3506	61	6	pols	pol	NOUN
dpc-3506	61	7	and	and	CCONJ
dpc-3506	61	8	aols	aol	NOUN
dpc-3506	61	9	.	.	PUNCT
dpc-3506	62	1	body	body	NOUN
dpc-3506	62	2	and	and	CCONJ
dpc-3506	62	3	extremities	extremity	NOUN
dpc-3506	62	4	were	be	AUX
dpc-3506	62	5	the	the	DET
dpc-3506	62	6	most	most	ADV
dpc-3506	62	7	frequently	frequently	ADV
dpc-3506	62	8	affected	affect	VERB
dpc-3506	62	9	body	body	NOUN
dpc-3506	62	10	sites	site	NOUN
dpc-3506	62	11	.	.	PUNCT
dpc-3506	63	1	head	head	NOUN
dpc-3506	63	2	and	and	CCONJ
dpc-3506	63	3	neck	neck	NOUN
dpc-3506	63	4	involvement	involvement	NOUN
dpc-3506	63	5	was	be	AUX
dpc-3506	63	6	more	more	ADV
dpc-3506	63	7	frequent	frequent	ADJ
dpc-3506	63	8	in	in	ADP
dpc-3506	63	9	patients	patient	NOUN
dpc-3506	63	10	with	with	ADP
dpc-3506	63	11	pols	pol	NOUN
dpc-3506	63	12	whereas	whereas	SCONJ
dpc-3506	63	13	,	,	PUNCT
dpc-3506	63	14	breast	breast	NOUN
dpc-3506	63	15	involvement	involvement	NOUN
dpc-3506	63	16	was	be	AUX
dpc-3506	63	17	more	more	ADV
dpc-3506	63	18	frequent	frequent	ADJ
dpc-3506	63	19	in	in	ADP
dpc-3506	63	20	aols	aol	NOUN
dpc-3506	63	21	patients	patient	NOUN
dpc-3506	63	22	.	.	PUNCT
dpc-3506	64	1	although	although	SCONJ
dpc-3506	64	2	arthralgia	arthralgia	NOUN
dpc-3506	64	3	was	be	AUX
dpc-3506	64	4	more	more	ADV
dpc-3506	64	5	frequent	frequent	ADJ
dpc-3506	64	6	among	among	ADP
dpc-3506	64	7	aols	aol	NOUN
dpc-3506	64	8	patients	patient	NOUN
dpc-3506	64	9	.	.	PUNCT
dpc-3506	65	1	laboratory	laboratory	NOUN
dpc-3506	65	2	findings	finding	NOUN
dpc-3506	65	3	,	,	PUNCT
dpc-3506	65	4	systemic	systemic	ADJ
dpc-3506	65	5	diseases	disease	NOUN
dpc-3506	65	6	and	and	CCONJ
dpc-3506	65	7	laboratory	laboratory	NOUN
dpc-3506	65	8	findings	finding	NOUN
dpc-3506	65	9	were	be	AUX
dpc-3506	65	10	similar	similar	ADJ
dpc-3506	65	11	among	among	ADP
dpc-3506	65	12	aols	aol	NOUN
dpc-3506	65	13	and	and	CCONJ
dpc-3506	65	14	pols	pol	NOUN
dpc-3506	65	15	patients	patient	NOUN
dpc-3506	65	16	.	.	PUNCT
dpc-3506	66	1	although	although	SCONJ
dpc-3506	66	2	,	,	PUNCT
dpc-3506	66	3	anti	anti	ADJ
dpc-3506	66	4	-	-	ADJ
dpc-3506	66	5	dsdna	dsdna	ADJ
dpc-3506	66	6	positivity	positivity	NOUN
dpc-3506	66	7	and	and	CCONJ
dpc-3506	66	8	systemic	systemic	ADJ
dpc-3506	66	9	steroid	steroid	NOUN
dpc-3506	66	10	treatment	treatment	NOUN
dpc-3506	66	11	frequencies	frequency	NOUN
dpc-3506	66	12	were	be	AUX
dpc-3506	66	13	higher	high	ADJ
dpc-3506	66	14	in	in	ADP
dpc-3506	66	15	aols	aols	NOUN
dpc-3506	66	16	patients	patient	NOUN
dpc-3506	66	17	the	the	DET
dpc-3506	66	18	results	result	NOUN
dpc-3506	66	19	did	do	AUX
dpc-3506	66	20	not	not	PART
dpc-3506	66	21	reach	reach	VERB
dpc-3506	66	22	statistically	statistically	ADV
dpc-3506	66	23	significant	significant	ADJ
dpc-3506	66	24	levels	level	NOUN
dpc-3506	66	25	.	.	PUNCT
dpc-3506	67	1	the	the	DET
dpc-3506	67	2	evaluation	evaluation	NOUN
dpc-3506	67	3	of	of	ADP
dpc-3506	67	4	demographical	demographical	ADJ
dpc-3506	67	5	,	,	PUNCT
dpc-3506	67	6	clinical	clinical	ADJ
dpc-3506	67	7	,	,	PUNCT
dpc-3506	67	8	laboratory	laboratory	NOUN
dpc-3506	67	9	findings	finding	NOUN
dpc-3506	67	10	,	,	PUNCT
dpc-3506	67	11	and	and	CCONJ
dpc-3506	67	12	treatment	treatment	NOUN
dpc-3506	67	13	based	base	VERB
dpc-3506	67	14	on	on	ADP
dpc-3506	67	15	the	the	DET
dpc-3506	67	16	type	type	NOUN
dpc-3506	67	17	of	of	ADP
dpc-3506	67	18	morphea	morphea	ADJ
dpc-3506	67	19	sclerosis	sclerosis	NOUN
dpc-3506	67	20	(	(	PUNCT
dpc-3506	67	21	tissue	tissue	NOUN
dpc-3506	67	22	fibrosis	fibrosis	NOUN
dpc-3506	67	23	)	)	PUNCT
dpc-3506	67	24	was	be	AUX
dpc-3506	67	25	significantly	significantly	ADV
dpc-3506	67	26	more	more	ADV
dpc-3506	67	27	common	common	ADJ
dpc-3506	67	28	in	in	ADP
dpc-3506	67	29	patients	patient	NOUN
dpc-3506	67	30	with	with	ADP
dpc-3506	67	31	generalized	generalized	ADJ
dpc-3506	67	32	morphea	morphea	NOUN
dpc-3506	67	33	(	(	PUNCT
dpc-3506	67	34	30.6	30.6	NUM
dpc-3506	67	35	%	%	NOUN
dpc-3506	67	36	,	,	PUNCT
dpc-3506	67	37	p	p	NOUN
dpc-3506	67	38	=	=	NOUN
dpc-3506	67	39	0.001	0.001	NUM
dpc-3506	67	40	)	)	PUNCT
dpc-3506	67	41	.	.	PUNCT
dpc-3506	68	1	in	in	ADP
dpc-3506	68	2	generalized	generalized	ADJ
dpc-3506	68	3	morphea	morphea	NOUN
dpc-3506	68	4	,	,	PUNCT
dpc-3506	68	5	topical	topical	ADJ
dpc-3506	68	6	treatments	treatment	NOUN
dpc-3506	68	7	were	be	AUX
dpc-3506	68	8	significantly	significantly	ADV
dpc-3506	68	9	less	less	ADV
dpc-3506	68	10	common	common	ADJ
dpc-3506	68	11	,	,	PUNCT
dpc-3506	68	12	whereas	whereas	SCONJ
dpc-3506	68	13	methotrexate	methotrexate	NOUN
dpc-3506	68	14	(	(	PUNCT
dpc-3506	68	15	mtx	mtx	NOUN
dpc-3506	68	16	)	)	PUNCT
dpc-3506	68	17	and	and	CCONJ
dpc-3506	68	18	systemic	systemic	ADJ
dpc-3506	68	19	steroid	steroid	NOUN
dpc-3506	68	20	treatments	treatment	NOUN
dpc-3506	68	21	were	be	AUX
dpc-3506	68	22	used	use	VERB
dpc-3506	68	23	significantly	significantly	ADV
dpc-3506	68	24	more	more	ADV
dpc-3506	68	25	(	(	PUNCT
dpc-3506	68	26	p	p	NOUN
dpc-3506	68	27	values	value	NOUN
dpc-3506	68	28	<	<	X
dpc-3506	68	29	0.001	0.001	NUM
dpc-3506	68	30	,	,	PUNCT
dpc-3506	68	31	<	<	NOUN
dpc-3506	68	32	0.001	0.001	NUM
dpc-3506	68	33	,	,	PUNCT
dpc-3506	68	34	and	and	CCONJ
dpc-3506	68	35	0.028	0.028	NUM
dpc-3506	68	36	,	,	PUNCT
dpc-3506	68	37	respectively	respectively	ADV
dpc-3506	68	38	)	)	PUNCT
dpc-3506	68	39	.	.	PUNCT
dpc-3506	69	1	patients	patient	NOUN
dpc-3506	69	2	with	with	ADP
dpc-3506	69	3	original	original	ADJ
dpc-3506	69	4	article	article	NOUN
dpc-3506	69	5	|	|	ADV
dpc-3506	69	6	dermatol	dermatol	ADJ
dpc-3506	69	7	pract	pract	NOUN
dpc-3506	69	8	concept	concept	NOUN
dpc-3506	69	9	.	.	PUNCT
dpc-3506	70	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	70	2	3	3	NUM
dpc-3506	70	3	generalized	generalized	ADJ
dpc-3506	70	4	morphea	morphea	NOUN
dpc-3506	70	5	had	have	VERB
dpc-3506	70	6	significantly	significantly	ADV
dpc-3506	70	7	higher	high	ADJ
dpc-3506	70	8	platelet	platelet	NOUN
dpc-3506	70	9	levels	level	NOUN
dpc-3506	70	10	(	(	PUNCT
dpc-3506	70	11	p	p	X
dpc-3506	70	12	=	=	NOUN
dpc-3506	70	13	0.010	0.010	NUM
dpc-3506	70	14	)	)	PUNCT
dpc-3506	70	15	,	,	PUNCT
dpc-3506	70	16	neutrophil	neutrophil	ADJ
dpc-3506	70	17	/	/	SYM
dpc-3506	70	18	lymphocyte	lymphocyte	ADJ
dpc-3506	70	19	ratios	ratio	NOUN
dpc-3506	70	20	(	(	PUNCT
dpc-3506	70	21	nlr	nlr	PROPN
dpc-3506	70	22	)	)	PUNCT
dpc-3506	70	23	(	(	PUNCT
dpc-3506	70	24	p	p	X
dpc-3506	70	25	=	=	NOUN
dpc-3506	70	26	0.029	0.029	NUM
dpc-3506	70	27	)	)	PUNCT
dpc-3506	70	28	and	and	CCONJ
dpc-3506	70	29	age	age	NOUN
dpc-3506	70	30	of	of	ADP
dpc-3506	70	31	onset	onset	NOUN
dpc-3506	70	32	(	(	PUNCT
dpc-3506	70	33	p	p	X
dpc-3506	70	34	=	=	NOUN
dpc-3506	70	35	0.042	0.042	NUM
dpc-3506	70	36	)	)	PUNCT
dpc-3506	70	37	.	.	PUNCT
dpc-3506	71	1	patients	patient	NOUN
dpc-3506	71	2	with	with	ADP
dpc-3506	71	3	linear	linear	PROPN
dpc-3506	71	4	morphea	morphea	PROPN
dpc-3506	71	5	had	have	VERB
dpc-3506	71	6	a	a	DET
dpc-3506	71	7	significantly	significantly	ADV
dpc-3506	71	8	lower	low	ADJ
dpc-3506	71	9	mean	mean	ADJ
dpc-3506	71	10	age	age	NOUN
dpc-3506	71	11	and	and	CCONJ
dpc-3506	71	12	age	age	NOUN
dpc-3506	71	13	of	of	ADP
dpc-3506	71	14	onset	onset	NOUN
dpc-3506	71	15	(	(	PUNCT
dpc-3506	71	16	p	p	X
dpc-3506	71	17	=	=	PUNCT
dpc-3506	71	18	0.025	0.025	NUM
dpc-3506	71	19	and	and	CCONJ
dpc-3506	71	20	p	p	NOUN
dpc-3506	71	21	=	=	NOUN
dpc-3506	71	22	0.005	0.005	NUM
dpc-3506	71	23	)	)	PUNCT
dpc-3506	71	24	.	.	PUNCT
dpc-3506	72	1	patients	patient	NOUN
dpc-3506	72	2	with	with	ADP
dpc-3506	72	3	linear	linear	PROPN
dpc-3506	72	4	morphea	morphea	PROPN
dpc-3506	72	5	had	have	VERB
dpc-3506	72	6	a	a	DET
dpc-3506	72	7	significantly	significantly	ADV
dpc-3506	72	8	longer	long	ADJ
dpc-3506	72	9	duration	duration	NOUN
dpc-3506	72	10	of	of	ADP
dpc-3506	72	11	disease	disease	NOUN
dpc-3506	72	12	(	(	PUNCT
dpc-3506	72	13	p	p	X
dpc-3506	72	14	=	=	NOUN
dpc-3506	72	15	0.016	0.016	NUM
dpc-3506	72	16	)	)	PUNCT
dpc-3506	72	17	.	.	PUNCT
dpc-3506	73	1	at	at	ADV
dpc-3506	73	2	least	least	ADV
dpc-3506	73	3	one	one	NUM
dpc-3506	73	4	laboratory	laboratory	NOUN
dpc-3506	73	5	finding	finding	NOUN
dpc-3506	73	6	was	be	AUX
dpc-3506	73	7	abnormal	abnormal	ADJ
dpc-3506	73	8	in	in	ADP
dpc-3506	73	9	21	21	NUM
dpc-3506	73	10	%	%	NOUN
dpc-3506	73	11	of	of	ADP
dpc-3506	73	12	the	the	DET
dpc-3506	73	13	patients	patient	NOUN
dpc-3506	73	14	with	with	ADP
dpc-3506	73	15	linear	linear	PROPN
dpc-3506	73	16	morphea	morphea	PROPN
dpc-3506	73	17	(	(	PUNCT
dpc-3506	73	18	p	p	X
dpc-3506	73	19	 	 	SPACE
dpc-3506	73	20	=	=	NOUN
dpc-3506	73	21	0.024	0.024	NUM
dpc-3506	73	22	)	)	PUNCT
dpc-3506	73	23	.	.	PUNCT
dpc-3506	74	1	in	in	ADP
dpc-3506	74	2	non	non	ADJ
dpc-3506	74	3	-	-	ADJ
dpc-3506	74	4	linear	linear	ADJ
dpc-3506	74	5	morphea	morphea	NOUN
dpc-3506	74	6	,	,	PUNCT
dpc-3506	74	7	this	this	DET
dpc-3506	74	8	rate	rate	NOUN
dpc-3506	74	9	was	be	AUX
dpc-3506	74	10	8.1	8.1	NUM
dpc-3506	74	11	%	%	NOUN
dpc-3506	74	12	.	.	PUNCT
dpc-3506	75	1	eighty	eighty	NUM
dpc-3506	75	2	percent	percent	NOUN
dpc-3506	75	3	of	of	ADP
dpc-3506	75	4	patients	patient	NOUN
dpc-3506	75	5	with	with	ADP
dpc-3506	75	6	plaque	plaque	NOUN
dpc-3506	75	7	-	-	PUNCT
dpc-3506	75	8	type	type	NOUN
dpc-3506	75	9	morphea	morphea	NOUN
dpc-3506	75	10	were	be	AUX
dpc-3506	75	11	female	female	ADJ
dpc-3506	75	12	while	while	SCONJ
dpc-3506	75	13	91.5	91.5	NUM
dpc-3506	75	14	%	%	NOUN
dpc-3506	75	15	of	of	ADP
dpc-3506	75	16	the	the	DET
dpc-3506	75	17	patients	patient	NOUN
dpc-3506	75	18	with	with	ADP
dpc-3506	75	19	non	non	ADJ
dpc-3506	75	20	-	-	ADJ
dpc-3506	75	21	plaque	plaque	ADJ
dpc-3506	75	22	morphea	morphea	NOUN
dpc-3506	75	23	were	be	AUX
dpc-3506	75	24	female	female	ADJ
dpc-3506	75	25	.	.	PUNCT
dpc-3506	76	1	number	number	NOUN
dpc-3506	76	2	of	of	ADP
dpc-3506	76	3	males	male	NOUN
dpc-3506	76	4	was	be	AUX
dpc-3506	76	5	significantly	significantly	ADV
dpc-3506	76	6	higher	high	ADJ
dpc-3506	76	7	in	in	ADP
dpc-3506	76	8	plaque	plaque	NOUN
dpc-3506	76	9	-	-	PUNCT
dpc-3506	76	10	type	type	NOUN
dpc-3506	76	11	morphea	morphea	NOUN
dpc-3506	76	12	(	(	PUNCT
dpc-3506	76	13	p	p	X
dpc-3506	76	14	=	=	PROPN
dpc-3506	76	15	0.046	0.046	NUM
dpc-3506	76	16	)	)	PUNCT
dpc-3506	76	17	.	.	PUNCT
dpc-3506	77	1	sclerosis	sclerosis	NOUN
dpc-3506	77	2	was	be	AUX
dpc-3506	77	3	found	find	VERB
dpc-3506	77	4	in	in	ADP
dpc-3506	77	5	28.2	28.2	NUM
dpc-3506	77	6	%	%	NOUN
dpc-3506	77	7	of	of	ADP
dpc-3506	77	8	patients	patient	NOUN
dpc-3506	77	9	with	with	ADP
dpc-3506	77	10	plaque	plaque	NOUN
dpc-3506	77	11	-	-	PUNCT
dpc-3506	77	12	type	type	NOUN
dpc-3506	77	13	morphea	morphea	NOUN
dpc-3506	77	14	and	and	CCONJ
dpc-3506	77	15	in	in	ADP
dpc-3506	77	16	45.8	45.8	NUM
dpc-3506	77	17	%	%	NOUN
dpc-3506	77	18	of	of	ADP
dpc-3506	77	19	patients	patient	NOUN
dpc-3506	77	20	with	with	ADP
dpc-3506	77	21	non	non	ADJ
dpc-3506	77	22	-	-	ADJ
dpc-3506	77	23	plaque	plaque	ADJ
dpc-3506	77	24	morphea	morphea	NOUN
dpc-3506	77	25	.	.	PUNCT
dpc-3506	78	1	in	in	ADP
dpc-3506	78	2	plaque	plaque	NOUN
dpc-3506	78	3	-	-	PUNCT
dpc-3506	78	4	type	type	NOUN
dpc-3506	78	5	morphea	morphea	NOUN
dpc-3506	78	6	,	,	PUNCT
dpc-3506	78	7	sclerosis	sclerosis	NOUN
dpc-3506	78	8	was	be	AUX
dpc-3506	78	9	less	less	ADV
dpc-3506	78	10	prevalent	prevalent	ADJ
dpc-3506	78	11	(	(	PUNCT
dpc-3506	78	12	p	p	NOUN
dpc-3506	78	13	=	=	NOUN
dpc-3506	78	14	0.019	0.019	NUM
dpc-3506	78	15	)	)	PUNCT
dpc-3506	78	16	,	,	PUNCT
dpc-3506	78	17	and	and	CCONJ
dpc-3506	78	18	additional	additional	ADJ
dpc-3506	78	19	skin	skin	NOUN
dpc-3506	78	20	diseases	disease	NOUN
dpc-3506	78	21	were	be	AUX
dpc-3506	78	22	more	more	ADV
dpc-3506	78	23	prevalent	prevalent	ADJ
dpc-3506	78	24	(	(	PUNCT
dpc-3506	78	25	p	p	X
dpc-3506	78	26	=	=	NOUN
dpc-3506	78	27	0.049	0.049	NUM
dpc-3506	78	28	)	)	PUNCT
dpc-3506	78	29	.	.	PUNCT
dpc-3506	79	1	patients	patient	NOUN
dpc-3506	79	2	with	with	ADP
dpc-3506	79	3	plaque	plaque	NOUN
dpc-3506	79	4	-	-	PUNCT
dpc-3506	79	5	type	type	NOUN
dpc-3506	79	6	morphea	morphea	NOUN
dpc-3506	79	7	received	receive	VERB
dpc-3506	79	8	significantly	significantly	ADV
dpc-3506	79	9	less	less	ADJ
dpc-3506	79	10	mtx	mtx	NOUN
dpc-3506	79	11	therapy	therapy	NOUN
dpc-3506	79	12	and	and	CCONJ
dpc-3506	79	13	significantly	significantly	ADV
dpc-3506	79	14	more	more	ADV
dpc-3506	79	15	topical	topical	ADJ
dpc-3506	79	16	treatments	treatment	NOUN
dpc-3506	79	17	(	(	PUNCT
dpc-3506	79	18	p	p	X
dpc-3506	79	19	 	 	SPACE
dpc-3506	79	20	values	value	NOUN
dpc-3506	79	21	0.004	0.004	NUM
dpc-3506	79	22	and	and	CCONJ
dpc-3506	79	23	<	<	X
dpc-3506	79	24	0.001	0.001	NUM
dpc-3506	79	25	,	,	PUNCT
dpc-3506	79	26	respectively	respectively	ADV
dpc-3506	79	27	)	)	PUNCT
dpc-3506	79	28	.	.	PUNCT
dpc-3506	80	1	the	the	DET
dpc-3506	80	2	evaluation	evaluation	NOUN
dpc-3506	80	3	of	of	ADP
dpc-3506	80	4	demographic	demographic	ADJ
dpc-3506	80	5	,	,	PUNCT
dpc-3506	80	6	clinical	clinical	ADJ
dpc-3506	80	7	,	,	PUNCT
dpc-3506	80	8	and	and	CCONJ
dpc-3506	80	9	 	 	SPACE
dpc-3506	80	10	laboratory	laboratory	NOUN
dpc-3506	80	11	findings	finding	NOUN
dpc-3506	80	12	based	base	VERB
dpc-3506	80	13	on	on	ADP
dpc-3506	80	14	involved	involved	ADJ
dpc-3506	80	15	sites	site	NOUN
dpc-3506	80	16	pediatric	pediatric	ADJ
dpc-3506	80	17	onset	onset	NOUN
dpc-3506	80	18	was	be	AUX
dpc-3506	80	19	more	more	ADV
dpc-3506	80	20	frequent	frequent	ADJ
dpc-3506	80	21	in	in	ADP
dpc-3506	80	22	patients	patient	NOUN
dpc-3506	80	23	with	with	ADP
dpc-3506	80	24	head	head	NOUN
dpc-3506	80	25	and	and	CCONJ
dpc-3506	80	26	neck	neck	NOUN
dpc-3506	80	27	involvement	involvement	NOUN
dpc-3506	80	28	(	(	PUNCT
dpc-3506	80	29	figures	figure	NOUN
dpc-3506	80	30	3	3	NUM
dpc-3506	80	31	and	and	CCONJ
dpc-3506	80	32	4	4	NUM
dpc-3506	80	33	)	)	PUNCT
dpc-3506	80	34	.	.	PUNCT
dpc-3506	81	1	the	the	DET
dpc-3506	81	2	mean	mean	ADJ
dpc-3506	81	3	age	age	NOUN
dpc-3506	81	4	and	and	CCONJ
dpc-3506	81	5	age	age	NOUN
dpc-3506	81	6	of	of	ADP
dpc-3506	81	7	onset	onset	NOUN
dpc-3506	81	8	of	of	ADP
dpc-3506	81	9	the	the	DET
dpc-3506	81	10	disease	disease	NOUN
dpc-3506	81	11	in	in	ADP
dpc-3506	81	12	patients	patient	NOUN
dpc-3506	81	13	with	with	ADP
dpc-3506	81	14	head	head	NOUN
dpc-3506	81	15	and	and	CCONJ
dpc-3506	81	16	neck	neck	NOUN
dpc-3506	81	17	involvement	involvement	NOUN
dpc-3506	81	18	were	be	AUX
dpc-3506	81	19	significantly	significantly	ADV
dpc-3506	81	20	lower	low	ADJ
dpc-3506	81	21	(	(	PUNCT
dpc-3506	81	22	p	p	X
dpc-3506	81	23	=	=	NOUN
dpc-3506	81	24	0.003	0.003	NUM
dpc-3506	81	25	and	and	CCONJ
dpc-3506	81	26	p	p	X
dpc-3506	81	27	<	<	X
dpc-3506	81	28	0.001	0.001	NUM
dpc-3506	81	29	)	)	PUNCT
dpc-3506	81	30	.	.	PUNCT
dpc-3506	82	1	patients	patient	NOUN
dpc-3506	82	2	with	with	ADP
dpc-3506	82	3	body	body	NOUN
dpc-3506	82	4	involvement	involvement	NOUN
dpc-3506	82	5	used	use	VERB
dpc-3506	82	6	mtx	mtx	NOUN
dpc-3506	82	7	and	and	CCONJ
dpc-3506	82	8	systemic	systemic	ADJ
dpc-3506	82	9	steroids	steroid	NOUN
dpc-3506	82	10	at	at	ADP
dpc-3506	82	11	a	a	DET
dpc-3506	82	12	higher	high	ADJ
dpc-3506	82	13	rate	rate	NOUN
dpc-3506	82	14	(	(	PUNCT
dpc-3506	82	15	p	p	NOUN
dpc-3506	82	16	=	=	NOUN
dpc-3506	82	17	0.024	0.024	NUM
dpc-3506	82	18	)	)	PUNCT
dpc-3506	82	19	.	.	PUNCT
dpc-3506	83	1	their	their	PRON
dpc-3506	83	2	mean	mean	ADJ
dpc-3506	83	3	age	age	NOUN
dpc-3506	83	4	and	and	CCONJ
dpc-3506	83	5	disease	disease	NOUN
dpc-3506	83	6	age	age	NOUN
dpc-3506	83	7	of	of	ADP
dpc-3506	83	8	onset	onset	NOUN
dpc-3506	83	9	were	be	AUX
dpc-3506	83	10	significantly	significantly	ADV
dpc-3506	83	11	higher	high	ADJ
dpc-3506	83	12	(	(	PUNCT
dpc-3506	83	13	both	both	CCONJ
dpc-3506	83	14	p	p	X
dpc-3506	83	15	=	=	NOUN
dpc-3506	83	16	0.005	0.005	NUM
dpc-3506	83	17	)	)	PUNCT
dpc-3506	83	18	and	and	CCONJ
dpc-3506	83	19	platelet	platelet	NOUN
dpc-3506	83	20	levels	level	NOUN
dpc-3506	83	21	were	be	AUX
dpc-3506	83	22	significantly	significantly	ADV
dpc-3506	83	23	higher	high	ADJ
dpc-3506	83	24	(	(	PUNCT
dpc-3506	83	25	p	p	X
dpc-3506	83	26	=	=	NOUN
dpc-3506	83	27	0.017	0.017	NUM
dpc-3506	83	28	)	)	PUNCT
dpc-3506	83	29	.	.	PUNCT
dpc-3506	84	1	table	table	NOUN
dpc-3506	84	2	1	1	NUM
dpc-3506	84	3	.	.	PUNCT
dpc-3506	85	1	general	general	ADJ
dpc-3506	85	2	clinical	clinical	ADJ
dpc-3506	85	3	,	,	PUNCT
dpc-3506	85	4	demographic	demographic	ADJ
dpc-3506	85	5	characteristics	characteristic	NOUN
dpc-3506	85	6	of	of	ADP
dpc-3506	85	7	all	all	DET
dpc-3506	85	8	patients	patient	NOUN
dpc-3506	85	9	and	and	CCONJ
dpc-3506	85	10	comparison	comparison	NOUN
dpc-3506	85	11	of	of	ADP
dpc-3506	85	12	pediatric	pediatric	ADJ
dpc-3506	85	13	and	and	CCONJ
dpc-3506	85	14	 	 	SPACE
dpc-3506	85	15	adult	adult	NOUN
dpc-3506	85	16	-	-	PUNCT
dpc-3506	85	17	onset	onset	NOUN
dpc-3506	85	18	morphea	morphea	NOUN
dpc-3506	85	19	patients	patient	NOUN
dpc-3506	85	20	.	.	PUNCT
dpc-3506	86	1	characteristics	characteristic	NOUN
dpc-3506	86	2	total	total	ADJ
dpc-3506	86	3	patient	patient	NOUN
dpc-3506	86	4	n	n	PROPN
dpc-3506	86	5	=	=	SYM
dpc-3506	86	6	183	183	NUM
dpc-3506	86	7	(	(	PUNCT
dpc-3506	86	8	100	100	NUM
dpc-3506	86	9	%	%	NOUN
dpc-3506	86	10	)	)	PUNCT
dpc-3506	86	11	adult	adult	NOUN
dpc-3506	86	12	-	-	PUNCT
dpc-3506	86	13	onset	onset	NOUN
dpc-3506	86	14	n	n	PROPN
dpc-3506	86	15	=	=	SYM
dpc-3506	86	16	142	142	NUM
dpc-3506	86	17	(	(	PUNCT
dpc-3506	86	18	77.6	77.6	NUM
dpc-3506	86	19	%	%	NOUN
dpc-3506	86	20	)	)	PUNCT
dpc-3506	86	21	pediatric	pediatric	NOUN
dpc-3506	86	22	-	-	PUNCT
dpc-3506	86	23	onset	onset	NOUN
dpc-3506	86	24	n	n	NOUN
dpc-3506	86	25	=	=	SYM
dpc-3506	86	26	41	41	NUM
dpc-3506	86	27	(	(	PUNCT
dpc-3506	86	28	22.4	22.4	NUM
dpc-3506	86	29	%	%	NOUN
dpc-3506	86	30	)	)	PUNCT
dpc-3506	87	1	p	p	DET
dpc-3506	87	2	gender	gender	NOUN
dpc-3506	87	3	female	female	ADJ
dpc-3506	87	4	male	male	NOUN
dpc-3506	87	5	153	153	NUM
dpc-3506	87	6	(	(	PUNCT
dpc-3506	87	7	83.6	83.6	NUM
dpc-3506	87	8	)	)	PUNCT
dpc-3506	87	9	30	30	NUM
dpc-3506	87	10	(	(	PUNCT
dpc-3506	87	11	16.4	16.4	NUM
dpc-3506	87	12	)	)	PUNCT
dpc-3506	87	13	120	120	NUM
dpc-3506	87	14	(	(	PUNCT
dpc-3506	87	15	84.5	84.5	NUM
dpc-3506	87	16	)	)	PUNCT
dpc-3506	87	17	22	22	NUM
dpc-3506	87	18	(	(	PUNCT
dpc-3506	87	19	15.5	15.5	NUM
dpc-3506	87	20	)	)	PUNCT
dpc-3506	87	21	33	33	NUM
dpc-3506	87	22	(	(	PUNCT
dpc-3506	87	23	80.5	80.5	NUM
dpc-3506	87	24	)	)	SYM
dpc-3506	87	25	8	8	NUM
dpc-3506	87	26	(	(	PUNCT
dpc-3506	87	27	19.5	19.5	NUM
dpc-3506	87	28	)	)	PUNCT
dpc-3506	87	29	0.54	0.54	NUM
dpc-3506	87	30	age	age	NOUN
dpc-3506	87	31	-*years	-*year	NOUN
dpc-3506	87	32	(	(	PUNCT
dpc-3506	87	33	18	18	NUM
dpc-3506	87	34	-	-	SYM
dpc-3506	87	35	82)a	82)a	NUM
dpc-3506	87	36	41.1	41.1	NUM
dpc-3506	87	37	(	(	PUNCT
dpc-3506	87	38	16.9	16.9	NUM
dpc-3506	87	39	)	)	PUNCT
dpc-3506	87	40	45.5	45.5	NUM
dpc-3506	87	41	(	(	PUNCT
dpc-3506	87	42	34	34	NUM
dpc-3506	87	43	-	-	SYM
dpc-3506	87	44	59	59	NUM
dpc-3506	87	45	)	)	PUNCT
dpc-3506	87	46	21	21	NUM
dpc-3506	87	47	(	(	PUNCT
dpc-3506	87	48	15.5	15.5	NUM
dpc-3506	87	49	-	-	SYM
dpc-3506	87	50	28	28	NUM
dpc-3506	87	51	)	)	PUNCT
dpc-3506	87	52	<	<	X
dpc-3506	87	53	0.001	0.001	NUM
dpc-3506	87	54	age	age	NOUN
dpc-3506	87	55	of	of	ADP
dpc-3506	87	56	onset	onset	ADJ
dpc-3506	87	57	yearsb	yearsb	PROPN
dpc-3506	87	58	36	36	NUM
dpc-3506	87	59	(	(	PUNCT
dpc-3506	87	60	19.5	19.5	NUM
dpc-3506	87	61	-	-	SYM
dpc-3506	87	62	55	55	NUM
dpc-3506	87	63	)	)	PUNCT
dpc-3506	87	64	43	43	NUM
dpc-3506	87	65	(	(	PUNCT
dpc-3506	87	66	29.5	29.5	NUM
dpc-3506	87	67	-	-	SYM
dpc-3506	87	68	57	57	NUM
dpc-3506	87	69	)	)	PUNCT
dpc-3506	87	70	13.5	13.5	NUM
dpc-3506	87	71	(	(	PUNCT
dpc-3506	87	72	12	12	NUM
dpc-3506	87	73	-	-	SYM
dpc-3506	87	74	17	17	NUM
dpc-3506	87	75	)	)	PUNCT
dpc-3506	87	76	<	<	X
dpc-3506	87	77	0.001	0.001	NUM
dpc-3506	87	78	duration	duration	NOUN
dpc-3506	87	79	of	of	ADP
dpc-3506	87	80	the	the	DET
dpc-3506	87	81	disease	disease	NOUN
dpc-3506	87	82	yearsb	yearsb	NOUN
dpc-3506	87	83	2	2	NUM
dpc-3506	87	84	(	(	PUNCT
dpc-3506	87	85	1	1	NUM
dpc-3506	87	86	-	-	SYM
dpc-3506	87	87	6	6	NUM
dpc-3506	87	88	)	)	PUNCT
dpc-3506	87	89	1	1	NUM
dpc-3506	87	90	(	(	PUNCT
dpc-3506	87	91	1	1	NUM
dpc-3506	87	92	-	-	SYM
dpc-3506	87	93	2	2	NUM
dpc-3506	87	94	)	)	PUNCT
dpc-3506	87	95	8	8	NUM
dpc-3506	87	96	(	(	PUNCT
dpc-3506	87	97	5.3	5.3	NUM
dpc-3506	87	98	-	-	SYM
dpc-3506	87	99	12.8	12.8	NUM
dpc-3506	87	100	)	)	PUNCT
dpc-3506	87	101	<	<	X
dpc-3506	87	102	0.001	0.001	NUM
dpc-3506	87	103	morphea	morphea	ADJ
dpc-3506	87	104	type	type	NOUN
dpc-3506	87	105	plaque	plaque	NOUN
dpc-3506	87	106	linear	linear	NOUN
dpc-3506	87	107	generalized	generalize	VERB
dpc-3506	87	108	mixed	mixed	ADJ
dpc-3506	87	109	124	124	NUM
dpc-3506	87	110	(	(	PUNCT
dpc-3506	87	111	67.8	67.8	NUM
dpc-3506	87	112	)	)	PUNCT
dpc-3506	87	113	20	20	NUM
dpc-3506	87	114	(	(	PUNCT
dpc-3506	87	115	10.9	10.9	NUM
dpc-3506	87	116	)	)	PUNCT
dpc-3506	87	117	33	33	NUM
dpc-3506	87	118	(	(	PUNCT
dpc-3506	87	119	18	18	NUM
dpc-3506	87	120	)	)	PUNCT
dpc-3506	87	121	6	6	NUM
dpc-3506	87	122	(	(	PUNCT
dpc-3506	87	123	3.3	3.3	NUM
dpc-3506	87	124	)	)	PUNCT
dpc-3506	87	125	98	98	NUM
dpc-3506	87	126	(	(	PUNCT
dpc-3506	87	127	69	69	NUM
dpc-3506	87	128	)	)	PUNCT
dpc-3506	87	129	12	12	NUM
dpc-3506	87	130	(	(	PUNCT
dpc-3506	87	131	8.5	8.5	NUM
dpc-3506	87	132	)	)	PUNCT
dpc-3506	87	133	27	27	NUM
dpc-3506	87	134	(	(	PUNCT
dpc-3506	87	135	19	19	NUM
dpc-3506	87	136	)	)	PUNCT
dpc-3506	87	137	5	5	NUM
dpc-3506	87	138	(	(	PUNCT
dpc-3506	87	139	3.5	3.5	NUM
dpc-3506	87	140	)	)	PUNCT
dpc-3506	87	141	26	26	NUM
dpc-3506	87	142	(	(	PUNCT
dpc-3506	87	143	63.4	63.4	NUM
dpc-3506	87	144	)	)	SYM
dpc-3506	87	145	8	8	NUM
dpc-3506	87	146	(	(	PUNCT
dpc-3506	87	147	19.5	19.5	NUM
dpc-3506	87	148	)	)	PUNCT
dpc-3506	87	149	6	6	NUM
dpc-3506	87	150	(	(	PUNCT
dpc-3506	87	151	18.2	18.2	NUM
dpc-3506	87	152	)	)	SYM
dpc-3506	87	153	1	1	NUM
dpc-3506	87	154	(	(	PUNCT
dpc-3506	87	155	2.4	2.4	NUM
dpc-3506	87	156	)	)	PUNCT
dpc-3506	87	157	0.25	0.25	NUM
dpc-3506	87	158	involved	involve	VERB
dpc-3506	87	159	sites	site	NOUN
dpc-3506	87	160	head	head	VERB
dpc-3506	87	161	/	/	SYM
dpc-3506	87	162	neck	neck	NOUN
dpc-3506	87	163	body	body	NOUN
dpc-3506	87	164	extremity	extremity	NOUN
dpc-3506	87	165	inguinal	inguinal	ADJ
dpc-3506	87	166	areas	area	NOUN
dpc-3506	87	167	breast	breast	NOUN
dpc-3506	87	168	19	19	NUM
dpc-3506	87	169	(	(	PUNCT
dpc-3506	87	170	10.4	10.4	NUM
dpc-3506	87	171	)	)	PUNCT
dpc-3506	87	172	115	115	NUM
dpc-3506	87	173	(	(	PUNCT
dpc-3506	87	174	62.8	62.8	NUM
dpc-3506	87	175	)	)	PUNCT
dpc-3506	87	176	101	101	NUM
dpc-3506	87	177	(	(	PUNCT
dpc-3506	87	178	55.2	55.2	NUM
dpc-3506	87	179	)	)	PUNCT
dpc-3506	87	180	23	23	NUM
dpc-3506	87	181	(	(	PUNCT
dpc-3506	87	182	12.6	12.6	NUM
dpc-3506	87	183	)	)	PUNCT
dpc-3506	87	184	13	13	NUM
dpc-3506	87	185	(	(	PUNCT
dpc-3506	87	186	7.1	7.1	NUM
dpc-3506	87	187	)	)	PUNCT
dpc-3506	87	188	7	7	NUM
dpc-3506	87	189	(	(	PUNCT
dpc-3506	87	190	4.9	4.9	NUM
dpc-3506	87	191	)	)	PUNCT
dpc-3506	87	192	94	94	NUM
dpc-3506	87	193	(	(	PUNCT
dpc-3506	87	194	66.2	66.2	NUM
dpc-3506	87	195	)	)	PUNCT
dpc-3506	87	196	79	79	NUM
dpc-3506	87	197	(	(	PUNCT
dpc-3506	87	198	55.6	55.6	NUM
dpc-3506	87	199	)	)	SYM
dpc-3506	87	200	20	20	NUM
dpc-3506	87	201	(	(	PUNCT
dpc-3506	87	202	14.1	14.1	NUM
dpc-3506	87	203	)	)	PUNCT
dpc-3506	87	204	13	13	NUM
dpc-3506	87	205	(	(	PUNCT
dpc-3506	87	206	9.2	9.2	NUM
dpc-3506	87	207	)	)	PUNCT
dpc-3506	87	208	12	12	NUM
dpc-3506	87	209	(	(	PUNCT
dpc-3506	87	210	29.3	29.3	NUM
dpc-3506	87	211	)	)	PUNCT
dpc-3506	87	212	21	21	NUM
dpc-3506	87	213	(	(	PUNCT
dpc-3506	87	214	51.2	51.2	NUM
dpc-3506	87	215	)	)	PUNCT
dpc-3506	87	216	22	22	NUM
dpc-3506	87	217	(	(	PUNCT
dpc-3506	87	218	53.7	53.7	NUM
dpc-3506	87	219	)	)	PUNCT
dpc-3506	87	220	3	3	NUM
dpc-3506	87	221	(	(	PUNCT
dpc-3506	87	222	7.3	7.3	NUM
dpc-3506	87	223	)	)	PUNCT
dpc-3506	87	224	0	0	PUNCT
dpc-3506	88	1	<	<	X
dpc-3506	88	2	0.001	0.001	NUM
dpc-3506	88	3	0.080	0.080	NUM
dpc-3506	88	4	0.82	0.82	NUM
dpc-3506	88	5	0.25	0.25	NUM
dpc-3506	88	6	0.043	0.043	NUM
dpc-3506	88	7	triggering	trigger	VERB
dpc-3506	88	8	factors	factor	NOUN
dpc-3506	88	9	(	(	PUNCT
dpc-3506	88	10	exp;vaccination	exp;vaccination	NOUN
dpc-3506	88	11	,	,	PUNCT
dpc-3506	88	12	laser	laser	NOUN
dpc-3506	88	13	application	application	NOUN
dpc-3506	88	14	,	,	PUNCT
dpc-3506	88	15	surgery	surgery	NOUN
dpc-3506	88	16	,	,	PUNCT
dpc-3506	88	17	trauma	trauma	NOUN
dpc-3506	88	18	,	,	PUNCT
dpc-3506	88	19	autoimmunity	autoimmunity	NOUN
dpc-3506	88	20	and	and	CCONJ
dpc-3506	88	21	 	 	SPACE
dpc-3506	88	22	psychological	psychological	ADJ
dpc-3506	88	23	stress	stress	NOUN
dpc-3506	88	24	)	)	PUNCT
dpc-3506	89	1	yes	yes	INTJ
dpc-3506	90	1	no	no	DET
dpc-3506	90	2	12	12	NUM
dpc-3506	90	3	(	(	PUNCT
dpc-3506	90	4	6.6	6.6	NUM
dpc-3506	90	5	)	)	PUNCT
dpc-3506	90	6	171	171	NUM
dpc-3506	90	7	(	(	PUNCT
dpc-3506	90	8	93.4	93.4	NUM
dpc-3506	90	9	)	)	PUNCT
dpc-3506	90	10	9	9	NUM
dpc-3506	90	11	(	(	PUNCT
dpc-3506	90	12	6.3	6.3	NUM
dpc-3506	90	13	)	)	PUNCT
dpc-3506	90	14	133	133	NUM
dpc-3506	90	15	(	(	PUNCT
dpc-3506	90	16	93.7	93.7	NUM
dpc-3506	90	17	)	)	PUNCT
dpc-3506	90	18	3	3	NUM
dpc-3506	90	19	(	(	PUNCT
dpc-3506	90	20	7.3	7.3	NUM
dpc-3506	90	21	)	)	PUNCT
dpc-3506	90	22	38	38	NUM
dpc-3506	90	23	(	(	PUNCT
dpc-3506	90	24	92.7	92.7	NUM
dpc-3506	90	25	)	)	PUNCT
dpc-3506	90	26	0.82	0.82	NUM
dpc-3506	90	27	sclerosis	sclerosis	NOUN
dpc-3506	90	28	presence	presence	NOUN
dpc-3506	91	1	yes	yes	INTJ
dpc-3506	92	1	no	no	DET
dpc-3506	92	2	62	62	NUM
dpc-3506	92	3	(	(	PUNCT
dpc-3506	92	4	33.9	33.9	NUM
dpc-3506	92	5	)	)	PUNCT
dpc-3506	92	6	121	121	NUM
dpc-3506	92	7	(	(	PUNCT
dpc-3506	92	8	66.1	66.1	NUM
dpc-3506	92	9	)	)	PUNCT
dpc-3506	92	10	49	49	NUM
dpc-3506	92	11	(	(	PUNCT
dpc-3506	92	12	34.5	34.5	NUM
dpc-3506	92	13	)	)	PUNCT
dpc-3506	92	14	93	93	NUM
dpc-3506	92	15	(	(	PUNCT
dpc-3506	92	16	65.5	65.5	NUM
dpc-3506	92	17	)	)	PUNCT
dpc-3506	92	18	13	13	NUM
dpc-3506	92	19	(	(	PUNCT
dpc-3506	92	20	31.7	31.7	NUM
dpc-3506	92	21	)	)	SYM
dpc-3506	92	22	28	28	NUM
dpc-3506	92	23	(	(	PUNCT
dpc-3506	92	24	68.3	68.3	NUM
dpc-3506	92	25	)	)	PUNCT
dpc-3506	92	26	0.74	0.74	NUM
dpc-3506	92	27	pigmentation	pigmentation	NOUN
dpc-3506	92	28	presence	presence	NOUN
dpc-3506	93	1	yes	yes	INTJ
dpc-3506	93	2	no	no	DET
dpc-3506	93	3	55	55	NUM
dpc-3506	93	4	(	(	PUNCT
dpc-3506	93	5	30.1	30.1	NUM
dpc-3506	93	6	)	)	PUNCT
dpc-3506	93	7	128	128	NUM
dpc-3506	93	8	(	(	PUNCT
dpc-3506	93	9	69.9	69.9	NUM
dpc-3506	93	10	)	)	PUNCT
dpc-3506	93	11	29	29	NUM
dpc-3506	93	12	(	(	PUNCT
dpc-3506	93	13	30.3	30.3	NUM
dpc-3506	93	14	)	)	PUNCT
dpc-3506	93	15	99	99	NUM
dpc-3506	93	16	(	(	PUNCT
dpc-3506	93	17	69.7	69.7	NUM
dpc-3506	93	18	)	)	PUNCT
dpc-3506	93	19	12	12	NUM
dpc-3506	93	20	(	(	PUNCT
dpc-3506	93	21	29.3	29.3	NUM
dpc-3506	93	22	)	)	PUNCT
dpc-3506	93	23	29	29	NUM
dpc-3506	93	24	(	(	PUNCT
dpc-3506	93	25	70.7	70.7	NUM
dpc-3506	93	26	)	)	PUNCT
dpc-3506	93	27	0.90	0.90	NUM
dpc-3506	93	28	arthralgia	arthralgia	NOUN
dpc-3506	93	29	presence	presence	NOUN
dpc-3506	94	1	yes	yes	INTJ
dpc-3506	95	1	no	no	DET
dpc-3506	95	2	19	19	NUM
dpc-3506	95	3	(	(	PUNCT
dpc-3506	95	4	10.4	10.4	NUM
dpc-3506	95	5	)	)	PUNCT
dpc-3506	95	6	164	164	NUM
dpc-3506	95	7	(	(	PUNCT
dpc-3506	95	8	89.6	89.6	NUM
dpc-3506	95	9	)	)	PUNCT
dpc-3506	95	10	18	18	NUM
dpc-3506	95	11	(	(	PUNCT
dpc-3506	95	12	12.7	12.7	NUM
dpc-3506	95	13	)	)	PUNCT
dpc-3506	95	14	124	124	NUM
dpc-3506	95	15	(	(	PUNCT
dpc-3506	95	16	87.3	87.3	NUM
dpc-3506	95	17	)	)	PUNCT
dpc-3506	95	18	1	1	NUM
dpc-3506	95	19	(	(	PUNCT
dpc-3506	95	20	2.4	2.4	NUM
dpc-3506	95	21	)	)	PUNCT
dpc-3506	95	22	40	40	NUM
dpc-3506	95	23	(	(	PUNCT
dpc-3506	95	24	97.6	97.6	NUM
dpc-3506	95	25	)	)	PUNCT
dpc-3506	95	26	0.058	0.058	NUM
dpc-3506	95	27	amain	amain	ADV
dpc-3506	95	28	(	(	PUNCT
dpc-3506	95	29	standard	standard	ADJ
dpc-3506	95	30	deviation	deviation	NOUN
dpc-3506	95	31	,	,	PUNCT
dpc-3506	95	32	sd	sd	NOUN
dpc-3506	95	33	)	)	PUNCT
dpc-3506	95	34	,	,	PUNCT
dpc-3506	95	35	bmedian	bmedian	PROPN
dpc-3506	95	36	(	(	PUNCT
dpc-3506	95	37	interquartile	interquartile	NOUN
dpc-3506	95	38	range	range	NOUN
dpc-3506	95	39	)	)	PUNCT
dpc-3506	95	40	.	.	PUNCT
dpc-3506	96	1	4	4	NUM
dpc-3506	96	2	original	original	ADJ
dpc-3506	96	3	article	article	NOUN
dpc-3506	96	4	|	|	ADV
dpc-3506	96	5	dermatol	dermatol	ADJ
dpc-3506	96	6	pract	pract	NOUN
dpc-3506	96	7	concept	concept	NOUN
dpc-3506	96	8	.	.	PUNCT
dpc-3506	97	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	97	2	breast	breast	NOUN
dpc-3506	97	3	involvement	involvement	NOUN
dpc-3506	97	4	.	.	PUNCT
dpc-3506	98	1	patients	patient	NOUN
dpc-3506	98	2	with	with	ADP
dpc-3506	98	3	breast	breast	NOUN
dpc-3506	98	4	involvement	involvement	NOUN
dpc-3506	98	5	had	have	VERB
dpc-3506	98	6	a	a	DET
dpc-3506	98	7	significantly	significantly	ADV
dpc-3506	98	8	lower	low	ADJ
dpc-3506	98	9	hb	hb	NOUN
dpc-3506	98	10	(	(	PUNCT
dpc-3506	98	11	p	p	NOUN
dpc-3506	98	12	=	=	NOUN
dpc-3506	98	13	0.017	0.017	NUM
dpc-3506	98	14	)	)	PUNCT
dpc-3506	98	15	.	.	PUNCT
dpc-3506	99	1	all	all	PRON
dpc-3506	99	2	of	of	ADP
dpc-3506	99	3	the	the	DET
dpc-3506	99	4	patients	patient	NOUN
dpc-3506	99	5	with	with	ADP
dpc-3506	99	6	inguinal	inguinal	ADJ
dpc-3506	99	7	involvement	involvement	NOUN
dpc-3506	99	8	were	be	AUX
dpc-3506	99	9	female	female	ADJ
dpc-3506	99	10	.	.	PUNCT
dpc-3506	100	1	the	the	DET
dpc-3506	100	2	patients	patient	NOUN
dpc-3506	100	3	were	be	AUX
dpc-3506	100	4	significantly	significantly	ADV
dpc-3506	100	5	older	old	ADJ
dpc-3506	100	6	(	(	PUNCT
dpc-3506	100	7	p	p	X
dpc-3506	100	8	=	=	NOUN
dpc-3506	100	9	0.012	0.012	NUM
dpc-3506	100	10	)	)	PUNCT
dpc-3506	100	11	,	,	PUNCT
dpc-3506	100	12	and	and	CCONJ
dpc-3506	100	13	their	their	PRON
dpc-3506	100	14	hb	hb	NOUN
dpc-3506	100	15	levels	level	NOUN
dpc-3506	100	16	were	be	AUX
dpc-3506	100	17	lower	low	ADJ
dpc-3506	100	18	than	than	ADP
dpc-3506	100	19	the	the	DET
dpc-3506	100	20	patients	patient	NOUN
dpc-3506	100	21	without	without	ADP
dpc-3506	100	22	inguinal	inguinal	ADJ
dpc-3506	100	23	involvement	involvement	NOUN
dpc-3506	100	24	(	(	PUNCT
dpc-3506	100	25	p	p	X
dpc-3506	100	26	=	=	NOUN
dpc-3506	100	27	0.042	0.042	NUM
dpc-3506	100	28	)	)	PUNCT
dpc-3506	100	29	.	.	PUNCT
dpc-3506	101	1	sclerosis	sclerosis	NOUN
dpc-3506	101	2	was	be	AUX
dpc-3506	101	3	more	more	ADV
dpc-3506	101	4	common	common	ADJ
dpc-3506	101	5	in	in	ADP
dpc-3506	101	6	patients	patient	NOUN
dpc-3506	101	7	with	with	ADP
dpc-3506	101	8	inguinal	inguinal	ADJ
dpc-3506	101	9	involvement	involvement	NOUN
dpc-3506	101	10	(	(	PUNCT
dpc-3506	101	11	p	p	X
dpc-3506	101	12	=	=	NOUN
dpc-3506	101	13	0.014	0.014	NUM
dpc-3506	101	14	)	)	PUNCT
dpc-3506	101	15	.	.	PUNCT
dpc-3506	102	1	the	the	DET
dpc-3506	102	2	incidence	incidence	NOUN
dpc-3506	102	3	of	of	ADP
dpc-3506	102	4	diabetes	diabetes	NOUN
dpc-3506	102	5	in	in	ADP
dpc-3506	102	6	patients	patient	NOUN
dpc-3506	102	7	with	with	ADP
dpc-3506	102	8	inguinal	inguinal	ADJ
dpc-3506	102	9	involvement	involvement	NOUN
dpc-3506	102	10	was	be	AUX
dpc-3506	102	11	higher	high	ADJ
dpc-3506	102	12	(	(	PUNCT
dpc-3506	102	13	p	p	NOUN
dpc-3506	102	14	=	=	NOUN
dpc-3506	102	15	0.040	0.040	NUM
dpc-3506	102	16	)	)	PUNCT
dpc-3506	102	17	table	table	NOUN
dpc-3506	102	18	1	1	NUM
dpc-3506	102	19	shows	show	VERB
dpc-3506	102	20	the	the	DET
dpc-3506	102	21	clinical	clinical	ADJ
dpc-3506	102	22	characteristics	characteristic	NOUN
dpc-3506	102	23	of	of	ADP
dpc-3506	102	24	the	the	DET
dpc-3506	102	25	patients	patient	NOUN
dpc-3506	102	26	including	include	VERB
dpc-3506	102	27	triggering	trigger	VERB
dpc-3506	102	28	agents	agent	NOUN
dpc-3506	102	29	and	and	CCONJ
dpc-3506	102	30	presence	presence	NOUN
dpc-3506	102	31	of	of	ADP
dpc-3506	102	32	arthralgia	arthralgia	PROPN
dpc-3506	102	33	.	.	PUNCT
dpc-3506	103	1	table	table	NOUN
dpc-3506	103	2	2	2	NUM
dpc-3506	103	3	illustrates	illustrate	VERB
dpc-3506	103	4	the	the	DET
dpc-3506	103	5	laboratory	laboratory	NOUN
dpc-3506	103	6	findings	finding	NOUN
dpc-3506	103	7	and	and	CCONJ
dpc-3506	103	8	the	the	DET
dpc-3506	103	9	table	table	NOUN
dpc-3506	103	10	3	3	NUM
dpc-3506	103	11	shows	show	VERB
dpc-3506	103	12	the	the	DET
dpc-3506	103	13	accompanying	accompany	VERB
dpc-3506	103	14	comorbidities	comorbiditie	NOUN
dpc-3506	103	15	.	.	PUNCT
dpc-3506	104	1	the	the	DET
dpc-3506	104	2	treatments	treatment	NOUN
dpc-3506	104	3	given	give	VERB
dpc-3506	104	4	to	to	ADP
dpc-3506	104	5	pediatric	pediatric	ADJ
dpc-3506	104	6	morphea	morphea	PROPN
dpc-3506	104	7	and	and	CCONJ
dpc-3506	104	8	adult	adult	NOUN
dpc-3506	104	9	morphea	morphea	NOUN
dpc-3506	104	10	were	be	AUX
dpc-3506	104	11	shown	show	VERB
dpc-3506	104	12	table	table	NOUN
dpc-3506	104	13	4	4	NUM
dpc-3506	104	14	.	.	PUNCT
dpc-3506	104	15	figure	figure	NOUN
dpc-3506	104	16	1	1	NUM
dpc-3506	104	17	.	.	PUNCT
dpc-3506	104	18	plaque	plaque	NOUN
dpc-3506	104	19	type	type	NOUN
dpc-3506	104	20	morphea	morphea	PROPN
dpc-3506	104	21	.	.	PUNCT
dpc-3506	105	1	figure	figure	NOUN
dpc-3506	105	2	2	2	NUM
dpc-3506	105	3	.	.	PUNCT
dpc-3506	105	4	en	en	PROPN
dpc-3506	105	5	coup	coup	PROPN
dpc-3506	105	6	de	de	PROPN
dpc-3506	105	7	sabre	sabre	PROPN
dpc-3506	105	8	.	.	PUNCT
dpc-3506	106	1	figure	figure	NOUN
dpc-3506	106	2	3	3	NUM
dpc-3506	106	3	.	.	PUNCT
dpc-3506	106	4	plaque	plaque	NOUN
dpc-3506	106	5	type	type	NOUN
dpc-3506	106	6	morphea	morphea	NOUN
dpc-3506	106	7	on	on	ADP
dpc-3506	106	8	the	the	DET
dpc-3506	106	9	face	face	NOUN
dpc-3506	106	10	.	.	PUNCT
dpc-3506	107	1	all	all	DET
dpc-3506	107	2	patients	patient	NOUN
dpc-3506	107	3	with	with	ADP
dpc-3506	107	4	breast	breast	NOUN
dpc-3506	107	5	involvement	involvement	NOUN
dpc-3506	107	6	were	be	AUX
dpc-3506	107	7	adult	adult	NOUN
dpc-3506	107	8	-	-	PUNCT
dpc-3506	107	9	onset	onset	NOUN
dpc-3506	107	10	.	.	PUNCT
dpc-3506	108	1	anti	anti	ADJ
dpc-3506	108	2	-	-	ADJ
dpc-3506	108	3	dsdna	dsdna	ADJ
dpc-3506	108	4	positivity	positivity	NOUN
dpc-3506	108	5	was	be	AUX
dpc-3506	108	6	seen	see	VERB
dpc-3506	108	7	in	in	ADP
dpc-3506	108	8	37.5	37.5	NUM
dpc-3506	108	9	%	%	NOUN
dpc-3506	108	10	of	of	ADP
dpc-3506	108	11	the	the	DET
dpc-3506	108	12	patients	patient	NOUN
dpc-3506	108	13	with	with	ADP
dpc-3506	108	14	breast	breast	NOUN
dpc-3506	108	15	involvement	involvement	NOUN
dpc-3506	108	16	and	and	CCONJ
dpc-3506	108	17	in	in	ADP
dpc-3506	108	18	9.2	9.2	NUM
dpc-3506	108	19	%	%	NOUN
dpc-3506	108	20	of	of	ADP
dpc-3506	108	21	the	the	DET
dpc-3506	108	22	patients	patient	NOUN
dpc-3506	108	23	without	without	ADP
dpc-3506	108	24	breast	breast	NOUN
dpc-3506	108	25	involvement	involvement	NOUN
dpc-3506	108	26	.	.	PUNCT
dpc-3506	109	1	anti	anti	ADJ
dpc-3506	109	2	-	-	ADJ
dpc-3506	109	3	dsdna	dsdna	ADJ
dpc-3506	109	4	positivity	positivity	NOUN
dpc-3506	109	5	was	be	AUX
dpc-3506	109	6	significantly	significantly	ADV
dpc-3506	109	7	higher	high	ADJ
dpc-3506	109	8	in	in	ADP
dpc-3506	109	9	the	the	DET
dpc-3506	109	10	patients	patient	NOUN
dpc-3506	109	11	with	with	ADP
dpc-3506	109	12	breast	breast	NOUN
dpc-3506	109	13	involvement	involvement	NOUN
dpc-3506	109	14	(	(	PUNCT
dpc-3506	109	15	p	p	X
dpc-3506	109	16	=	=	NOUN
dpc-3506	109	17	0.014	0.014	NUM
dpc-3506	109	18	)	)	PUNCT
dpc-3506	109	19	.	.	PUNCT
dpc-3506	110	1	hemoglobin	hemoglobin	NOUN
dpc-3506	110	2	(	(	PUNCT
dpc-3506	110	3	hb	hb	PROPN
dpc-3506	110	4	)	)	PUNCT
dpc-3506	110	5	levels	level	NOUN
dpc-3506	110	6	were	be	AUX
dpc-3506	110	7	12.4	12.4	NUM
dpc-3506	110	8	(	(	PUNCT
dpc-3506	110	9	sd	sd	ADP
dpc-3506	110	10	1.4	1.4	NUM
dpc-3506	110	11	)	)	PUNCT
dpc-3506	110	12	in	in	ADP
dpc-3506	110	13	patients	patient	NOUN
dpc-3506	110	14	with	with	ADP
dpc-3506	110	15	breast	breast	NOUN
dpc-3506	110	16	involvement	involvement	NOUN
dpc-3506	110	17	and	and	CCONJ
dpc-3506	110	18	13.6	13.6	NUM
dpc-3506	110	19	(	(	PUNCT
dpc-3506	110	20	sd	sd	ADP
dpc-3506	110	21	1.4	1.4	NUM
dpc-3506	110	22	)	)	PUNCT
dpc-3506	110	23	in	in	ADP
dpc-3506	110	24	patients	patient	NOUN
dpc-3506	110	25	without	without	ADP
dpc-3506	110	26	figure	figure	NOUN
dpc-3506	110	27	4	4	NUM
dpc-3506	110	28	.	.	PUNCT
dpc-3506	110	29	atrophic	atrophic	ADJ
dpc-3506	110	30	morphea	morphea	PROPN
dpc-3506	110	31	.	.	PUNCT
dpc-3506	111	1	original	original	ADJ
dpc-3506	111	2	article	article	NOUN
dpc-3506	111	3	|	|	ADV
dpc-3506	111	4	dermatol	dermatol	ADJ
dpc-3506	111	5	pract	pract	NOUN
dpc-3506	111	6	concept	concept	NOUN
dpc-3506	111	7	.	.	PUNCT
dpc-3506	112	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	112	2	5	5	NUM
dpc-3506	112	3	of	of	ADP
dpc-3506	112	4	the	the	DET
dpc-3506	112	5	patients	patient	NOUN
dpc-3506	112	6	,	,	PUNCT
dpc-3506	112	7	especially	especially	ADV
dpc-3506	112	8	in	in	ADP
dpc-3506	112	9	the	the	DET
dpc-3506	112	10	group	group	NOUN
dpc-3506	112	11	with	with	ADP
dpc-3506	112	12	linear	linear	PROPN
dpc-3506	112	13	morphea	morphea	PROPN
dpc-3506	112	14	.	.	PUNCT
dpc-3506	113	1	since	since	SCONJ
dpc-3506	113	2	the	the	DET
dpc-3506	113	3	platelet	platelet	NOUN
dpc-3506	113	4	and	and	CCONJ
dpc-3506	113	5	esr	esr	PROPN
dpc-3506	113	6	levels	level	NOUN
dpc-3506	113	7	are	be	AUX
dpc-3506	113	8	significantly	significantly	ADV
dpc-3506	113	9	lower	low	ADJ
dpc-3506	113	10	in	in	ADP
dpc-3506	113	11	this	this	DET
dpc-3506	113	12	type	type	NOUN
dpc-3506	113	13	compared	compare	VERB
dpc-3506	113	14	to	to	ADP
dpc-3506	113	15	the	the	DET
dpc-3506	113	16	generalized	generalized	ADJ
dpc-3506	113	17	type	type	NOUN
dpc-3506	113	18	,	,	PUNCT
dpc-3506	113	19	there	there	PRON
dpc-3506	113	20	may	may	AUX
dpc-3506	113	21	be	be	AUX
dpc-3506	113	22	a	a	DET
dpc-3506	113	23	lower	low	ADJ
dpc-3506	113	24	risk	risk	NOUN
dpc-3506	113	25	of	of	ADP
dpc-3506	113	26	systemic	systemic	ADJ
dpc-3506	113	27	involvement	involvement	NOUN
dpc-3506	113	28	and	and	CCONJ
dpc-3506	113	29	a	a	DET
dpc-3506	113	30	lower	low	ADJ
dpc-3506	113	31	tendency	tendency	NOUN
dpc-3506	113	32	to	to	PART
dpc-3506	113	33	thrombosis	thrombosis	VERB
dpc-3506	113	34	.	.	PUNCT
dpc-3506	114	1	the	the	DET
dpc-3506	114	2	fact	fact	NOUN
dpc-3506	114	3	that	that	SCONJ
dpc-3506	114	4	the	the	DET
dpc-3506	114	5	extremity	extremity	NOUN
dpc-3506	114	6	involvement	involvement	NOUN
dpc-3506	114	7	is	be	AUX
dpc-3506	114	8	around	around	ADV
dpc-3506	114	9	50	50	NUM
dpc-3506	114	10	%	%	NOUN
dpc-3506	114	11	in	in	ADP
dpc-3506	114	12	both	both	DET
dpc-3506	114	13	types	type	NOUN
dpc-3506	114	14	of	of	ADP
dpc-3506	114	15	onset	onset	NOUN
dpc-3506	114	16	suggests	suggest	VERB
dpc-3506	114	17	that	that	SCONJ
dpc-3506	114	18	the	the	DET
dpc-3506	114	19	disease	disease	NOUN
dpc-3506	114	20	has	have	VERB
dpc-3506	114	21	a	a	DET
dpc-3506	114	22	progressive	progressive	ADJ
dpc-3506	114	23	course	course	NOUN
dpc-3506	114	24	.	.	PUNCT
dpc-3506	115	1	in	in	ADP
dpc-3506	115	2	various	various	ADJ
dpc-3506	115	3	studies	study	NOUN
dpc-3506	115	4	,	,	PUNCT
dpc-3506	115	5	the	the	DET
dpc-3506	115	6	incidence	incidence	NOUN
dpc-3506	115	7	of	of	ADP
dpc-3506	115	8	plaque	plaque	NOUN
dpc-3506	115	9	type	type	NOUN
dpc-3506	115	10	in	in	ADP
dpc-3506	115	11	children	child	NOUN
dpc-3506	115	12	ranges	range	VERB
dpc-3506	115	13	from	from	ADP
dpc-3506	115	14	15.3	15.3	NUM
dpc-3506	115	15	%	%	NOUN
dpc-3506	115	16	to	to	ADP
dpc-3506	115	17	69.2	69.2	NUM
dpc-3506	115	18	%	%	NOUN
dpc-3506	115	19	[	[	X
dpc-3506	115	20	6,14	6,14	NUM
dpc-3506	115	21	-	-	SYM
dpc-3506	115	22	17	17	NUM
dpc-3506	115	23	]	]	PUNCT
dpc-3506	115	24	.	.	PUNCT
dpc-3506	116	1	in	in	ADP
dpc-3506	116	2	the	the	DET
dpc-3506	116	3	present	present	ADJ
dpc-3506	116	4	study	study	NOUN
dpc-3506	116	5	,	,	PUNCT
dpc-3506	116	6	the	the	DET
dpc-3506	116	7	plaque	plaque	NOUN
dpc-3506	116	8	type	type	NOUN
dpc-3506	116	9	was	be	AUX
dpc-3506	116	10	found	find	VERB
dpc-3506	116	11	to	to	PART
dpc-3506	116	12	be	be	AUX
dpc-3506	116	13	high	high	ADJ
dpc-3506	116	14	in	in	ADP
dpc-3506	116	15	both	both	DET
dpc-3506	116	16	groups	group	NOUN
dpc-3506	116	17	.	.	PUNCT
dpc-3506	117	1	this	this	DET
dpc-3506	117	2	rate	rate	NOUN
dpc-3506	117	3	was	be	AUX
dpc-3506	117	4	similar	similar	ADJ
dpc-3506	117	5	to	to	ADP
dpc-3506	117	6	the	the	DET
dpc-3506	117	7	rates	rate	NOUN
dpc-3506	117	8	in	in	ADP
dpc-3506	117	9	our	our	PRON
dpc-3506	117	10	previous	previous	ADJ
dpc-3506	117	11	research	research	NOUN
dpc-3506	117	12	with	with	ADP
dpc-3506	117	13	children	child	NOUN
dpc-3506	117	14	cases	case	NOUN
dpc-3506	117	15	[	[	X
dpc-3506	117	16	17	17	NUM
dpc-3506	117	17	]	]	PUNCT
dpc-3506	117	18	.	.	PUNCT
dpc-3506	118	1	a	a	DET
dpc-3506	118	2	significant	significant	ADJ
dpc-3506	118	3	data	datum	NOUN
dpc-3506	118	4	here	here	ADV
dpc-3506	118	5	was	be	AUX
dpc-3506	118	6	that	that	SCONJ
dpc-3506	118	7	the	the	DET
dpc-3506	118	8	plaque	plaque	NOUN
dpc-3506	118	9	type	type	NOUN
dpc-3506	118	10	was	be	AUX
dpc-3506	118	11	higher	high	ADJ
dpc-3506	118	12	in	in	ADP
dpc-3506	118	13	men	man	NOUN
dpc-3506	118	14	,	,	PUNCT
dpc-3506	118	15	but	but	CCONJ
dpc-3506	118	16	sclerosis	sclerosis	NOUN
dpc-3506	118	17	was	be	AUX
dpc-3506	118	18	less	less	ADV
dpc-3506	118	19	common	common	ADJ
dpc-3506	118	20	than	than	ADP
dpc-3506	118	21	other	other	ADJ
dpc-3506	118	22	types	type	NOUN
dpc-3506	118	23	.	.	PUNCT
dpc-3506	119	1	morphea	morphea	PROPN
dpc-3506	119	2	appears	appear	VERB
dpc-3506	119	3	to	to	PART
dpc-3506	119	4	have	have	VERB
dpc-3506	119	5	a	a	DET
dpc-3506	119	6	milder	mild	ADJ
dpc-3506	119	7	course	course	NOUN
dpc-3506	119	8	in	in	ADP
dpc-3506	119	9	men	man	NOUN
dpc-3506	119	10	.	.	PUNCT
dpc-3506	120	1	this	this	DET
dpc-3506	120	2	finding	finding	NOUN
dpc-3506	120	3	also	also	ADV
dpc-3506	120	4	supports	support	VERB
dpc-3506	120	5	the	the	DET
dpc-3506	120	6	view	view	NOUN
dpc-3506	120	7	that	that	SCONJ
dpc-3506	120	8	autoimmune	autoimmune	ADJ
dpc-3506	120	9	diseases	disease	NOUN
dpc-3506	120	10	are	be	AUX
dpc-3506	120	11	more	more	ADV
dpc-3506	120	12	frequent	frequent	ADJ
dpc-3506	120	13	and	and	CCONJ
dpc-3506	120	14	more	more	ADV
dpc-3506	120	15	severe	severe	ADJ
dpc-3506	120	16	in	in	ADP
dpc-3506	120	17	women	woman	NOUN
dpc-3506	120	18	.	.	PUNCT
dpc-3506	121	1	mixed	mixed	ADJ
dpc-3506	121	2	type	type	NOUN
dpc-3506	121	3	,	,	PUNCT
dpc-3506	121	4	in	in	ADP
dpc-3506	121	5	which	which	PRON
dpc-3506	121	6	more	more	ADJ
dpc-3506	121	7	than	than	ADP
dpc-3506	121	8	one	one	NUM
dpc-3506	121	9	type	type	NOUN
dpc-3506	121	10	of	of	ADP
dpc-3506	121	11	morphea	morphea	NOUN
dpc-3506	121	12	coexists	coexist	NOUN
dpc-3506	121	13	,	,	PUNCT
dpc-3506	121	14	was	be	AUX
dpc-3506	121	15	found	find	VERB
dpc-3506	121	16	at	at	ADP
dpc-3506	121	17	a	a	DET
dpc-3506	121	18	rate	rate	NOUN
dpc-3506	121	19	of	of	ADP
dpc-3506	121	20	7.6%-23	7.6%-23	NOUN
dpc-3506	121	21	%	%	NOUN
dpc-3506	121	22	in	in	ADP
dpc-3506	121	23	various	various	ADJ
dpc-3506	121	24	studies	study	NOUN
dpc-3506	121	25	in	in	ADP
dpc-3506	121	26	children	child	NOUN
dpc-3506	122	1	[	[	X
dpc-3506	122	2	2,13,15	2,13,15	NUM
dpc-3506	122	3	-	-	SYM
dpc-3506	122	4	17	17	NUM
dpc-3506	122	5	]	]	PUNCT
dpc-3506	122	6	.	.	PUNCT
dpc-3506	123	1	saracino	saracino	PROPN
dpc-3506	123	2	et	et	PROPN
dpc-3506	123	3	al	al	PROPN
dpc-3506	123	4	reported	report	VERB
dpc-3506	123	5	mixed	mixed	ADJ
dpc-3506	123	6	type	type	NOUN
dpc-3506	123	7	morphea	morphea	NOUN
dpc-3506	123	8	in	in	ADP
dpc-3506	123	9	27.1	27.1	NUM
dpc-3506	123	10	%	%	NOUN
dpc-3506	123	11	of	of	ADP
dpc-3506	123	12	the	the	DET
dpc-3506	123	13	adults	adult	NOUN
dpc-3506	123	14	with	with	ADP
dpc-3506	123	15	morphea	morphea	PROPN
dpc-3506	123	16	,	,	PUNCT
dpc-3506	123	17	in	in	ADP
dpc-3506	123	18	28	28	NUM
dpc-3506	123	19	%	%	NOUN
dpc-3506	123	20	of	of	ADP
dpc-3506	123	21	pols	pol	NOUN
dpc-3506	123	22	and	and	CCONJ
dpc-3506	123	23	25.9	25.9	NUM
dpc-3506	123	24	%	%	NOUN
dpc-3506	123	25	of	of	ADP
dpc-3506	123	26	aols	aol	NOUN
dpc-3506	123	27	[	[	X
dpc-3506	123	28	18	18	NUM
dpc-3506	123	29	]	]	PUNCT
dpc-3506	123	30	.	.	PUNCT
dpc-3506	124	1	in	in	ADP
dpc-3506	124	2	our	our	PRON
dpc-3506	124	3	study	study	NOUN
dpc-3506	124	4	,	,	PUNCT
dpc-3506	124	5	we	we	PRON
dpc-3506	124	6	found	find	VERB
dpc-3506	124	7	that	that	SCONJ
dpc-3506	124	8	mixed	mixed	ADJ
dpc-3506	124	9	type	type	NOUN
dpc-3506	124	10	morphea	morphea	NOUN
dpc-3506	124	11	was	be	AUX
dpc-3506	124	12	3.3	3.3	NUM
dpc-3506	124	13	%	%	NOUN
dpc-3506	124	14	lower	low	ADJ
dpc-3506	124	15	in	in	ADP
dpc-3506	124	16	total	total	ADJ
dpc-3506	124	17	,	,	PUNCT
dpc-3506	124	18	3.5	3.5	NUM
dpc-3506	124	19	%	%	NOUN
dpc-3506	124	20	lower	low	ADJ
dpc-3506	124	21	in	in	ADP
dpc-3506	124	22	aols	aol	NOUN
dpc-3506	124	23	and	and	CCONJ
dpc-3506	124	24	2.4	2.4	NUM
dpc-3506	124	25	%	%	NOUN
dpc-3506	124	26	lower	low	ADJ
dpc-3506	124	27	in	in	ADP
dpc-3506	124	28	pols	pol	NOUN
dpc-3506	124	29	.	.	PUNCT
dpc-3506	125	1	conclusions	conclusion	NOUN
dpc-3506	125	2	in	in	ADP
dpc-3506	125	3	our	our	PRON
dpc-3506	125	4	study	study	NOUN
dpc-3506	125	5	,	,	PUNCT
dpc-3506	125	6	the	the	DET
dpc-3506	125	7	characteristics	characteristic	NOUN
dpc-3506	125	8	of	of	ADP
dpc-3506	125	9	pediatric	pediatric	ADJ
dpc-3506	125	10	and	and	CCONJ
dpc-3506	125	11	adult	adult	NOUN
dpc-3506	125	12	-	-	PUNCT
dpc-3506	125	13	onset	onset	NOUN
dpc-3506	125	14	morphea	morphea	NOUN
dpc-3506	125	15	patients	patient	NOUN
dpc-3506	125	16	were	be	AUX
dpc-3506	125	17	compared	compare	VERB
dpc-3506	125	18	,	,	PUNCT
dpc-3506	125	19	and	and	CCONJ
dpc-3506	125	20	some	some	PRON
dpc-3506	125	21	of	of	ADP
dpc-3506	125	22	them	they	PRON
dpc-3506	125	23	showed	show	VERB
dpc-3506	125	24	similarities	similarity	NOUN
dpc-3506	125	25	with	with	ADP
dpc-3506	125	26	the	the	DET
dpc-3506	125	27	literature	literature	NOUN
dpc-3506	125	28	,	,	PUNCT
dpc-3506	125	29	while	while	SCONJ
dpc-3506	125	30	some	some	DET
dpc-3506	125	31	findings	finding	NOUN
dpc-3506	125	32	showed	show	VERB
dpc-3506	125	33	differences	difference	NOUN
dpc-3506	125	34	[	[	X
dpc-3506	125	35	8	8	NUM
dpc-3506	125	36	-	-	SYM
dpc-3506	125	37	19	19	NUM
dpc-3506	125	38	]	]	PUNCT
dpc-3506	125	39	.	.	PUNCT
dpc-3506	126	1	according	accord	VERB
dpc-3506	126	2	to	to	ADP
dpc-3506	126	3	the	the	DET
dpc-3506	126	4	previous	previous	ADJ
dpc-3506	126	5	studies	study	NOUN
dpc-3506	126	6	,	,	PUNCT
dpc-3506	126	7	disease	disease	NOUN
dpc-3506	126	8	onset	onset	NOUN
dpc-3506	126	9	was	be	AUX
dpc-3506	126	10	between	between	ADP
dpc-3506	126	11	the	the	DET
dpc-3506	126	12	ages	age	NOUN
dpc-3506	126	13	of	of	ADP
dpc-3506	126	14	2	2	NUM
dpc-3506	126	15	and	and	CCONJ
dpc-3506	126	16	14	14	NUM
dpc-3506	126	17	for	for	ADP
dpc-3506	126	18	children	child	NOUN
dpc-3506	126	19	and	and	CCONJ
dpc-3506	126	20	43.3	43.3	NUM
dpc-3506	126	21	to	to	ADP
dpc-3506	126	22	44.8	44.8	NUM
dpc-3506	126	23	for	for	ADP
dpc-3506	126	24	adults	adult	NOUN
dpc-3506	126	25	[	[	X
dpc-3506	126	26	8,11,13,15,17,18,20	8,11,13,15,17,18,20	NUM
dpc-3506	126	27	]	]	X
dpc-3506	126	28	.	.	PUNCT
dpc-3506	127	1	we	we	PRON
dpc-3506	127	2	found	find	VERB
dpc-3506	127	3	that	that	SCONJ
dpc-3506	127	4	the	the	DET
dpc-3506	127	5	average	average	ADJ
dpc-3506	127	6	age	age	NOUN
dpc-3506	127	7	at	at	ADP
dpc-3506	127	8	which	which	PRON
dpc-3506	127	9	the	the	DET
dpc-3506	127	10	disease	disease	NOUN
dpc-3506	127	11	manifested	manifest	VERB
dpc-3506	127	12	itself	itself	PRON
dpc-3506	127	13	was	be	AUX
dpc-3506	127	14	36	36	NUM
dpc-3506	127	15	-	-	SYM
dpc-3506	127	16	43	43	NUM
dpc-3506	127	17	for	for	ADP
dpc-3506	127	18	aols	aol	NOUN
dpc-3506	127	19	,	,	PUNCT
dpc-3506	127	20	and	and	CCONJ
dpc-3506	127	21	13.5	13.5	NUM
dpc-3506	127	22	for	for	ADP
dpc-3506	127	23	pols	pol	NOUN
dpc-3506	127	24	.	.	PUNCT
dpc-3506	128	1	the	the	DET
dpc-3506	128	2	incidence	incidence	NOUN
dpc-3506	128	3	of	of	ADP
dpc-3506	128	4	linear	linear	PROPN
dpc-3506	128	5	morphea	morphea	PROPN
dpc-3506	128	6	in	in	ADP
dpc-3506	128	7	children	child	NOUN
dpc-3506	128	8	range	range	VERB
dpc-3506	128	9	from	from	ADP
dpc-3506	128	10	15.3	15.3	NUM
dpc-3506	128	11	%	%	NOUN
dpc-3506	128	12	to	to	ADP
dpc-3506	128	13	81	81	NUM
dpc-3506	128	14	%	%	NOUN
dpc-3506	128	15	[	[	X
dpc-3506	128	16	2,4,5,11,17,18,21	2,4,5,11,17,18,21	NUM
dpc-3506	128	17	]	]	PUNCT
dpc-3506	128	18	.	.	PUNCT
dpc-3506	129	1	in	in	ADP
dpc-3506	129	2	this	this	DET
dpc-3506	129	3	study	study	NOUN
dpc-3506	129	4	,	,	PUNCT
dpc-3506	129	5	linear	linear	PROPN
dpc-3506	129	6	morphea	morphea	PROPN
dpc-3506	129	7	was	be	AUX
dpc-3506	129	8	found	find	VERB
dpc-3506	129	9	to	to	PART
dpc-3506	129	10	be	be	AUX
dpc-3506	129	11	19.5	19.5	NUM
dpc-3506	129	12	%	%	NOUN
dpc-3506	129	13	for	for	ADP
dpc-3506	129	14	pols	pol	NOUN
dpc-3506	129	15	and	and	CCONJ
dpc-3506	129	16	8.5	8.5	NUM
dpc-3506	129	17	%	%	NOUN
dpc-3506	129	18	for	for	ADP
dpc-3506	129	19	aols	aol	NOUN
dpc-3506	129	20	supporting	support	VERB
dpc-3506	129	21	the	the	DET
dpc-3506	129	22	fact	fact	NOUN
dpc-3506	129	23	that	that	SCONJ
dpc-3506	129	24	the	the	DET
dpc-3506	129	25	linear	linear	ADJ
dpc-3506	129	26	type	type	NOUN
dpc-3506	129	27	starts	start	VERB
dpc-3506	129	28	more	more	ADV
dpc-3506	129	29	frequently	frequently	ADV
dpc-3506	129	30	in	in	ADP
dpc-3506	129	31	the	the	DET
dpc-3506	129	32	childhood	childhood	NOUN
dpc-3506	129	33	[	[	X
dpc-3506	129	34	6,11,14	6,11,14	NUM
dpc-3506	129	35	]	]	PUNCT
dpc-3506	129	36	.	.	PUNCT
dpc-3506	130	1	those	those	DET
dpc-3506	130	2	patients	patient	NOUN
dpc-3506	130	3	with	with	ADP
dpc-3506	130	4	the	the	DET
dpc-3506	130	5	pediatric	pediatric	ADJ
dpc-3506	130	6	onset	onset	NOUN
dpc-3506	130	7	naturally	naturally	ADV
dpc-3506	130	8	had	have	VERB
dpc-3506	130	9	a	a	DET
dpc-3506	130	10	longer	long	ADJ
dpc-3506	130	11	duration	duration	NOUN
dpc-3506	130	12	of	of	ADP
dpc-3506	130	13	illness	illness	NOUN
dpc-3506	130	14	.	.	PUNCT
dpc-3506	131	1	some	some	DET
dpc-3506	131	2	researchers	researcher	NOUN
dpc-3506	131	3	state	state	VERB
dpc-3506	131	4	that	that	SCONJ
dpc-3506	131	5	the	the	DET
dpc-3506	131	6	disease	disease	NOUN
dpc-3506	131	7	is	be	AUX
dpc-3506	131	8	more	more	ADV
dpc-3506	131	9	active	active	ADJ
dpc-3506	131	10	(	(	PUNCT
dpc-3506	131	11	20%-59	20%-59	NUM
dpc-3506	131	12	%	%	NOUN
dpc-3506	131	13	)	)	PUNCT
dpc-3506	131	14	in	in	ADP
dpc-3506	131	15	patients	patient	NOUN
dpc-3506	131	16	with	with	ADP
dpc-3506	131	17	pols	pol	NOUN
dpc-3506	131	18	[	[	X
dpc-3506	131	19	2,5,11	2,5,11	NUM
dpc-3506	131	20	]	]	PUNCT
dpc-3506	131	21	.	.	PUNCT
dpc-3506	132	1	the	the	DET
dpc-3506	132	2	linear	linear	ADJ
dpc-3506	132	3	type	type	NOUN
dpc-3506	132	4	was	be	AUX
dpc-3506	132	5	also	also	ADV
dpc-3506	132	6	reported	report	VERB
dpc-3506	132	7	to	to	PART
dpc-3506	132	8	be	be	AUX
dpc-3506	132	9	more	more	ADV
dpc-3506	132	10	sclerotic	sclerotic	ADJ
dpc-3506	132	11	than	than	ADP
dpc-3506	132	12	in	in	ADP
dpc-3506	132	13	adult	adult	NOUN
dpc-3506	132	14	-	-	PUNCT
dpc-3506	132	15	onset	onset	NOUN
dpc-3506	132	16	patients	patient	NOUN
dpc-3506	132	17	,	,	PUNCT
dpc-3506	132	18	and	and	CCONJ
dpc-3506	132	19	in	in	ADP
dpc-3506	132	20	the	the	DET
dpc-3506	132	21	present	present	ADJ
dpc-3506	132	22	study	study	NOUN
dpc-3506	132	23	,	,	PUNCT
dpc-3506	132	24	we	we	PRON
dpc-3506	132	25	found	find	VERB
dpc-3506	132	26	that	that	SCONJ
dpc-3506	132	27	there	there	PRON
dpc-3506	132	28	was	be	VERB
dpc-3506	132	29	more	more	ADJ
dpc-3506	132	30	sclerosis	sclerosis	NOUN
dpc-3506	132	31	in	in	ADP
dpc-3506	132	32	both	both	CCONJ
dpc-3506	132	33	linear	linear	ADJ
dpc-3506	132	34	and	and	CCONJ
dpc-3506	132	35	generalized	generalized	ADJ
dpc-3506	132	36	types	type	NOUN
dpc-3506	132	37	.	.	PUNCT
dpc-3506	133	1	sarocino	sarocino	PROPN
dpc-3506	133	2	et	et	PROPN
dpc-3506	133	3	al	al	PROPN
dpc-3506	133	4	found	find	VERB
dpc-3506	133	5	laboratory	laboratory	NOUN
dpc-3506	133	6	anomalies	anomaly	NOUN
dpc-3506	133	7	as	as	ADP
dpc-3506	133	8	40.4	40.4	NUM
dpc-3506	133	9	%	%	NOUN
dpc-3506	133	10	in	in	ADP
dpc-3506	133	11	linear	linear	ADJ
dpc-3506	133	12	type	type	NOUN
dpc-3506	133	13	[	[	X
dpc-3506	133	14	18	18	NUM
dpc-3506	133	15	]	]	PUNCT
dpc-3506	133	16	.	.	PUNCT
dpc-3506	134	1	in	in	ADP
dpc-3506	134	2	this	this	DET
dpc-3506	134	3	study	study	NOUN
dpc-3506	134	4	,	,	PUNCT
dpc-3506	134	5	at	at	ADP
dpc-3506	134	6	least	least	ADV
dpc-3506	134	7	one	one	NUM
dpc-3506	134	8	laboratory	laboratory	NOUN
dpc-3506	134	9	anomaly	anomaly	NOUN
dpc-3506	134	10	was	be	AUX
dpc-3506	134	11	present	present	ADJ
dpc-3506	134	12	in	in	ADP
dpc-3506	134	13	21	21	NUM
dpc-3506	134	14	%	%	NOUN
dpc-3506	134	15	table	table	NOUN
dpc-3506	134	16	2	2	NUM
dpc-3506	134	17	.	.	PUNCT
dpc-3506	134	18	laboratory	laboratory	NOUN
dpc-3506	134	19	findings	finding	NOUN
dpc-3506	134	20	of	of	ADP
dpc-3506	134	21	all	all	DET
dpc-3506	134	22	patients	patient	NOUN
dpc-3506	134	23	with	with	ADP
dpc-3506	134	24	morphea	morphea	PROPN
dpc-3506	134	25	and	and	CCONJ
dpc-3506	134	26	comparison	comparison	NOUN
dpc-3506	134	27	of	of	ADP
dpc-3506	134	28	pediatric	pediatric	ADJ
dpc-3506	134	29	and	and	CCONJ
dpc-3506	134	30	adultonset	adultonset	NOUN
dpc-3506	134	31	morphea	morphea	NOUN
dpc-3506	134	32	patients	patient	NOUN
dpc-3506	134	33	.	.	PUNCT
dpc-3506	135	1	characteristic	characteristic	ADJ
dpc-3506	135	2	total	total	ADJ
dpc-3506	135	3	patient	patient	NOUN
dpc-3506	135	4	n	n	CCONJ
dpc-3506	135	5	(	(	PUNCT
dpc-3506	135	6	%	%	INTJ
dpc-3506	135	7	)	)	PUNCT
dpc-3506	135	8	adult	adult	NOUN
dpc-3506	135	9	-	-	PUNCT
dpc-3506	135	10	onset	onset	NOUN
dpc-3506	135	11	n	n	NOUN
dpc-3506	135	12	(	(	PUNCT
dpc-3506	135	13	%	%	INTJ
dpc-3506	135	14	)	)	PUNCT
dpc-3506	135	15	pediatric	pediatric	ADJ
dpc-3506	135	16	-	-	PUNCT
dpc-3506	135	17	onset	onset	NOUN
dpc-3506	135	18	n	n	NOUN
dpc-3506	135	19	(	(	PUNCT
dpc-3506	135	20	%	%	INTJ
dpc-3506	135	21	)	)	PUNCT
dpc-3506	136	1	p	p	NOUN
dpc-3506	136	2	borelia	borelia	VERB
dpc-3506	136	3	positive	positive	ADJ
dpc-3506	136	4	negative	negative	ADJ
dpc-3506	136	5	5	5	NUM
dpc-3506	136	6	(	(	PUNCT
dpc-3506	136	7	6	6	NUM
dpc-3506	136	8	)	)	SYM
dpc-3506	136	9	79	79	NUM
dpc-3506	136	10	(	(	PUNCT
dpc-3506	136	11	94	94	NUM
dpc-3506	136	12	)	)	PUNCT
dpc-3506	136	13	3	3	NUM
dpc-3506	136	14	(	(	PUNCT
dpc-3506	136	15	4.8	4.8	NUM
dpc-3506	136	16	)	)	PUNCT
dpc-3506	136	17	60	60	NUM
dpc-3506	136	18	(	(	PUNCT
dpc-3506	136	19	95.2	95.2	NUM
dpc-3506	136	20	)	)	SYM
dpc-3506	136	21	2	2	NUM
dpc-3506	136	22	(	(	PUNCT
dpc-3506	136	23	9.5	9.5	NUM
dpc-3506	136	24	)	)	PUNCT
dpc-3506	136	25	19	19	NUM
dpc-3506	136	26	(	(	PUNCT
dpc-3506	136	27	90.5	90.5	NUM
dpc-3506	136	28	)	)	PUNCT
dpc-3506	136	29	0.42	0.42	NUM
dpc-3506	136	30	ana	ana	PROPN
dpc-3506	136	31	positive	positive	ADJ
dpc-3506	136	32	negative	negative	ADJ
dpc-3506	136	33	51	51	NUM
dpc-3506	136	34	(	(	PUNCT
dpc-3506	136	35	38.6	38.6	NUM
dpc-3506	136	36	)	)	PUNCT
dpc-3506	136	37	81	81	NUM
dpc-3506	136	38	(	(	PUNCT
dpc-3506	136	39	61.4	61.4	NUM
dpc-3506	136	40	)	)	PUNCT
dpc-3506	136	41	41	41	NUM
dpc-3506	136	42	(	(	PUNCT
dpc-3506	136	43	38.3	38.3	NUM
dpc-3506	136	44	)	)	PUNCT
dpc-3506	136	45	66	66	NUM
dpc-3506	136	46	(	(	PUNCT
dpc-3506	136	47	61.7	61.7	NUM
dpc-3506	136	48	)	)	PUNCT
dpc-3506	136	49	10	10	NUM
dpc-3506	136	50	(	(	PUNCT
dpc-3506	136	51	40	40	NUM
dpc-3506	136	52	)	)	SYM
dpc-3506	136	53	15	15	NUM
dpc-3506	136	54	(	(	PUNCT
dpc-3506	136	55	60	60	NUM
dpc-3506	136	56	)	)	PUNCT
dpc-3506	136	57	0.88	0.88	NUM
dpc-3506	136	58	anti	anti	ADJ
dpc-3506	136	59	-	-	ADJ
dpc-3506	136	60	dsdna	dsdna	ADV
dpc-3506	136	61	positive	positive	ADJ
dpc-3506	136	62	negative	negative	ADJ
dpc-3506	136	63	13	13	NUM
dpc-3506	136	64	(	(	PUNCT
dpc-3506	136	65	11.1	11.1	NUM
dpc-3506	136	66	)	)	PUNCT
dpc-3506	136	67	104	104	NUM
dpc-3506	136	68	(	(	PUNCT
dpc-3506	136	69	88.9	88.9	NUM
dpc-3506	136	70	)	)	PUNCT
dpc-3506	136	71	13	13	NUM
dpc-3506	136	72	(	(	PUNCT
dpc-3506	136	73	13.7	13.7	NUM
dpc-3506	136	74	)	)	PUNCT
dpc-3506	136	75	82	82	NUM
dpc-3506	136	76	(	(	PUNCT
dpc-3506	136	77	86.3	86.3	NUM
dpc-3506	136	78	)	)	PUNCT
dpc-3506	136	79	0	0	NUM
dpc-3506	137	1	(	(	PUNCT
dpc-3506	137	2	0	0	NUM
dpc-3506	137	3	)	)	PUNCT
dpc-3506	137	4	22	22	NUM
dpc-3506	137	5	(	(	PUNCT
dpc-3506	137	6	100	100	NUM
dpc-3506	137	7	)	)	PUNCT
dpc-3506	137	8	0.066	0.066	NUM
dpc-3506	137	9	hba	hba	NOUN
dpc-3506	137	10	13.5	13.5	NUM
dpc-3506	137	11	(	(	PUNCT
dpc-3506	137	12	1.4	1.4	NUM
dpc-3506	137	13	)	)	PUNCT
dpc-3506	137	14	13.5	13.5	NUM
dpc-3506	137	15	(	(	PUNCT
dpc-3506	137	16	1.4	1.4	NUM
dpc-3506	137	17	)	)	PUNCT
dpc-3506	137	18	13.5	13.5	NUM
dpc-3506	137	19	(	(	PUNCT
dpc-3506	137	20	1.7	1.7	NUM
dpc-3506	137	21	)	)	PUNCT
dpc-3506	137	22	0.71	0.71	NUM
dpc-3506	137	23	leukocytea	leukocytea	NOUN
dpc-3506	137	24	6.7	6.7	NUM
dpc-3506	137	25	(	(	PUNCT
dpc-3506	137	26	1.8	1.8	NUM
dpc-3506	137	27	)	)	PUNCT
dpc-3506	137	28	6.8	6.8	NUM
dpc-3506	137	29	(	(	PUNCT
dpc-3506	137	30	1.8	1.8	NUM
dpc-3506	137	31	)	)	PUNCT
dpc-3506	137	32	6.1	6.1	NUM
dpc-3506	137	33	(	(	PUNCT
dpc-3506	137	34	1.4	1.4	NUM
dpc-3506	137	35	)	)	PUNCT
dpc-3506	137	36	0.14	0.14	NUM
dpc-3506	137	37	plateleta	plateleta	NOUN
dpc-3506	137	38	276.7	276.7	NUM
dpc-3506	137	39	(	(	PUNCT
dpc-3506	137	40	67.8	67.8	NUM
dpc-3506	137	41	)	)	PUNCT
dpc-3506	137	42	275.1	275.1	NUM
dpc-3506	137	43	(	(	PUNCT
dpc-3506	137	44	66.6	66.6	NUM
dpc-3506	137	45	)	)	PUNCT
dpc-3506	137	46	288.9	288.9	NUM
dpc-3506	137	47	(	(	PUNCT
dpc-3506	137	48	77.6	77.6	NUM
dpc-3506	137	49	)	)	PUNCT
dpc-3506	137	50	0.78	0.78	NUM
dpc-3506	137	51	nlrb	nlrb	ADJ
dpc-3506	137	52	1.9	1.9	NUM
dpc-3506	137	53	(	(	PUNCT
dpc-3506	137	54	1.5	1.5	NUM
dpc-3506	137	55	-	-	SYM
dpc-3506	137	56	2.6	2.6	NUM
dpc-3506	137	57	)	)	PUNCT
dpc-3506	137	58	1.9	1.9	NUM
dpc-3506	137	59	(	(	PUNCT
dpc-3506	137	60	1.5	1.5	NUM
dpc-3506	137	61	-	-	SYM
dpc-3506	137	62	2.6	2.6	NUM
dpc-3506	137	63	)	)	PUNCT
dpc-3506	137	64	1.9	1.9	NUM
dpc-3506	137	65	(	(	PUNCT
dpc-3506	137	66	1.3	1.3	NUM
dpc-3506	137	67	-	-	SYM
dpc-3506	137	68	2.2	2.2	NUM
dpc-3506	137	69	)	)	PUNCT
dpc-3506	137	70	0.33	0.33	NUM
dpc-3506	137	71	eosinophilb	eosinophilb	NOUN
dpc-3506	137	72	0.14	0.14	NUM
dpc-3506	137	73	(	(	PUNCT
dpc-3506	137	74	0.08	0.08	NUM
dpc-3506	137	75	-	-	SYM
dpc-3506	137	76	0.25	0.25	NUM
dpc-3506	137	77	)	)	PUNCT
dpc-3506	137	78	0.14	0.14	NUM
dpc-3506	137	79	(	(	PUNCT
dpc-3506	137	80	0.09	0.09	NUM
dpc-3506	137	81	-	-	PUNCT
dpc-3506	137	82	0.25	0.25	NUM
dpc-3506	137	83	)	)	PUNCT
dpc-3506	137	84	0.15	0.15	NUM
dpc-3506	137	85	(	(	PUNCT
dpc-3506	137	86	0.07	0.07	NUM
dpc-3506	137	87	-	-	SYM
dpc-3506	137	88	0.29	0.29	NUM
dpc-3506	137	89	)	)	PUNCT
dpc-3506	137	90	0.95	0.95	NUM
dpc-3506	137	91	eosinophil	eosinophil	ADJ
dpc-3506	137	92	(	(	PUNCT
dpc-3506	137	93	%	%	INTJ
dpc-3506	137	94	)	)	PUNCT
dpc-3506	137	95	b	b	NOUN
dpc-3506	137	96	2.1	2.1	NUM
dpc-3506	137	97	(	(	PUNCT
dpc-3506	137	98	1.2	1.2	NUM
dpc-3506	137	99	-	-	SYM
dpc-3506	137	100	3.4	3.4	NUM
dpc-3506	137	101	)	)	PUNCT
dpc-3506	137	102	2.1	2.1	NUM
dpc-3506	137	103	(	(	PUNCT
dpc-3506	137	104	1.2	1.2	NUM
dpc-3506	137	105	-	-	SYM
dpc-3506	137	106	3.4	3.4	NUM
dpc-3506	137	107	)	)	PUNCT
dpc-3506	137	108	2.6	2.6	NUM
dpc-3506	137	109	(	(	PUNCT
dpc-3506	137	110	1	1	NUM
dpc-3506	137	111	-	-	SYM
dpc-3506	137	112	3.2	3.2	NUM
dpc-3506	137	113	)	)	PUNCT
dpc-3506	137	114	0.77	0.77	NUM
dpc-3506	137	115	sedimentationb	sedimentationb	NOUN
dpc-3506	137	116	10	10	NUM
dpc-3506	137	117	(	(	PUNCT
dpc-3506	137	118	6	6	NUM
dpc-3506	137	119	-	-	SYM
dpc-3506	137	120	19	19	NUM
dpc-3506	137	121	)	)	PUNCT
dpc-3506	137	122	10	10	NUM
dpc-3506	137	123	(	(	PUNCT
dpc-3506	137	124	6	6	NUM
dpc-3506	137	125	-	-	SYM
dpc-3506	137	126	19	19	NUM
dpc-3506	137	127	)	)	PUNCT
dpc-3506	137	128	9	9	NUM
dpc-3506	137	129	(	(	PUNCT
dpc-3506	137	130	5.3	5.3	NUM
dpc-3506	137	131	-	-	SYM
dpc-3506	137	132	17	17	NUM
dpc-3506	137	133	)	)	PUNCT
dpc-3506	137	134	0.52	0.52	NUM
dpc-3506	137	135	crpb	crpb	NOUN
dpc-3506	137	136	0.06	0.06	NUM
dpc-3506	137	137	(	(	PUNCT
dpc-3506	137	138	0.01	0.01	NUM
dpc-3506	137	139	-	-	PUNCT
dpc-3506	137	140	7.5	7.5	NUM
dpc-3506	137	141	)	)	PUNCT
dpc-3506	137	142	0.07	0.07	NUM
dpc-3506	137	143	(	(	PUNCT
dpc-3506	137	144	0.01	0.01	NUM
dpc-3506	137	145	-	-	PUNCT
dpc-3506	137	146	10	10	NUM
dpc-3506	137	147	)	)	PUNCT
dpc-3506	137	148	0.03	0.03	NUM
dpc-3506	137	149	(	(	PUNCT
dpc-3506	137	150	0.005	0.005	NUM
dpc-3506	137	151	-	-	SYM
dpc-3506	137	152	2	2	NUM
dpc-3506	137	153	)	)	PUNCT
dpc-3506	137	154	0.17	0.17	NUM
dpc-3506	137	155	vit	vit	NOUN
dpc-3506	137	156	d	d	NOUN
dpc-3506	137	157	deficiency	deficiency	NOUN
dpc-3506	137	158	38	38	NUM
dpc-3506	137	159	(	(	PUNCT
dpc-3506	137	160	20.76	20.76	NUM
dpc-3506	137	161	%	%	NOUN
dpc-3506	137	162	)	)	PUNCT
dpc-3506	137	163	30	30	NUM
dpc-3506	137	164	(	(	PUNCT
dpc-3506	137	165	21.12	21.12	NUM
dpc-3506	137	166	)	)	PUNCT
dpc-3506	137	167	14	14	NUM
dpc-3506	137	168	(	(	PUNCT
dpc-3506	137	169	19.5	19.5	NUM
dpc-3506	137	170	)	)	PUNCT
dpc-3506	137	171	0.19	0.19	NUM
dpc-3506	137	172	iron	iron	NOUN
dpc-3506	137	173	deficiency	deficiency	NOUN
dpc-3506	137	174	47	47	NUM
dpc-3506	137	175	(	(	PUNCT
dpc-3506	137	176	25.68	25.68	NUM
dpc-3506	137	177	%	%	NOUN
dpc-3506	137	178	)	)	PUNCT
dpc-3506	137	179	33	33	NUM
dpc-3506	137	180	(	(	PUNCT
dpc-3506	137	181	23.23	23.23	NUM
dpc-3506	137	182	)	)	PUNCT
dpc-3506	137	183	14	14	NUM
dpc-3506	137	184	(	(	PUNCT
dpc-3506	137	185	34.1	34.1	NUM
dpc-3506	137	186	)	)	PUNCT
dpc-3506	137	187	0.11	0.11	NUM
dpc-3506	137	188	vit	vit	ADJ
dpc-3506	137	189	b12	b12	NOUN
dpc-3506	137	190	deficiency	deficiency	NOUN
dpc-3506	137	191	18	18	NUM
dpc-3506	137	192	(	(	PUNCT
dpc-3506	137	193	9.8	9.8	NUM
dpc-3506	137	194	%	%	NOUN
dpc-3506	137	195	)	)	PUNCT
dpc-3506	137	196	12	12	NUM
dpc-3506	137	197	(	(	PUNCT
dpc-3506	137	198	8.45	8.45	NUM
dpc-3506	137	199	)	)	PUNCT
dpc-3506	137	200	6	6	NUM
dpc-3506	137	201	(	(	PUNCT
dpc-3506	137	202	14.6	14.6	NUM
dpc-3506	137	203	)	)	PUNCT
dpc-3506	137	204	0.46	0.46	NUM
dpc-3506	137	205	nlr	nlr	PROPN
dpc-3506	138	1	=	=	PUNCT
dpc-3506	139	1	neutrophil	neutrophil	ADJ
dpc-3506	139	2	lymphocyte	lymphocyte	ADJ
dpc-3506	139	3	ratio	ratio	NOUN
dpc-3506	139	4	.	.	PUNCT
dpc-3506	140	1	amain	amain	ADV
dpc-3506	140	2	(	(	PUNCT
dpc-3506	140	3	standard	standard	ADJ
dpc-3506	140	4	deviation	deviation	NOUN
dpc-3506	140	5	,	,	PUNCT
dpc-3506	140	6	sd	sd	NOUN
dpc-3506	140	7	)	)	PUNCT
dpc-3506	140	8	,	,	PUNCT
dpc-3506	140	9	bmedian	bmedian	PROPN
dpc-3506	140	10	(	(	PUNCT
dpc-3506	140	11	interquartile	interquartile	NOUN
dpc-3506	140	12	range	range	NOUN
dpc-3506	140	13	)	)	PUNCT
dpc-3506	140	14	.	.	PUNCT
dpc-3506	141	1	6	6	NUM
dpc-3506	141	2	original	original	ADJ
dpc-3506	141	3	article	article	NOUN
dpc-3506	141	4	|	|	ADV
dpc-3506	141	5	dermatol	dermatol	ADJ
dpc-3506	141	6	pract	pract	NOUN
dpc-3506	141	7	concept	concept	NOUN
dpc-3506	141	8	.	.	PUNCT
dpc-3506	142	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	142	2	table	table	NOUN
dpc-3506	142	3	3	3	NUM
dpc-3506	142	4	.	.	PUNCT
dpc-3506	142	5	comparison	comparison	NOUN
dpc-3506	142	6	of	of	ADP
dpc-3506	142	7	presence	presence	NOUN
dpc-3506	142	8	of	of	ADP
dpc-3506	142	9	additional	additional	ADJ
dpc-3506	142	10	disease	disease	NOUN
dpc-3506	142	11	of	of	ADP
dpc-3506	142	12	adolescentand	adolescentand	ADJ
dpc-3506	142	13	adult	adult	NOUN
dpc-3506	142	14	-	-	PUNCT
dpc-3506	142	15	onset	onset	NOUN
dpc-3506	142	16	morphea	morphea	NOUN
dpc-3506	142	17	patients	patient	NOUN
dpc-3506	142	18	.	.	PUNCT
dpc-3506	143	1	comorbid	comorbid	NOUN
dpc-3506	143	2	diseases	disease	NOUN
dpc-3506	143	3	adult	adult	NOUN
dpc-3506	143	4	-	-	PUNCT
dpc-3506	143	5	onset	onset	NOUN
dpc-3506	143	6	n	n	NOUN
dpc-3506	143	7	=	=	SYM
dpc-3506	143	8	142	142	NUM
dpc-3506	143	9	patients	patient	NOUN
dpc-3506	143	10	pediatric	pediatric	ADJ
dpc-3506	143	11	onset	onset	NOUN
dpc-3506	143	12	n	n	NOUN
dpc-3506	143	13	=	=	SYM
dpc-3506	143	14	41	41	NUM
dpc-3506	143	15	patients	patient	NOUN
dpc-3506	143	16	total	total	VERB
dpc-3506	143	17	n	n	NOUN
dpc-3506	143	18	=	=	SYM
dpc-3506	143	19	183	183	NUM
dpc-3506	143	20	skin	skin	NOUN
dpc-3506	143	21	diseases	disease	NOUN
dpc-3506	143	22	n	n	PRON
dpc-3506	143	23	(	(	PUNCT
dpc-3506	143	24	%	%	INTJ
dpc-3506	143	25	)	)	PUNCT
dpc-3506	143	26	vitiligo	vitiligo	VERB
dpc-3506	143	27	psoriasis	psoriasis	NOUN
dpc-3506	143	28	a.areata	a.areata	ADJ
dpc-3506	143	29	lsa	lsa	PROPN
dpc-3506	143	30	bcc	bcc	PROPN
dpc-3506	143	31	verruka	verruka	PROPN
dpc-3506	143	32	vulgaris	vulgaris	NOUN
dpc-3506	143	33	3	3	NUM
dpc-3506	143	34	(	(	PUNCT
dpc-3506	143	35	2.11	2.11	NUM
dpc-3506	143	36	)	)	PUNCT
dpc-3506	143	37	3	3	NUM
dpc-3506	143	38	(	(	PUNCT
dpc-3506	143	39	2.11	2.11	NUM
dpc-3506	143	40	)	)	PUNCT
dpc-3506	143	41	2	2	NUM
dpc-3506	143	42	(	(	PUNCT
dpc-3506	143	43	1.4	1.4	NUM
dpc-3506	143	44	)	)	PUNCT
dpc-3506	143	45	3	3	NUM
dpc-3506	143	46	(	(	PUNCT
dpc-3506	143	47	2.11	2.11	NUM
dpc-3506	143	48	)	)	PUNCT
dpc-3506	143	49	1	1	NUM
dpc-3506	143	50	(	(	PUNCT
dpc-3506	143	51	0.7	0.7	NUM
dpc-3506	143	52	)	)	SYM
dpc-3506	143	53	1	1	NUM
dpc-3506	143	54	(	(	PUNCT
dpc-3506	143	55	0.7	0.7	NUM
dpc-3506	143	56	)	)	PUNCT
dpc-3506	143	57	13	13	NUM
dpc-3506	143	58	(	(	PUNCT
dpc-3506	143	59	7.1	7.1	NUM
dpc-3506	143	60	)	)	PUNCT
dpc-3506	143	61	3	3	NUM
dpc-3506	143	62	(	(	PUNCT
dpc-3506	143	63	1.63	1.63	NUM
dpc-3506	143	64	)	)	PUNCT
dpc-3506	143	65	3	3	NUM
dpc-3506	143	66	(	(	PUNCT
dpc-3506	143	67	1.63	1.63	NUM
dpc-3506	143	68	)	)	PUNCT
dpc-3506	143	69	2	2	NUM
dpc-3506	143	70	(	(	PUNCT
dpc-3506	143	71	1.09	1.09	NUM
dpc-3506	143	72	)	)	PUNCT
dpc-3506	143	73	3	3	NUM
dpc-3506	143	74	(	(	PUNCT
dpc-3506	143	75	1.63	1.63	NUM
dpc-3506	143	76	)	)	PUNCT
dpc-3506	143	77	1	1	NUM
dpc-3506	143	78	(	(	PUNCT
dpc-3506	143	79	0.5	0.5	NUM
dpc-3506	143	80	)	)	PUNCT
dpc-3506	143	81	1	1	NUM
dpc-3506	143	82	(	(	PUNCT
dpc-3506	143	83	0.5	0.5	NUM
dpc-3506	143	84	)	)	PUNCT
dpc-3506	143	85	rheumatological	rheumatological	ADJ
dpc-3506	143	86	diseases	disease	NOUN
dpc-3506	143	87	,	,	PUNCT
dpc-3506	143	88	n	n	PROPN
dpc-3506	143	89	(	(	PUNCT
dpc-3506	143	90	%	%	INTJ
dpc-3506	143	91	)	)	PUNCT
dpc-3506	143	92	ankylosing	ankylose	VERB
dpc-3506	143	93	spondylitis	spondylitis	NOUN
dpc-3506	143	94	rheumatoid	rheumatoid	NOUN
dpc-3506	143	95	arthritis	arthritis	NOUN
dpc-3506	143	96	scleroderma	scleroderma	NOUN
dpc-3506	143	97	sacroileitis	sacroileitis	ADV
dpc-3506	143	98	spondyloarthropathy	spondyloarthropathy	VERB
dpc-3506	143	99	1	1	NUM
dpc-3506	143	100	(	(	PUNCT
dpc-3506	143	101	0.7	0.7	NUM
dpc-3506	143	102	)	)	PUNCT
dpc-3506	143	103	3	3	NUM
dpc-3506	143	104	(	(	PUNCT
dpc-3506	143	105	2.11	2.11	NUM
dpc-3506	143	106	)	)	PUNCT
dpc-3506	143	107	1	1	NUM
dpc-3506	143	108	(	(	PUNCT
dpc-3506	143	109	0.7	0.7	NUM
dpc-3506	143	110	)	)	SYM
dpc-3506	143	111	1	1	NUM
dpc-3506	143	112	(	(	PUNCT
dpc-3506	143	113	0.7	0.7	NUM
dpc-3506	143	114	)	)	SYM
dpc-3506	143	115	1	1	NUM
dpc-3506	143	116	(	(	PUNCT
dpc-3506	143	117	0.7	0.7	NUM
dpc-3506	143	118	)	)	PUNCT
dpc-3506	143	119	7	7	NUM
dpc-3506	143	120	(	(	PUNCT
dpc-3506	143	121	3.18	3.18	NUM
dpc-3506	143	122	)	)	PUNCT
dpc-3506	143	123	2	2	NUM
dpc-3506	143	124	(	(	PUNCT
dpc-3506	143	125	1.09	1.09	NUM
dpc-3506	143	126	)	)	SYM
dpc-3506	143	127	2	2	NUM
dpc-3506	143	128	(	(	PUNCT
dpc-3506	143	129	1.09	1.09	NUM
dpc-3506	143	130	)	)	SYM
dpc-3506	143	131	1	1	NUM
dpc-3506	143	132	(	(	PUNCT
dpc-3506	143	133	0.5	0.5	NUM
dpc-3506	143	134	)	)	PUNCT
dpc-3506	143	135	1	1	NUM
dpc-3506	143	136	(	(	PUNCT
dpc-3506	143	137	0.5	0.5	NUM
dpc-3506	143	138	)	)	PUNCT
dpc-3506	143	139	1	1	NUM
dpc-3506	143	140	(	(	PUNCT
dpc-3506	143	141	0	0	NUM
dpc-3506	143	142	)	)	PUNCT
dpc-3506	143	143	thyroid	thyroid	NOUN
dpc-3506	143	144	disease	disease	NOUN
dpc-3506	143	145	n	n	PROPN
dpc-3506	143	146	(	(	PUNCT
dpc-3506	143	147	%	%	INTJ
dpc-3506	143	148	)	)	PUNCT
dpc-3506	143	149	15	15	NUM
dpc-3506	143	150	(	(	PUNCT
dpc-3506	143	151	10.56	10.56	NUM
dpc-3506	143	152	)	)	SYM
dpc-3506	143	153	1	1	NUM
dpc-3506	143	154	(	(	PUNCT
dpc-3506	143	155	2.4	2.4	NUM
dpc-3506	143	156	)	)	PUNCT
dpc-3506	143	157	16	16	NUM
dpc-3506	143	158	(	(	PUNCT
dpc-3506	143	159	8.74	8.74	NUM
dpc-3506	143	160	)	)	PUNCT
dpc-3506	143	161	diabetes	diabetes	NOUN
dpc-3506	143	162	mellitus	mellitus	NOUN
dpc-3506	143	163	n	n	PROPN
dpc-3506	143	164	(	(	PUNCT
dpc-3506	143	165	%	%	INTJ
dpc-3506	143	166	)	)	PUNCT
dpc-3506	143	167	11	11	NUM
dpc-3506	143	168	(	(	PUNCT
dpc-3506	143	169	7.74	7.74	NUM
dpc-3506	143	170	)	)	PUNCT
dpc-3506	143	171	3	3	NUM
dpc-3506	143	172	(	(	PUNCT
dpc-3506	143	173	7.31	7.31	NUM
dpc-3506	143	174	)	)	PUNCT
dpc-3506	143	175	14	14	NUM
dpc-3506	143	176	(	(	PUNCT
dpc-3506	143	177	7.65	7.65	NUM
dpc-3506	143	178	)	)	PUNCT
dpc-3506	143	179	hypertension	hypertension	NOUN
dpc-3506	143	180	,	,	PUNCT
dpc-3506	143	181	n	n	CCONJ
dpc-3506	143	182	(	(	PUNCT
dpc-3506	143	183	%	%	INTJ
dpc-3506	143	184	)	)	PUNCT
dpc-3506	143	185	15	15	NUM
dpc-3506	143	186	(	(	PUNCT
dpc-3506	143	187	10.56	10.56	NUM
dpc-3506	143	188	)	)	SYM
dpc-3506	143	189	2	2	NUM
dpc-3506	143	190	(	(	PUNCT
dpc-3506	143	191	4.9	4.9	NUM
dpc-3506	143	192	)	)	PUNCT
dpc-3506	143	193	17	17	NUM
dpc-3506	143	194	(	(	PUNCT
dpc-3506	143	195	7.1	7.1	NUM
dpc-3506	143	196	)	)	PUNCT
dpc-3506	143	197	asthma	asthma	NOUN
dpc-3506	143	198	n	n	PROPN
dpc-3506	143	199	(	(	PUNCT
dpc-3506	143	200	%	%	INTJ
dpc-3506	143	201	)	)	PUNCT
dpc-3506	143	202	3	3	NUM
dpc-3506	143	203	(	(	PUNCT
dpc-3506	143	204	2.11	2.11	NUM
dpc-3506	143	205	)	)	PUNCT
dpc-3506	143	206	2	2	NUM
dpc-3506	143	207	(	(	PUNCT
dpc-3506	143	208	4.9	4.9	NUM
dpc-3506	143	209	)	)	PUNCT
dpc-3506	143	210	5	5	NUM
dpc-3506	143	211	(	(	PUNCT
dpc-3506	143	212	1.73	1.73	NUM
dpc-3506	143	213	)	)	PUNCT
dpc-3506	143	214	fibromyalgia	fibromyalgia	NOUN
dpc-3506	143	215	,	,	PUNCT
dpc-3506	143	216	n	n	CCONJ
dpc-3506	143	217	(	(	PUNCT
dpc-3506	143	218	%	%	INTJ
dpc-3506	143	219	)	)	PUNCT
dpc-3506	143	220	2	2	NUM
dpc-3506	143	221	(	(	PUNCT
dpc-3506	143	222	1.4	1.4	NUM
dpc-3506	143	223	)	)	PUNCT
dpc-3506	143	224	2	2	NUM
dpc-3506	143	225	(	(	PUNCT
dpc-3506	143	226	1.09	1.09	NUM
dpc-3506	143	227	)	)	PUNCT
dpc-3506	143	228	ulcerative	ulcerative	ADJ
dpc-3506	143	229	colitis	colitis	NOUN
dpc-3506	143	230	,	,	PUNCT
dpc-3506	143	231	n	n	PROPN
dpc-3506	143	232	(	(	PUNCT
dpc-3506	143	233	%	%	INTJ
dpc-3506	143	234	)	)	PUNCT
dpc-3506	143	235	1	1	NUM
dpc-3506	143	236	(	(	PUNCT
dpc-3506	143	237	0.7	0.7	NUM
dpc-3506	143	238	)	)	SYM
dpc-3506	143	239	1	1	NUM
dpc-3506	143	240	(	(	PUNCT
dpc-3506	143	241	0.5	0.5	NUM
dpc-3506	143	242	)	)	PUNCT
dpc-3506	143	243	autoimmune	autoimmune	ADJ
dpc-3506	143	244	hepatitis	hepatitis	PROPN
dpc-3506	143	245	,	,	PUNCT
dpc-3506	143	246	n	n	CCONJ
dpc-3506	143	247	(	(	PUNCT
dpc-3506	143	248	%	%	INTJ
dpc-3506	143	249	)	)	PUNCT
dpc-3506	143	250	1	1	NUM
dpc-3506	143	251	(	(	PUNCT
dpc-3506	143	252	07	07	NUM
dpc-3506	143	253	)	)	SYM
dpc-3506	143	254	1	1	NUM
dpc-3506	143	255	(	(	PUNCT
dpc-3506	143	256	0.5	0.5	NUM
dpc-3506	143	257	)	)	PUNCT
dpc-3506	143	258	familial	familial	ADJ
dpc-3506	143	259	mediterranean	mediterranean	ADJ
dpc-3506	143	260	fever	fever	NOUN
dpc-3506	143	261	,	,	PUNCT
dpc-3506	143	262	n	n	PROPN
dpc-3506	143	263	(	(	PUNCT
dpc-3506	143	264	%	%	INTJ
dpc-3506	143	265	)	)	PUNCT
dpc-3506	143	266	2	2	NUM
dpc-3506	143	267	(	(	PUNCT
dpc-3506	143	268	1.4	1.4	NUM
dpc-3506	143	269	)	)	PUNCT
dpc-3506	143	270	2	2	NUM
dpc-3506	143	271	(	(	PUNCT
dpc-3506	143	272	1.09	1.09	NUM
dpc-3506	143	273	)	)	PUNCT
dpc-3506	143	274	ferritin	ferritin	ADJ
dpc-3506	143	275	deficiency	deficiency	NOUN
dpc-3506	143	276	anemia	anemia	NOUN
dpc-3506	143	277	n	n	CCONJ
dpc-3506	143	278	(	(	PUNCT
dpc-3506	143	279	%	%	INTJ
dpc-3506	143	280	)	)	PUNCT
dpc-3506	143	281	33	33	NUM
dpc-3506	143	282	(	(	PUNCT
dpc-3506	143	283	23.23	23.23	NUM
dpc-3506	143	284	)	)	PUNCT
dpc-3506	143	285	14	14	NUM
dpc-3506	143	286	(	(	PUNCT
dpc-3506	143	287	34.1	34.1	NUM
dpc-3506	143	288	)	)	PUNCT
dpc-3506	143	289	47	47	NUM
dpc-3506	143	290	(	(	PUNCT
dpc-3506	143	291	25.68	25.68	NUM
dpc-3506	143	292	)	)	PUNCT
dpc-3506	143	293	vitamin	vitamin	NOUN
dpc-3506	143	294	b12	b12	NOUN
dpc-3506	143	295	deficiency	deficiency	NOUN
dpc-3506	143	296	anemia	anemia	NOUN
dpc-3506	143	297	n	n	CCONJ
dpc-3506	143	298	(	(	PUNCT
dpc-3506	143	299	%	%	INTJ
dpc-3506	143	300	)	)	PUNCT
dpc-3506	143	301	12	12	NUM
dpc-3506	143	302	(	(	PUNCT
dpc-3506	143	303	8.45	8.45	NUM
dpc-3506	143	304	)	)	PUNCT
dpc-3506	143	305	6	6	NUM
dpc-3506	143	306	(	(	PUNCT
dpc-3506	143	307	14.6	14.6	NUM
dpc-3506	143	308	)	)	PUNCT
dpc-3506	143	309	18	18	NUM
dpc-3506	143	310	(	(	PUNCT
dpc-3506	143	311	9.8	9.8	NUM
dpc-3506	143	312	)	)	PUNCT
dpc-3506	143	313	vitamin	vitamin	NOUN
dpc-3506	143	314	d	d	NOUN
dpc-3506	143	315	deficiency	deficiency	NOUN
dpc-3506	143	316	n	n	PROPN
dpc-3506	143	317	(	(	PUNCT
dpc-3506	143	318	%	%	INTJ
dpc-3506	143	319	)	)	PUNCT
dpc-3506	143	320	30	30	NUM
dpc-3506	143	321	(	(	PUNCT
dpc-3506	143	322	21.12	21.12	NUM
dpc-3506	143	323	)	)	PUNCT
dpc-3506	143	324	8	8	NUM
dpc-3506	143	325	(	(	PUNCT
dpc-3506	143	326	19.5	19.5	NUM
dpc-3506	143	327	)	)	PUNCT
dpc-3506	143	328	38	38	NUM
dpc-3506	143	329	(	(	PUNCT
dpc-3506	143	330	20.76	20.76	NUM
dpc-3506	143	331	)	)	PUNCT
dpc-3506	143	332	depression	depression	NOUN
dpc-3506	143	333	n	n	PROPN
dpc-3506	143	334	(	(	PUNCT
dpc-3506	143	335	%	%	INTJ
dpc-3506	143	336	)	)	PUNCT
dpc-3506	143	337	2	2	NUM
dpc-3506	143	338	(	(	PUNCT
dpc-3506	143	339	1.4	1.4	NUM
dpc-3506	143	340	)	)	PUNCT
dpc-3506	143	341	1	1	NUM
dpc-3506	143	342	(	(	PUNCT
dpc-3506	143	343	2.4	2.4	NUM
dpc-3506	143	344	)	)	PUNCT
dpc-3506	143	345	3	3	NUM
dpc-3506	143	346	(	(	PUNCT
dpc-3506	143	347	1.63	1.63	NUM
dpc-3506	143	348	)	)	PUNCT
dpc-3506	143	349	other	other	ADJ
dpc-3506	143	350	diseases	disease	NOUN
dpc-3506	143	351	migraine	migraine	NOUN
dpc-3506	143	352	,	,	PUNCT
dpc-3506	143	353	vertigo	vertigo	NOUN
dpc-3506	143	354	,	,	PUNCT
dpc-3506	143	355	renal	renal	ADJ
dpc-3506	143	356	failure	failure	NOUN
dpc-3506	143	357	n	n	CCONJ
dpc-3506	143	358	(	(	PUNCT
dpc-3506	143	359	%	%	INTJ
dpc-3506	143	360	)	)	PUNCT
dpc-3506	143	361	3	3	NUM
dpc-3506	143	362	(	(	PUNCT
dpc-3506	143	363	1.4	1.4	NUM
dpc-3506	143	364	%	%	NOUN
dpc-3506	143	365	)	)	PUNCT
dpc-3506	143	366	3	3	NUM
dpc-3506	143	367	(	(	PUNCT
dpc-3506	143	368	1.5	1.5	NUM
dpc-3506	143	369	%	%	NOUN
dpc-3506	143	370	)	)	PUNCT
dpc-3506	143	371	total	total	NOUN
dpc-3506	143	372	n	n	CCONJ
dpc-3506	143	373	(	(	PUNCT
dpc-3506	143	374	%	%	INTJ
dpc-3506	143	375	)	)	PUNCT
dpc-3506	143	376	101	101	NUM
dpc-3506	143	377	(	(	PUNCT
dpc-3506	143	378	55.19	55.19	NUM
dpc-3506	143	379	%	%	NOUN
dpc-3506	143	380	)	)	PUNCT
dpc-3506	143	381	137	137	NUM
dpc-3506	143	382	(	(	PUNCT
dpc-3506	143	383	96.47	96.47	NUM
dpc-3506	143	384	%	%	NOUN
dpc-3506	143	385	)	)	PUNCT
dpc-3506	143	386	36	36	NUM
dpc-3506	143	387	(	(	PUNCT
dpc-3506	143	388	87.80	87.80	NUM
dpc-3506	143	389	%	%	NOUN
dpc-3506	143	390	)	)	PUNCT
dpc-3506	143	391	173	173	NUM
dpc-3506	143	392	(	(	PUNCT
dpc-3506	143	393	95	95	NUM
dpc-3506	143	394	%	%	NOUN
dpc-3506	143	395	)	)	PUNCT
dpc-3506	143	396	table	table	NOUN
dpc-3506	143	397	4	4	NUM
dpc-3506	143	398	.	.	PUNCT
dpc-3506	143	399	comparison	comparison	NOUN
dpc-3506	143	400	of	of	ADP
dpc-3506	143	401	treatments	treatment	NOUN
dpc-3506	143	402	given	give	VERB
dpc-3506	143	403	to	to	ADP
dpc-3506	143	404	pediatric	pediatric	ADJ
dpc-3506	143	405	morphea	morphea	PROPN
dpc-3506	143	406	and	and	CCONJ
dpc-3506	143	407	adult	adult	PROPN
dpc-3506	143	408	morphea	morphea	NOUN
dpc-3506	143	409	.	.	PUNCT
dpc-3506	144	1	treatments	treatment	NOUN
dpc-3506	144	2	used	use	VERB
dpc-3506	144	3	total	total	ADJ
dpc-3506	144	4	patients	patient	NOUN
dpc-3506	144	5	adult	adult	NOUN
dpc-3506	144	6	-	-	PUNCT
dpc-3506	144	7	onset	onset	NOUN
dpc-3506	144	8	pediatric	pediatric	NOUN
dpc-3506	144	9	-	-	PUNCT
dpc-3506	144	10	onset	onset	NOUN
dpc-3506	144	11	p	p	NOUN
dpc-3506	144	12	topical	topical	ADJ
dpc-3506	144	13	treatments	treatment	NOUN
dpc-3506	144	14	,	,	PUNCT
dpc-3506	144	15	n	n	CCONJ
dpc-3506	144	16	(	(	PUNCT
dpc-3506	144	17	%	%	INTJ
dpc-3506	144	18	)	)	PUNCT
dpc-3506	144	19	120(65.6	120(65.6	NUM
dpc-3506	144	20	)	)	PUNCT
dpc-3506	144	21	89	89	NUM
dpc-3506	144	22	(	(	PUNCT
dpc-3506	144	23	62.7	62.7	NUM
dpc-3506	144	24	)	)	PUNCT
dpc-3506	144	25	31	31	NUM
dpc-3506	144	26	(	(	PUNCT
dpc-3506	144	27	75.6	75.6	NUM
dpc-3506	144	28	)	)	PUNCT
dpc-3506	144	29	0.13	0.13	NUM
dpc-3506	144	30	methotrexate	methotrexate	NOUN
dpc-3506	144	31	,	,	PUNCT
dpc-3506	144	32	n	n	CCONJ
dpc-3506	144	33	(	(	PUNCT
dpc-3506	144	34	%	%	INTJ
dpc-3506	144	35	)	)	PUNCT
dpc-3506	144	36	50(27.3	50(27.3	NUM
dpc-3506	144	37	)	)	PUNCT
dpc-3506	144	38	39	39	NUM
dpc-3506	144	39	(	(	PUNCT
dpc-3506	144	40	27.5	27.5	NUM
dpc-3506	144	41	)	)	PUNCT
dpc-3506	144	42	11	11	NUM
dpc-3506	144	43	(	(	PUNCT
dpc-3506	144	44	26.8	26.8	NUM
dpc-3506	144	45	)	)	PUNCT
dpc-3506	144	46	0.94	0.94	NUM
dpc-3506	144	47	colchicine	colchicine	NOUN
dpc-3506	144	48	,	,	PUNCT
dpc-3506	144	49	n	n	PROPN
dpc-3506	144	50	(	(	PUNCT
dpc-3506	144	51	%	%	INTJ
dpc-3506	144	52	)	)	PUNCT
dpc-3506	144	53	31(16.9	31(16.9	NUM
dpc-3506	144	54	)	)	PUNCT
dpc-3506	144	55	21	21	NUM
dpc-3506	144	56	(	(	PUNCT
dpc-3506	144	57	14.8	14.8	NUM
dpc-3506	144	58	)	)	PUNCT
dpc-3506	144	59	10	10	NUM
dpc-3506	144	60	(	(	PUNCT
dpc-3506	144	61	24.4	24.4	NUM
dpc-3506	144	62	)	)	PUNCT
dpc-3506	144	63	0.15	0.15	NUM
dpc-3506	144	64	systemic	systemic	ADJ
dpc-3506	144	65	steroid	steroid	NOUN
dpc-3506	144	66	,	,	PUNCT
dpc-3506	144	67	n	n	PROPN
dpc-3506	144	68	(	(	PUNCT
dpc-3506	144	69	%	%	INTJ
dpc-3506	144	70	)	)	PUNCT
dpc-3506	144	71	12(6.6	12(6.6	NUM
dpc-3506	144	72	)	)	PUNCT
dpc-3506	144	73	12	12	NUM
dpc-3506	144	74	(	(	PUNCT
dpc-3506	144	75	8.5	8.5	NUM
dpc-3506	144	76	)	)	PUNCT
dpc-3506	144	77	0	0	NUM
dpc-3506	145	1	0.054	0.054	NUM
dpc-3506	145	2	phototherapy	phototherapy	NOUN
dpc-3506	145	3	,	,	PUNCT
dpc-3506	145	4	n	n	CCONJ
dpc-3506	145	5	(	(	PUNCT
dpc-3506	145	6	%	%	INTJ
dpc-3506	145	7	)	)	PUNCT
dpc-3506	145	8	9(4.9	9(4.9	NUM
dpc-3506	145	9	)	)	PUNCT
dpc-3506	145	10	7	7	NUM
dpc-3506	145	11	(	(	PUNCT
dpc-3506	145	12	4.9	4.9	NUM
dpc-3506	145	13	)	)	SYM
dpc-3506	145	14	2	2	NUM
dpc-3506	145	15	(	(	PUNCT
dpc-3506	145	16	4.9	4.9	NUM
dpc-3506	145	17	)	)	PUNCT
dpc-3506	145	18	0.99	0.99	NUM
dpc-3506	145	19	hydroxychloroquine	hydroxychloroquine	NOUN
dpc-3506	145	20	,	,	PUNCT
dpc-3506	145	21	n	n	PROPN
dpc-3506	145	22	(	(	PUNCT
dpc-3506	145	23	%	%	INTJ
dpc-3506	145	24	)	)	PUNCT
dpc-3506	145	25	7(3,8	7(3,8	NUM
dpc-3506	145	26	)	)	PUNCT
dpc-3506	145	27	5	5	NUM
dpc-3506	145	28	(	(	PUNCT
dpc-3506	145	29	3.5	3.5	NUM
dpc-3506	145	30	)	)	PUNCT
dpc-3506	145	31	2	2	NUM
dpc-3506	145	32	(	(	PUNCT
dpc-3506	145	33	4.9	4.9	NUM
dpc-3506	145	34	)	)	PUNCT
dpc-3506	145	35	0.69	0.69	NUM
dpc-3506	145	36	others	other	NOUN
dpc-3506	145	37	n	n	PRON
dpc-3506	145	38	(	(	PUNCT
dpc-3506	145	39	%	%	INTJ
dpc-3506	145	40	)	)	PUNCT
dpc-3506	145	41	zinc	zinc	NOUN
dpc-3506	145	42	,	,	PUNCT
dpc-3506	145	43	salazopyrin	salazopyrin	NOUN
dpc-3506	145	44	,	,	PUNCT
dpc-3506	145	45	vitamin	vitamin	NOUN
dpc-3506	145	46	d	d	X
dpc-3506	145	47	mycophenolate	mycophenolate	NOUN
dpc-3506	145	48	 	 	SPACE
dpc-3506	145	49	mofetil	mofetil	PROPN
dpc-3506	145	50	,	,	PUNCT
dpc-3506	145	51	azathioprine	azathioprine	NOUN
dpc-3506	145	52	,	,	PUNCT
dpc-3506	145	53	isotretinoin	isotretinoin	PROPN
dpc-3506	145	54	,	,	PUNCT
dpc-3506	145	55	10	10	NUM
dpc-3506	145	56	(	(	PUNCT
dpc-3506	145	57	1.09	1.09	NUM
dpc-3506	145	58	-	-	SYM
dpc-3506	145	59	0.54	0.54	NUM
dpc-3506	145	60	)	)	PUNCT
dpc-3506	145	61	7	7	NUM
dpc-3506	145	62	(	(	PUNCT
dpc-3506	145	63	4.9	4.9	NUM
dpc-3506	145	64	)	)	PUNCT
dpc-3506	145	65	3	3	NUM
dpc-3506	145	66	(	(	PUNCT
dpc-3506	145	67	7.3	7.3	NUM
dpc-3506	145	68	)	)	PUNCT
dpc-3506	145	69	untreated	untreated	ADJ
dpc-3506	145	70	n	n	PROPN
dpc-3506	145	71	(	(	PUNCT
dpc-3506	145	72	%	%	INTJ
dpc-3506	145	73	)	)	PUNCT
dpc-3506	145	74	22	22	NUM
dpc-3506	145	75	(	(	PUNCT
dpc-3506	145	76	15.38	15.38	NUM
dpc-3506	145	77	)	)	PUNCT
dpc-3506	145	78	6	6	NUM
dpc-3506	145	79	(	(	PUNCT
dpc-3506	145	80	4.22	4.22	NUM
dpc-3506	145	81	)	)	PUNCT
dpc-3506	145	82	0.84	0.84	NUM
dpc-3506	145	83	although	although	SCONJ
dpc-3506	145	84	the	the	DET
dpc-3506	145	85	affected	affect	VERB
dpc-3506	145	86	areas	area	NOUN
dpc-3506	145	87	were	be	AUX
dpc-3506	145	88	similar	similar	ADJ
dpc-3506	145	89	in	in	ADP
dpc-3506	145	90	both	both	DET
dpc-3506	145	91	groups	group	NOUN
dpc-3506	145	92	of	of	ADP
dpc-3506	145	93	patients	patient	NOUN
dpc-3506	145	94	,	,	PUNCT
dpc-3506	145	95	special	special	ADJ
dpc-3506	145	96	region	region	NOUN
dpc-3506	145	97	involvement	involvement	NOUN
dpc-3506	145	98	such	such	ADJ
dpc-3506	145	99	as	as	ADP
dpc-3506	145	100	the	the	DET
dpc-3506	145	101	inguinal	inguinal	ADJ
dpc-3506	145	102	region	region	NOUN
dpc-3506	145	103	was	be	AUX
dpc-3506	145	104	more	more	ADV
dpc-3506	145	105	common	common	ADJ
dpc-3506	145	106	in	in	ADP
dpc-3506	145	107	aols	aol	NOUN
dpc-3506	145	108	.	.	PUNCT
dpc-3506	146	1	breast	breast	NOUN
dpc-3506	146	2	involvement	involvement	NOUN
dpc-3506	146	3	was	be	AUX
dpc-3506	146	4	observed	observe	VERB
dpc-3506	146	5	only	only	ADV
dpc-3506	146	6	in	in	ADP
dpc-3506	146	7	aols	aol	NOUN
dpc-3506	146	8	.	.	PUNCT
dpc-3506	147	1	this	this	DET
dpc-3506	147	2	particular	particular	ADJ
dpc-3506	147	3	group	group	NOUN
dpc-3506	147	4	of	of	ADP
dpc-3506	147	5	patients	patient	NOUN
dpc-3506	147	6	were	be	AUX
dpc-3506	147	7	older	old	ADJ
dpc-3506	147	8	and	and	CCONJ
dpc-3506	147	9	female	female	ADJ
dpc-3506	147	10	.	.	PUNCT
dpc-3506	148	1	there	there	PRON
dpc-3506	148	2	are	be	VERB
dpc-3506	148	3	multiple	multiple	ADJ
dpc-3506	148	4	localizations	localization	NOUN
dpc-3506	148	5	in	in	ADP
dpc-3506	148	6	generalized	generalized	ADJ
dpc-3506	148	7	morphea	morphea	NOUN
dpc-3506	148	8	.	.	PUNCT
dpc-3506	149	1	the	the	DET
dpc-3506	149	2	previous	previous	ADJ
dpc-3506	149	3	studies	study	NOUN
dpc-3506	149	4	found	find	VERB
dpc-3506	149	5	it	it	PRON
dpc-3506	149	6	as	as	ADP
dpc-3506	149	7	7%-47	7%-47	NUM
dpc-3506	149	8	%	%	NOUN
dpc-3506	149	9	[	[	X
dpc-3506	149	10	2,4,6,17	2,4,6,17	NUM
dpc-3506	149	11	]	]	PUNCT
dpc-3506	149	12	.	.	PUNCT
dpc-3506	150	1	in	in	ADP
dpc-3506	150	2	our	our	PRON
dpc-3506	150	3	study	study	NOUN
dpc-3506	150	4	,	,	PUNCT
dpc-3506	150	5	the	the	DET
dpc-3506	150	6	rate	rate	NOUN
dpc-3506	150	7	of	of	ADP
dpc-3506	150	8	generalized	generalized	ADJ
dpc-3506	150	9	morphea	morphea	NOUN
dpc-3506	150	10	was	be	AUX
dpc-3506	150	11	18	18	NUM
dpc-3506	150	12	%	%	NOUN
dpc-3506	150	13	in	in	ADP
dpc-3506	150	14	total	total	NOUN
dpc-3506	150	15	,	,	PUNCT
dpc-3506	150	16	19	19	NUM
dpc-3506	150	17	%	%	NOUN
dpc-3506	150	18	in	in	ADP
dpc-3506	150	19	aols	aol	NOUN
dpc-3506	150	20	,	,	PUNCT
dpc-3506	150	21	and	and	CCONJ
dpc-3506	150	22	18.2	18.2	NUM
dpc-3506	150	23	%	%	NOUN
dpc-3506	150	24	in	in	ADP
dpc-3506	150	25	pols	pol	NOUN
dpc-3506	150	26	.	.	PUNCT
dpc-3506	151	1	high	high	ADJ
dpc-3506	151	2	platelet	platelet	NOUN
dpc-3506	151	3	levels	level	NOUN
dpc-3506	151	4	in	in	ADP
dpc-3506	151	5	this	this	DET
dpc-3506	151	6	group	group	NOUN
dpc-3506	151	7	of	of	ADP
dpc-3506	151	8	patients	patient	NOUN
dpc-3506	151	9	may	may	AUX
dpc-3506	151	10	indicate	indicate	VERB
dpc-3506	151	11	a	a	DET
dpc-3506	151	12	proclivity	proclivity	NOUN
dpc-3506	151	13	for	for	ADP
dpc-3506	151	14	original	original	ADJ
dpc-3506	151	15	article	article	NOUN
dpc-3506	151	16	|	|	ADV
dpc-3506	151	17	dermatol	dermatol	ADJ
dpc-3506	151	18	pract	pract	NOUN
dpc-3506	151	19	concept	concept	NOUN
dpc-3506	151	20	.	.	PUNCT
dpc-3506	152	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	152	2	7	7	NUM
dpc-3506	152	3	morphea	morphea	NOUN
dpc-3506	152	4	[	[	X
dpc-3506	152	5	13	13	NUM
dpc-3506	152	6	]	]	PUNCT
dpc-3506	152	7	.	.	PUNCT
dpc-3506	153	1	these	these	DET
dpc-3506	153	2	authors	author	NOUN
dpc-3506	153	3	found	find	VERB
dpc-3506	153	4	that	that	SCONJ
dpc-3506	153	5	patients	patient	NOUN
dpc-3506	153	6	with	with	ADP
dpc-3506	153	7	linear	linear	PROPN
dpc-3506	153	8	morphea	morphea	PROPN
dpc-3506	153	9	had	have	VERB
dpc-3506	153	10	a	a	DET
dpc-3506	153	11	high	high	ADJ
dpc-3506	153	12	number	number	NOUN
dpc-3506	153	13	of	of	ADP
dpc-3506	153	14	ocular	ocular	ADJ
dpc-3506	153	15	and	and	CCONJ
dpc-3506	153	16	neurological	neurological	ADJ
dpc-3506	153	17	findings	finding	NOUN
dpc-3506	153	18	[	[	X
dpc-3506	153	19	25,27	25,27	NUM
dpc-3506	153	20	]	]	PUNCT
dpc-3506	153	21	.	.	PUNCT
dpc-3506	154	1	however	however	ADV
dpc-3506	154	2	,	,	PUNCT
dpc-3506	154	3	unlike	unlike	ADP
dpc-3506	154	4	other	other	ADJ
dpc-3506	154	5	studies	study	NOUN
dpc-3506	154	6	conducted	conduct	VERB
dpc-3506	154	7	in	in	ADP
dpc-3506	154	8	turkey	turkey	NOUN
dpc-3506	154	9	,	,	PUNCT
dpc-3506	154	10	no	no	DET
dpc-3506	154	11	neurological	neurological	ADJ
dpc-3506	154	12	or	or	CCONJ
dpc-3506	154	13	ocular	ocular	ADJ
dpc-3506	154	14	involvement	involvement	NOUN
dpc-3506	154	15	was	be	AUX
dpc-3506	154	16	observed	observe	VERB
dpc-3506	154	17	in	in	ADP
dpc-3506	154	18	the	the	DET
dpc-3506	154	19	cases	case	NOUN
dpc-3506	154	20	with	with	ADP
dpc-3506	154	21	ecds	ecds	NOUN
dpc-3506	154	22	in	in	ADP
dpc-3506	154	23	our	our	PRON
dpc-3506	154	24	study	study	NOUN
dpc-3506	154	25	[	[	X
dpc-3506	154	26	8	8	NUM
dpc-3506	154	27	]	]	PUNCT
dpc-3506	154	28	.	.	PUNCT
dpc-3506	155	1	this	this	PRON
dpc-3506	155	2	could	could	AUX
dpc-3506	155	3	also	also	ADV
dpc-3506	155	4	be	be	AUX
dpc-3506	155	5	due	due	ADJ
dpc-3506	155	6	to	to	ADP
dpc-3506	155	7	the	the	DET
dpc-3506	155	8	fact	fact	NOUN
dpc-3506	155	9	that	that	SCONJ
dpc-3506	155	10	the	the	DET
dpc-3506	155	11	study	study	NOUN
dpc-3506	155	12	was	be	AUX
dpc-3506	155	13	retrospective	retrospective	ADJ
dpc-3506	155	14	and	and	CCONJ
dpc-3506	155	15	the	the	DET
dpc-3506	155	16	records	record	NOUN
dpc-3506	155	17	were	be	AUX
dpc-3506	155	18	missing	miss	VERB
dpc-3506	155	19	.	.	PUNCT
dpc-3506	156	1	various	various	ADJ
dpc-3506	156	2	laboratory	laboratory	NOUN
dpc-3506	156	3	changes	change	NOUN
dpc-3506	156	4	in	in	ADP
dpc-3506	156	5	the	the	DET
dpc-3506	156	6	serum	serum	NOUN
dpc-3506	156	7	of	of	ADP
dpc-3506	156	8	morphea	morphea	NOUN
dpc-3506	156	9	patients	patient	NOUN
dpc-3506	156	10	have	have	AUX
dpc-3506	156	11	also	also	ADV
dpc-3506	156	12	been	be	AUX
dpc-3506	156	13	observed	observe	VERB
dpc-3506	156	14	in	in	ADP
dpc-3506	156	15	studies	study	NOUN
dpc-3506	156	16	[	[	X
dpc-3506	156	17	15,28	15,28	NUM
dpc-3506	156	18	-	-	SYM
dpc-3506	156	19	31	31	NUM
dpc-3506	156	20	]	]	PUNCT
dpc-3506	156	21	.	.	PUNCT
dpc-3506	157	1	rheumatoid	rheumatoid	NOUN
dpc-3506	157	2	factor	factor	NOUN
dpc-3506	157	3	(	(	PUNCT
dpc-3506	157	4	rf	rf	NOUN
dpc-3506	157	5	)	)	PUNCT
dpc-3506	157	6	,	,	PUNCT
dpc-3506	157	7	c	c	NOUN
dpc-3506	157	8	-	-	PUNCT
dpc-3506	157	9	reactive	reactive	ADJ
dpc-3506	157	10	protein	protein	NOUN
dpc-3506	157	11	(	(	PUNCT
dpc-3506	157	12	crp	crp	PROPN
dpc-3506	157	13	)	)	PUNCT
dpc-3506	157	14	,	,	PUNCT
dpc-3506	157	15	and	and	CCONJ
dpc-3506	157	16	esr	esr	PROPN
dpc-3506	157	17	is	be	AUX
dpc-3506	157	18	higher	high	ADJ
dpc-3506	157	19	in	in	ADP
dpc-3506	157	20	patients	patient	NOUN
dpc-3506	157	21	with	with	ADP
dpc-3506	157	22	extracutaneous	extracutaneous	ADJ
dpc-3506	157	23	involvement	involvement	NOUN
dpc-3506	157	24	[	[	X
dpc-3506	157	25	13	13	NUM
dpc-3506	157	26	]	]	PUNCT
dpc-3506	157	27	.	.	PUNCT
dpc-3506	158	1	the	the	DET
dpc-3506	158	2	authors	author	NOUN
dpc-3506	158	3	reported	report	VERB
dpc-3506	158	4	high	high	ADJ
dpc-3506	158	5	inflammatory	inflammatory	ADJ
dpc-3506	158	6	parameters	parameter	NOUN
dpc-3506	158	7	(	(	PUNCT
dpc-3506	158	8	esr	esr	PROPN
dpc-3506	158	9	,	,	PUNCT
dpc-3506	158	10	crp	crp	PROPN
dpc-3506	158	11	,	,	PUNCT
dpc-3506	158	12	rf	rf	NOUN
dpc-3506	158	13	)	)	PUNCT
dpc-3506	158	14	rather	rather	ADV
dpc-3506	158	15	than	than	ADP
dpc-3506	158	16	skin	skin	NOUN
dpc-3506	158	17	manifestations	manifestation	NOUN
dpc-3506	158	18	,	,	PUNCT
dpc-3506	158	19	especially	especially	ADV
dpc-3506	158	20	in	in	ADP
dpc-3506	158	21	patients	patient	NOUN
dpc-3506	158	22	with	with	ADP
dpc-3506	158	23	deep	deep	ADJ
dpc-3506	158	24	morphea	morphea	NOUN
dpc-3506	158	25	and	and	CCONJ
dpc-3506	158	26	arthritis	arthritis	NOUN
dpc-3506	158	27	[	[	X
dpc-3506	158	28	13,14,32	13,14,32	NUM
dpc-3506	158	29	]	]	PUNCT
dpc-3506	158	30	.	.	PUNCT
dpc-3506	159	1	the	the	DET
dpc-3506	159	2	rf	rf	ADJ
dpc-3506	159	3	rate	rate	NOUN
dpc-3506	159	4	in	in	ADP
dpc-3506	159	5	the	the	DET
dpc-3506	159	6	patients	patient	NOUN
dpc-3506	159	7	with	with	ADP
dpc-3506	159	8	joint	joint	ADJ
dpc-3506	159	9	damage	damage	NOUN
dpc-3506	159	10	is	be	AUX
dpc-3506	159	11	up	up	ADP
dpc-3506	159	12	to	to	ADP
dpc-3506	159	13	25%-40	25%-40	NUM
dpc-3506	159	14	%	%	NOUN
dpc-3506	159	15	[	[	X
dpc-3506	159	16	13,28,33	13,28,33	NUM
dpc-3506	159	17	]	]	X
dpc-3506	159	18	morphea	morphea	NOUN
dpc-3506	159	19	is	be	AUX
dpc-3506	159	20	frequently	frequently	ADV
dpc-3506	159	21	associated	associate	VERB
dpc-3506	159	22	with	with	ADP
dpc-3506	159	23	auto	auto	NOUN
dpc-3506	159	24	-	-	PUNCT
dpc-3506	159	25	antibody	antibody	NOUN
dpc-3506	159	26	positivity	positivity	NOUN
dpc-3506	159	27	[	[	X
dpc-3506	159	28	28,31,33	28,31,33	NUM
dpc-3506	159	29	-	-	SYM
dpc-3506	159	30	35	35	NUM
dpc-3506	159	31	]	]	PUNCT
dpc-3506	159	32	.	.	PUNCT
dpc-3506	160	1	the	the	DET
dpc-3506	160	2	clinical	clinical	ADJ
dpc-3506	160	3	and	and	CCONJ
dpc-3506	160	4	prognostic	prognostic	ADJ
dpc-3506	160	5	significance	significance	NOUN
dpc-3506	160	6	of	of	ADP
dpc-3506	160	7	these	these	DET
dpc-3506	160	8	autoantibodies	autoantibody	NOUN
dpc-3506	160	9	is	be	AUX
dpc-3506	160	10	unknown	unknown	ADJ
dpc-3506	160	11	[	[	X
dpc-3506	160	12	13	13	NUM
dpc-3506	160	13	]	]	PUNCT
dpc-3506	160	14	.	.	PUNCT
dpc-3506	161	1	in	in	ADP
dpc-3506	161	2	the	the	DET
dpc-3506	161	3	generalized	generalized	ADJ
dpc-3506	161	4	type	type	NOUN
dpc-3506	161	5	,	,	PUNCT
dpc-3506	161	6	it	it	PRON
dpc-3506	161	7	may	may	AUX
dpc-3506	161	8	be	be	AUX
dpc-3506	161	9	especially	especially	ADV
dpc-3506	161	10	important	important	ADJ
dpc-3506	161	11	in	in	ADP
dpc-3506	161	12	clinical	clinical	ADJ
dpc-3506	161	13	and	and	CCONJ
dpc-3506	161	14	prognostic	prognostic	ADJ
dpc-3506	161	15	terms	term	NOUN
dpc-3506	161	16	or	or	CCONJ
dpc-3506	161	17	for	for	ADP
dpc-3506	161	18	investigating	investigate	VERB
dpc-3506	161	19	the	the	DET
dpc-3506	161	20	presence	presence	NOUN
dpc-3506	161	21	of	of	ADP
dpc-3506	161	22	comorbid	comorbid	NOUN
dpc-3506	161	23	diseases	disease	NOUN
dpc-3506	161	24	[	[	X
dpc-3506	161	25	31	31	NUM
dpc-3506	161	26	]	]	PUNCT
dpc-3506	161	27	.	.	PUNCT
dpc-3506	162	1	in	in	ADP
dpc-3506	162	2	the	the	DET
dpc-3506	162	3	literature	literature	NOUN
dpc-3506	162	4	,	,	PUNCT
dpc-3506	162	5	ana	ana	PROPN
dpc-3506	162	6	positivity	positivity	NOUN
dpc-3506	162	7	was	be	AUX
dpc-3506	162	8	detected	detect	VERB
dpc-3506	162	9	in	in	ADP
dpc-3506	162	10	5.9%-68.7	5.9%-68.7	NUM
dpc-3506	162	11	%	%	NOUN
dpc-3506	162	12	of	of	ADP
dpc-3506	162	13	the	the	DET
dpc-3506	162	14	cases	case	NOUN
dpc-3506	162	15	[	[	X
dpc-3506	162	16	6,15,17,25,31	6,15,17,25,31	NOUN
dpc-3506	162	17	]	]	X
dpc-3506	162	18	.	.	PUNCT
dpc-3506	163	1	the	the	DET
dpc-3506	163	2	rate	rate	NOUN
dpc-3506	163	3	of	of	ADP
dpc-3506	163	4	ana	ana	PROPN
dpc-3506	163	5	positivity	positivity	NOUN
dpc-3506	163	6	has	have	AUX
dpc-3506	163	7	been	be	AUX
dpc-3506	163	8	reported	report	VERB
dpc-3506	163	9	to	to	PART
dpc-3506	163	10	be	be	AUX
dpc-3506	163	11	higher	high	ADJ
dpc-3506	163	12	in	in	ADP
dpc-3506	163	13	patients	patient	NOUN
dpc-3506	163	14	with	with	ADP
dpc-3506	163	15	generalized	generalized	ADJ
dpc-3506	163	16	and	and	CCONJ
dpc-3506	163	17	mixed	mixed	ADJ
dpc-3506	163	18	types	type	NOUN
dpc-3506	163	19	,	,	PUNCT
dpc-3506	163	20	as	as	ADV
dpc-3506	163	21	well	well	ADV
dpc-3506	163	22	as	as	ADP
dpc-3506	163	23	those	those	PRON
dpc-3506	163	24	with	with	ADP
dpc-3506	163	25	extracutaneous	extracutaneous	ADJ
dpc-3506	163	26	involvement	involvement	NOUN
dpc-3506	164	1	[	[	X
dpc-3506	164	2	6,10,11,15,31,34	6,10,11,15,31,34	NOUN
dpc-3506	164	3	]	]	X
dpc-3506	164	4	.	.	PUNCT
dpc-3506	165	1	according	accord	VERB
dpc-3506	165	2	to	to	ADP
dpc-3506	165	3	some	some	DET
dpc-3506	165	4	studies	study	NOUN
dpc-3506	165	5	,	,	PUNCT
dpc-3506	165	6	there	there	PRON
dpc-3506	165	7	is	be	VERB
dpc-3506	165	8	no	no	DET
dpc-3506	165	9	difference	difference	NOUN
dpc-3506	165	10	in	in	ADP
dpc-3506	165	11	the	the	DET
dpc-3506	165	12	ana	ana	PROPN
dpc-3506	165	13	ratio	ratio	NOUN
dpc-3506	165	14	among	among	ADP
dpc-3506	165	15	the	the	DET
dpc-3506	165	16	various	various	ADJ
dpc-3506	165	17	subtypes	subtype	NOUN
dpc-3506	165	18	of	of	ADP
dpc-3506	165	19	morphea	morphea	PROPN
dpc-3506	165	20	,	,	PUNCT
dpc-3506	165	21	but	but	CCONJ
dpc-3506	165	22	the	the	DET
dpc-3506	165	23	presence	presence	NOUN
dpc-3506	165	24	of	of	ADP
dpc-3506	165	25	extracutaneous	extracutaneous	ADJ
dpc-3506	165	26	findings	finding	NOUN
dpc-3506	165	27	may	may	AUX
dpc-3506	165	28	increase	increase	VERB
dpc-3506	165	29	these	these	DET
dpc-3506	165	30	rates	rate	NOUN
dpc-3506	165	31	[	[	X
dpc-3506	165	32	28,34	28,34	X
dpc-3506	165	33	]	]	X
dpc-3506	165	34	.	.	PUNCT
dpc-3506	166	1	some	some	DET
dpc-3506	166	2	studies	study	NOUN
dpc-3506	166	3	have	have	AUX
dpc-3506	166	4	also	also	ADV
dpc-3506	166	5	reported	report	VERB
dpc-3506	166	6	that	that	SCONJ
dpc-3506	166	7	ana	ana	PROPN
dpc-3506	166	8	positivity	positivity	NOUN
dpc-3506	166	9	varies	vary	VERB
dpc-3506	166	10	between	between	ADP
dpc-3506	166	11	patients	patient	NOUN
dpc-3506	166	12	with	with	ADP
dpc-3506	166	13	aols	aol	NOUN
dpc-3506	166	14	and	and	CCONJ
dpc-3506	166	15	pols	pol	NOUN
dpc-3506	166	16	[	[	X
dpc-3506	166	17	6,10,11,19,31	6,10,11,19,31	NOUN
dpc-3506	166	18	]	]	PUNCT
dpc-3506	166	19	.	.	PUNCT
dpc-3506	167	1	in	in	ADP
dpc-3506	167	2	our	our	PRON
dpc-3506	167	3	study	study	NOUN
dpc-3506	167	4	,	,	PUNCT
dpc-3506	167	5	the	the	DET
dpc-3506	167	6	ana	ana	PROPN
dpc-3506	167	7	positivity	positivity	NOUN
dpc-3506	167	8	rate	rate	NOUN
dpc-3506	167	9	was	be	AUX
dpc-3506	167	10	found	find	VERB
dpc-3506	167	11	38.3	38.3	NUM
dpc-3506	167	12	%	%	NOUN
dpc-3506	167	13	for	for	ADP
dpc-3506	167	14	aols	aol	NOUN
dpc-3506	167	15	and	and	CCONJ
dpc-3506	167	16	40	40	NUM
dpc-3506	167	17	%	%	NOUN
dpc-3506	167	18	for	for	ADP
dpc-3506	167	19	pols	pol	NOUN
dpc-3506	167	20	,	,	PUNCT
dpc-3506	167	21	which	which	PRON
dpc-3506	167	22	was	be	AUX
dpc-3506	167	23	similar	similar	ADJ
dpc-3506	167	24	in	in	ADP
dpc-3506	167	25	both	both	DET
dpc-3506	167	26	groups	group	NOUN
dpc-3506	167	27	.	.	PUNCT
dpc-3506	168	1	in	in	ADP
dpc-3506	168	2	addition	addition	NOUN
dpc-3506	168	3	to	to	ADP
dpc-3506	168	4	ana	ana	PROPN
dpc-3506	168	5	,	,	PUNCT
dpc-3506	168	6	scl-70	scl-70	PROPN
dpc-3506	168	7	,	,	PUNCT
dpc-3506	168	8	anti	anti	ADJ
dpc-3506	168	9	-	-	ADJ
dpc-3506	168	10	dsdna	dsdna	ADJ
dpc-3506	168	11	,	,	PUNCT
dpc-3506	168	12	anti	anti	ADJ
dpc-3506	168	13	-	-	ADJ
dpc-3506	168	14	histone	histone	ADJ
dpc-3506	168	15	antibody	antibody	NOUN
dpc-3506	168	16	positivity	positivity	NOUN
dpc-3506	168	17	can	can	AUX
dpc-3506	168	18	be	be	AUX
dpc-3506	168	19	seen	see	VERB
dpc-3506	168	20	in	in	ADP
dpc-3506	168	21	patients	patient	NOUN
dpc-3506	168	22	.	.	PUNCT
dpc-3506	169	1	some	some	DET
dpc-3506	169	2	researchers	researcher	NOUN
dpc-3506	169	3	found	find	VERB
dpc-3506	169	4	anti	anti	ADJ
dpc-3506	169	5	-	-	ADJ
dpc-3506	169	6	dsdna	dsdna	ADJ
dpc-3506	169	7	positivity	positivity	NOUN
dpc-3506	169	8	in	in	ADP
dpc-3506	169	9	4%-8	4%-8	NUM
dpc-3506	169	10	%	%	NOUN
dpc-3506	169	11	of	of	ADP
dpc-3506	169	12	morphea	morphea	NOUN
dpc-3506	169	13	patients	patient	NOUN
dpc-3506	169	14	with	with	ADP
dpc-3506	169	15	aols	aol	NOUN
dpc-3506	169	16	and	and	CCONJ
dpc-3506	169	17	pols	pol	NOUN
dpc-3506	169	18	[	[	X
dpc-3506	169	19	25	25	NUM
dpc-3506	169	20	]	]	PUNCT
dpc-3506	169	21	.	.	PUNCT
dpc-3506	170	1	these	these	DET
dpc-3506	170	2	rates	rate	NOUN
dpc-3506	170	3	were	be	AUX
dpc-3506	170	4	particularly	particularly	ADV
dpc-3506	170	5	higher	high	ADJ
dpc-3506	170	6	in	in	ADP
dpc-3506	170	7	those	those	PRON
dpc-3506	170	8	with	with	ADP
dpc-3506	170	9	the	the	DET
dpc-3506	170	10	linear	linear	ADJ
dpc-3506	170	11	type	type	NOUN
dpc-3506	170	12	and	and	CCONJ
dpc-3506	170	13	with	with	ADP
dpc-3506	170	14	joint	joint	ADJ
dpc-3506	170	15	involvement	involvement	NOUN
dpc-3506	170	16	[	[	X
dpc-3506	170	17	28,29	28,29	X
dpc-3506	170	18	]	]	PUNCT
dpc-3506	170	19	.	.	PUNCT
dpc-3506	171	1	in	in	ADP
dpc-3506	171	2	our	our	PRON
dpc-3506	171	3	study	study	NOUN
dpc-3506	171	4	,	,	PUNCT
dpc-3506	171	5	the	the	DET
dpc-3506	171	6	anti	anti	ADJ
dpc-3506	171	7	-	-	ADJ
dpc-3506	171	8	dsdna	dsdna	ADJ
dpc-3506	171	9	antibody	antibody	NOUN
dpc-3506	171	10	was	be	AUX
dpc-3506	171	11	found	find	VERB
dpc-3506	171	12	positive	positive	ADJ
dpc-3506	171	13	only	only	ADV
dpc-3506	171	14	for	for	ADP
dpc-3506	171	15	aols	aol	NOUN
dpc-3506	171	16	(	(	PUNCT
dpc-3506	171	17	13.7	13.7	NUM
dpc-3506	171	18	%	%	NOUN
dpc-3506	171	19	,	,	PUNCT
dpc-3506	171	20	n	n	NOUN
dpc-3506	171	21	=	=	SYM
dpc-3506	171	22	13	13	NUM
dpc-3506	171	23	)	)	PUNCT
dpc-3506	171	24	,	,	PUNCT
dpc-3506	171	25	but	but	CCONJ
dpc-3506	171	26	not	not	PART
dpc-3506	171	27	for	for	ADP
dpc-3506	171	28	pols	pol	NOUN
dpc-3506	171	29	.	.	PUNCT
dpc-3506	172	1	sato	sato	PROPN
dpc-3506	172	2	et	et	PROPN
dpc-3506	172	3	al	al	PROPN
dpc-3506	172	4	found	find	VERB
dpc-3506	172	5	that	that	SCONJ
dpc-3506	172	6	anti	anti	ADJ
dpc-3506	172	7	-	-	ADJ
dpc-3506	172	8	histone	histone	ADJ
dpc-3506	172	9	antibodies	antibody	NOUN
dpc-3506	172	10	were	be	AUX
dpc-3506	172	11	related	relate	VERB
dpc-3506	172	12	to	to	ADP
dpc-3506	172	13	the	the	DET
dpc-3506	172	14	number	number	NOUN
dpc-3506	172	15	of	of	ADP
dpc-3506	172	16	morphea	morphea	ADJ
dpc-3506	172	17	lesions	lesion	NOUN
dpc-3506	172	18	and	and	CCONJ
dpc-3506	172	19	the	the	DET
dpc-3506	172	20	skin	skin	NOUN
dpc-3506	172	21	localization	localization	NOUN
dpc-3506	172	22	of	of	ADP
dpc-3506	172	23	the	the	DET
dpc-3506	172	24	lesions	lesion	NOUN
dpc-3506	172	25	,	,	PUNCT
dpc-3506	172	26	and	and	CCONJ
dpc-3506	172	27	suggested	suggest	VERB
dpc-3506	172	28	that	that	SCONJ
dpc-3506	172	29	they	they	PRON
dpc-3506	172	30	may	may	AUX
dpc-3506	172	31	be	be	AUX
dpc-3506	172	32	serological	serological	ADJ
dpc-3506	172	33	indicators	indicator	NOUN
dpc-3506	172	34	in	in	ADP
dpc-3506	172	35	cases	case	NOUN
dpc-3506	172	36	with	with	ADP
dpc-3506	172	37	generalized	generalized	ADJ
dpc-3506	172	38	morphea	morphea	NOUN
dpc-3506	173	1	[	[	X
dpc-3506	173	2	29	29	NUM
dpc-3506	173	3	]	]	PUNCT
dpc-3506	173	4	.	.	PUNCT
dpc-3506	174	1	we	we	PRON
dpc-3506	174	2	detected	detect	VERB
dpc-3506	174	3	anti	anti	ADJ
dpc-3506	174	4	-	-	ADJ
dpc-3506	174	5	histone	histone	ADJ
dpc-3506	174	6	antibodies	antibody	NOUN
dpc-3506	174	7	in	in	ADP
dpc-3506	174	8	only	only	ADV
dpc-3506	174	9	one	one	NUM
dpc-3506	174	10	patient	patient	NOUN
dpc-3506	174	11	.	.	PUNCT
dpc-3506	175	1	the	the	DET
dpc-3506	175	2	presence	presence	NOUN
dpc-3506	175	3	of	of	ADP
dpc-3506	175	4	autoantibodies	autoantibody	NOUN
dpc-3506	175	5	may	may	AUX
dpc-3506	175	6	indicate	indicate	VERB
dpc-3506	175	7	that	that	DET
dpc-3506	175	8	morphea	morphea	PROPN
dpc-3506	175	9	is	be	AUX
dpc-3506	175	10	a	a	DET
dpc-3506	175	11	connective	connective	ADJ
dpc-3506	175	12	tissue	tissue	NOUN
dpc-3506	175	13	disease	disease	NOUN
dpc-3506	175	14	with	with	ADP
dpc-3506	175	15	systemic	systemic	ADJ
dpc-3506	175	16	involvement	involvement	NOUN
dpc-3506	175	17	rather	rather	ADV
dpc-3506	175	18	than	than	ADP
dpc-3506	175	19	a	a	DET
dpc-3506	175	20	skin	skin	NOUN
dpc-3506	175	21	disease	disease	NOUN
dpc-3506	175	22	[	[	X
dpc-3506	175	23	31,35	31,35	NOUN
dpc-3506	175	24	]	]	PUNCT
dpc-3506	175	25	.	.	PUNCT
dpc-3506	176	1	due	due	ADP
dpc-3506	176	2	to	to	ADP
dpc-3506	176	3	the	the	DET
dpc-3506	176	4	incomplete	incomplete	ADJ
dpc-3506	176	5	understanding	understanding	NOUN
dpc-3506	176	6	of	of	ADP
dpc-3506	176	7	the	the	DET
dpc-3506	176	8	cause	cause	NOUN
dpc-3506	176	9	of	of	ADP
dpc-3506	176	10	morphea	morphea	NOUN
dpc-3506	176	11	,	,	PUNCT
dpc-3506	176	12	there	there	PRON
dpc-3506	176	13	is	be	VERB
dpc-3506	176	14	no	no	DET
dpc-3506	176	15	specific	specific	ADJ
dpc-3506	176	16	effective	effective	ADJ
dpc-3506	176	17	treatment	treatment	NOUN
dpc-3506	176	18	.	.	PUNCT
dpc-3506	177	1	the	the	DET
dpc-3506	177	2	purpose	purpose	NOUN
dpc-3506	177	3	of	of	ADP
dpc-3506	177	4	thrombosis	thrombosis	NOUN
dpc-3506	177	5	.	.	PUNCT
dpc-3506	178	1	more	more	ADJ
dpc-3506	178	2	research	research	NOUN
dpc-3506	178	3	should	should	AUX
dpc-3506	178	4	be	be	AUX
dpc-3506	178	5	conducted	conduct	VERB
dpc-3506	178	6	on	on	ADP
dpc-3506	178	7	this	this	DET
dpc-3506	178	8	subject	subject	NOUN
dpc-3506	178	9	.	.	PUNCT
dpc-3506	179	1	the	the	DET
dpc-3506	179	2	ratios	ratio	NOUN
dpc-3506	179	3	of	of	ADP
dpc-3506	179	4	neutrophils	neutrophil	NOUN
dpc-3506	179	5	/	/	SYM
dpc-3506	179	6	lymphocytes	lymphocyte	NOUN
dpc-3506	179	7	(	(	PUNCT
dpc-3506	179	8	nlr	nlr	PROPN
dpc-3506	179	9	)	)	PUNCT
dpc-3506	179	10	,	,	PUNCT
dpc-3506	179	11	which	which	PRON
dpc-3506	179	12	are	be	AUX
dpc-3506	179	13	indicators	indicator	NOUN
dpc-3506	179	14	of	of	ADP
dpc-3506	179	15	acute	acute	ADJ
dpc-3506	179	16	inflammation	inflammation	NOUN
dpc-3506	179	17	in	in	ADP
dpc-3506	179	18	this	this	DET
dpc-3506	179	19	type	type	NOUN
dpc-3506	179	20	,	,	PUNCT
dpc-3506	179	21	were	be	AUX
dpc-3506	179	22	also	also	ADV
dpc-3506	179	23	found	find	VERB
dpc-3506	179	24	to	to	PART
dpc-3506	179	25	be	be	AUX
dpc-3506	179	26	significantly	significantly	ADV
dpc-3506	179	27	higher	high	ADJ
dpc-3506	179	28	.	.	PUNCT
dpc-3506	180	1	this	this	PRON
dpc-3506	180	2	may	may	AUX
dpc-3506	180	3	indicate	indicate	VERB
dpc-3506	180	4	that	that	SCONJ
dpc-3506	180	5	there	there	PRON
dpc-3506	180	6	is	be	VERB
dpc-3506	180	7	a	a	DET
dpc-3506	180	8	tendency	tendency	NOUN
dpc-3506	180	9	of	of	ADP
dpc-3506	180	10	inflammation	inflammation	NOUN
dpc-3506	180	11	in	in	ADP
dpc-3506	180	12	generalized	generalized	ADJ
dpc-3506	180	13	morphea	morphea	NOUN
dpc-3506	180	14	,	,	PUNCT
dpc-3506	180	15	and	and	CCONJ
dpc-3506	180	16	that	that	SCONJ
dpc-3506	180	17	it	it	PRON
dpc-3506	180	18	may	may	AUX
dpc-3506	180	19	be	be	AUX
dpc-3506	180	20	even	even	ADV
dpc-3506	180	21	more	more	ADV
dpc-3506	180	22	progressive	progressive	ADJ
dpc-3506	180	23	.	.	PUNCT
dpc-3506	181	1	therefore	therefore	ADV
dpc-3506	181	2	,	,	PUNCT
dpc-3506	181	3	these	these	DET
dpc-3506	181	4	markers	marker	NOUN
dpc-3506	181	5	can	can	AUX
dpc-3506	181	6	be	be	AUX
dpc-3506	181	7	used	use	VERB
dpc-3506	181	8	for	for	ADP
dpc-3506	181	9	treatment	treatment	NOUN
dpc-3506	181	10	follow	follow	NOUN
dpc-3506	181	11	-	-	PUNCT
dpc-3506	181	12	up	up	NOUN
dpc-3506	181	13	and	and	CCONJ
dpc-3506	181	14	progression	progression	NOUN
dpc-3506	181	15	[	[	X
dpc-3506	181	16	22	22	NUM
dpc-3506	181	17	]	]	PUNCT
dpc-3506	181	18	.	.	PUNCT
dpc-3506	182	1	in	in	ADP
dpc-3506	182	2	various	various	ADJ
dpc-3506	182	3	studies	study	NOUN
dpc-3506	182	4	,	,	PUNCT
dpc-3506	182	5	factors	factor	NOUN
dpc-3506	182	6	that	that	PRON
dpc-3506	182	7	can	can	AUX
dpc-3506	182	8	trigger	trigger	VERB
dpc-3506	182	9	the	the	DET
dpc-3506	182	10	formation	formation	NOUN
dpc-3506	182	11	of	of	ADP
dpc-3506	182	12	the	the	DET
dpc-3506	182	13	disease	disease	NOUN
dpc-3506	182	14	in	in	ADP
dpc-3506	182	15	morphea	morphea	PROPN
dpc-3506	182	16	were	be	AUX
dpc-3506	182	17	identified	identify	VERB
dpc-3506	182	18	as	as	ADP
dpc-3506	182	19	7.3	7.3	NUM
dpc-3506	182	20	-	-	SYM
dpc-3506	182	21	16.6	16.6	NUM
dpc-3506	182	22	%	%	NOUN
dpc-3506	182	23	[	[	X
dpc-3506	182	24	3,18,23	3,18,23	NUM
dpc-3506	182	25	]	]	PUNCT
dpc-3506	182	26	.	.	PUNCT
dpc-3506	183	1	saracino	saracino	PROPN
dpc-3506	183	2	et	et	PROPN
dpc-3506	183	3	al	al	PROPN
dpc-3506	183	4	determined	determine	VERB
dpc-3506	183	5	the	the	DET
dpc-3506	183	6	presence	presence	NOUN
dpc-3506	183	7	of	of	ADP
dpc-3506	183	8	triggering	trigger	VERB
dpc-3506	183	9	factors	factor	NOUN
dpc-3506	183	10	as	as	ADP
dpc-3506	183	11	16.5	16.5	NUM
dpc-3506	183	12	%	%	NOUN
dpc-3506	183	13	in	in	ADP
dpc-3506	183	14	all	all	DET
dpc-3506	183	15	morphea	morphea	NOUN
dpc-3506	183	16	patients	patient	NOUN
dpc-3506	183	17	,	,	PUNCT
dpc-3506	183	18	20.9	20.9	NUM
dpc-3506	183	19	%	%	NOUN
dpc-3506	183	20	in	in	ADP
dpc-3506	183	21	aols	aol	NOUN
dpc-3506	183	22	and	and	CCONJ
dpc-3506	183	23	14.7	14.7	NUM
dpc-3506	183	24	%	%	NOUN
dpc-3506	183	25	in	in	ADP
dpc-3506	183	26	pols	pol	NOUN
dpc-3506	183	27	[	[	X
dpc-3506	183	28	18	18	NUM
dpc-3506	183	29	]	]	PUNCT
dpc-3506	183	30	.	.	PUNCT
dpc-3506	184	1	we	we	PRON
dpc-3506	184	2	found	find	VERB
dpc-3506	184	3	these	these	DET
dpc-3506	184	4	rates	rate	NOUN
dpc-3506	184	5	as	as	ADP
dpc-3506	184	6	6.6	6.6	NUM
dpc-3506	184	7	%	%	NOUN
dpc-3506	184	8	in	in	ADP
dpc-3506	184	9	general	general	ADJ
dpc-3506	184	10	,	,	PUNCT
dpc-3506	184	11	6.3	6.3	NUM
dpc-3506	184	12	%	%	NOUN
dpc-3506	184	13	in	in	ADP
dpc-3506	184	14	aols	aol	NOUN
dpc-3506	184	15	and	and	CCONJ
dpc-3506	184	16	7.3	7.3	NUM
dpc-3506	184	17	%	%	NOUN
dpc-3506	184	18	in	in	ADP
dpc-3506	184	19	pols	pol	NOUN
dpc-3506	184	20	.	.	PUNCT
dpc-3506	185	1	these	these	PRON
dpc-3506	185	2	were	be	AUX
dpc-3506	185	3	consistent	consistent	ADJ
dpc-3506	185	4	with	with	ADP
dpc-3506	185	5	the	the	DET
dpc-3506	185	6	literature	literature	NOUN
dpc-3506	185	7	.	.	PUNCT
dpc-3506	186	1	some	some	DET
dpc-3506	186	2	studies	study	NOUN
dpc-3506	186	3	confirm	confirm	VERB
dpc-3506	186	4	the	the	DET
dpc-3506	186	5	association	association	NOUN
dpc-3506	186	6	of	of	ADP
dpc-3506	186	7	infectious	infectious	ADJ
dpc-3506	186	8	agents	agent	NOUN
dpc-3506	186	9	such	such	ADJ
dpc-3506	186	10	as	as	ADP
dpc-3506	186	11	borrelia	borrelia	NOUN
dpc-3506	186	12	with	with	ADP
dpc-3506	186	13	morphea	morphea	PROPN
dpc-3506	186	14	,	,	PUNCT
dpc-3506	186	15	while	while	SCONJ
dpc-3506	186	16	others	other	NOUN
dpc-3506	186	17	do	do	VERB
dpc-3506	186	18	not	not	PART
dpc-3506	186	19	[	[	X
dpc-3506	186	20	3,24	3,24	X
dpc-3506	186	21	]	]	PUNCT
dpc-3506	186	22	.	.	PUNCT
dpc-3506	187	1	only	only	ADV
dpc-3506	187	2	5	5	NUM
dpc-3506	187	3	(	(	PUNCT
dpc-3506	187	4	6	6	NUM
dpc-3506	187	5	%	%	NOUN
dpc-3506	187	6	)	)	PUNCT
dpc-3506	187	7	of	of	ADP
dpc-3506	187	8	the	the	DET
dpc-3506	187	9	cases	case	NOUN
dpc-3506	187	10	in	in	ADP
dpc-3506	187	11	the	the	DET
dpc-3506	187	12	present	present	ADJ
dpc-3506	187	13	study	study	NOUN
dpc-3506	187	14	were	be	AUX
dpc-3506	187	15	detected	detect	VERB
dpc-3506	187	16	to	to	PART
dpc-3506	187	17	have	have	VERB
dpc-3506	187	18	the	the	DET
dpc-3506	187	19	borrelia	borrelia	ADJ
dpc-3506	187	20	antibody	antibody	NOUN
dpc-3506	187	21	.	.	PUNCT
dpc-3506	188	1	in	in	ADP
dpc-3506	188	2	morphea	morphea	PROPN
dpc-3506	188	3	patients	patient	NOUN
dpc-3506	188	4	,	,	PUNCT
dpc-3506	188	5	extracutaneous	extracutaneous	ADJ
dpc-3506	188	6	abnormalities	abnormality	NOUN
dpc-3506	188	7	have	have	AUX
dpc-3506	188	8	also	also	ADV
dpc-3506	188	9	been	be	AUX
dpc-3506	188	10	reported	report	VERB
dpc-3506	188	11	in	in	ADP
dpc-3506	188	12	addition	addition	NOUN
dpc-3506	188	13	to	to	ADP
dpc-3506	188	14	skin	skin	NOUN
dpc-3506	188	15	abnormalities	abnormality	NOUN
dpc-3506	188	16	[	[	X
dpc-3506	188	17	14,25	14,25	X
dpc-3506	188	18	]	]	PUNCT
dpc-3506	188	19	.	.	PUNCT
dpc-3506	189	1	these	these	DET
dpc-3506	189	2	findings	finding	NOUN
dpc-3506	189	3	range	range	VERB
dpc-3506	189	4	from	from	ADP
dpc-3506	189	5	10.9	10.9	NUM
dpc-3506	189	6	%	%	NOUN
dpc-3506	189	7	to	to	ADP
dpc-3506	189	8	46	46	NUM
dpc-3506	189	9	%	%	NOUN
dpc-3506	189	10	[	[	X
dpc-3506	189	11	18,20,25	18,20,25	NUM
dpc-3506	189	12	]	]	PUNCT
dpc-3506	189	13	.	.	PUNCT
dpc-3506	190	1	there	there	PRON
dpc-3506	190	2	have	have	AUX
dpc-3506	190	3	been	be	AUX
dpc-3506	190	4	reports	report	NOUN
dpc-3506	190	5	of	of	ADP
dpc-3506	190	6	extracutaneous	extracutaneous	ADJ
dpc-3506	190	7	involvement	involvement	NOUN
dpc-3506	190	8	being	be	AUX
dpc-3506	190	9	more	more	ADV
dpc-3506	190	10	prevalent	prevalent	ADJ
dpc-3506	190	11	in	in	ADP
dpc-3506	190	12	generalized	generalized	ADJ
dpc-3506	190	13	and	and	CCONJ
dpc-3506	190	14	mixed	mixed	ADJ
dpc-3506	190	15	type	type	NOUN
dpc-3506	191	1	[	[	X
dpc-3506	191	2	13,17	13,17	NOUN
dpc-3506	191	3	]	]	PUNCT
dpc-3506	191	4	.	.	PUNCT
dpc-3506	192	1	we	we	PRON
dpc-3506	192	2	found	find	VERB
dpc-3506	192	3	extracutaneous	extracutaneous	ADJ
dpc-3506	192	4	involvement	involvement	NOUN
dpc-3506	192	5	(	(	PUNCT
dpc-3506	192	6	arthralgia	arthralgia	NOUN
dpc-3506	192	7	)	)	PUNCT
dpc-3506	192	8	in	in	ADP
dpc-3506	192	9	10.4	10.4	NUM
dpc-3506	192	10	%	%	NOUN
dpc-3506	192	11	of	of	ADP
dpc-3506	192	12	the	the	DET
dpc-3506	192	13	cases	case	NOUN
dpc-3506	192	14	.	.	PUNCT
dpc-3506	193	1	the	the	DET
dpc-3506	193	2	low	low	ADJ
dpc-3506	193	3	rate	rate	NOUN
dpc-3506	193	4	might	might	AUX
dpc-3506	193	5	be	be	AUX
dpc-3506	193	6	due	due	ADJ
dpc-3506	193	7	to	to	ADP
dpc-3506	193	8	the	the	DET
dpc-3506	193	9	fact	fact	NOUN
dpc-3506	193	10	that	that	SCONJ
dpc-3506	193	11	the	the	DET
dpc-3506	193	12	cases	case	NOUN
dpc-3506	193	13	could	could	AUX
dpc-3506	193	14	not	not	PART
dpc-3506	193	15	be	be	AUX
dpc-3506	193	16	questioned	question	VERB
dpc-3506	193	17	because	because	SCONJ
dpc-3506	193	18	of	of	ADP
dpc-3506	193	19	the	the	DET
dpc-3506	193	20	retrospective	retrospective	ADJ
dpc-3506	193	21	nature	nature	NOUN
dpc-3506	193	22	of	of	ADP
dpc-3506	193	23	the	the	DET
dpc-3506	193	24	study	study	NOUN
dpc-3506	193	25	.	.	PUNCT
dpc-3506	194	1	some	some	DET
dpc-3506	194	2	authors	author	NOUN
dpc-3506	194	3	have	have	AUX
dpc-3506	194	4	reported	report	VERB
dpc-3506	194	5	more	more	ADV
dpc-3506	194	6	frequent	frequent	ADJ
dpc-3506	194	7	(	(	PUNCT
dpc-3506	194	8	43%-45	43%-45	NUM
dpc-3506	194	9	%	%	NOUN
dpc-3506	194	10	)	)	PUNCT
dpc-3506	194	11	deformities	deformity	NOUN
dpc-3506	194	12	in	in	ADP
dpc-3506	194	13	children	child	NOUN
dpc-3506	194	14	with	with	ADP
dpc-3506	194	15	linear	linear	PROPN
dpc-3506	194	16	morphea	morphea	PROPN
dpc-3506	195	1	[	[	X
dpc-3506	195	2	15,16	15,16	NUM
dpc-3506	195	3	]	]	PUNCT
dpc-3506	195	4	.	.	PUNCT
dpc-3506	196	1	saracino	saracino	NOUN
dpc-3506	196	2	et	et	PROPN
dpc-3506	196	3	al	al	PROPN
dpc-3506	196	4	detected	detect	VERB
dpc-3506	196	5	functional	functional	ADJ
dpc-3506	196	6	impairment	impairment	NOUN
dpc-3506	196	7	in	in	ADP
dpc-3506	196	8	24.8	24.8	NUM
dpc-3506	196	9	%	%	NOUN
dpc-3506	196	10	of	of	ADP
dpc-3506	196	11	adult	adult	NOUN
dpc-3506	196	12	,	,	PUNCT
dpc-3506	196	13	28	28	NUM
dpc-3506	196	14	%	%	NOUN
dpc-3506	196	15	of	of	ADP
dpc-3506	196	16	pediatric	pediatric	NOUN
dpc-3506	196	17	-	-	PUNCT
dpc-3506	196	18	onset	onset	NOUN
dpc-3506	196	19	and	and	CCONJ
dpc-3506	196	20	20.7	20.7	NUM
dpc-3506	196	21	%	%	NOUN
dpc-3506	196	22	of	of	ADP
dpc-3506	196	23	adult	adult	NOUN
dpc-3506	196	24	-	-	PUNCT
dpc-3506	196	25	onset	onset	NOUN
dpc-3506	196	26	patients	patient	NOUN
dpc-3506	196	27	 	 	SPACE
dpc-3506	197	1	[	[	X
dpc-3506	197	2	18	18	NUM
dpc-3506	197	3	]	]	PUNCT
dpc-3506	197	4	.	.	PUNCT
dpc-3506	198	1	in	in	ADP
dpc-3506	198	2	our	our	PRON
dpc-3506	198	3	study	study	NOUN
dpc-3506	198	4	,	,	PUNCT
dpc-3506	198	5	although	although	SCONJ
dpc-3506	198	6	linear	linear	PROPN
dpc-3506	198	7	morphea	morphea	PROPN
dpc-3506	198	8	was	be	AUX
dpc-3506	198	9	found	find	VERB
dpc-3506	198	10	in	in	ADP
dpc-3506	198	11	10.9	10.9	NUM
dpc-3506	198	12	%	%	NOUN
dpc-3506	198	13	of	of	ADP
dpc-3506	198	14	the	the	DET
dpc-3506	198	15	cases	case	NOUN
dpc-3506	198	16	,	,	PUNCT
dpc-3506	198	17	no	no	DET
dpc-3506	198	18	functional	functional	ADJ
dpc-3506	198	19	impairment	impairment	NOUN
dpc-3506	198	20	was	be	AUX
dpc-3506	198	21	detected	detect	VERB
dpc-3506	198	22	except	except	SCONJ
dpc-3506	198	23	for	for	ADP
dpc-3506	198	24	cosmetic	cosmetic	ADJ
dpc-3506	198	25	problems	problem	NOUN
dpc-3506	198	26	.	.	PUNCT
dpc-3506	199	1	morphea	morphea	PROPN
dpc-3506	199	2	is	be	AUX
dpc-3506	199	3	an	an	DET
dpc-3506	199	4	immune	immune	ADJ
dpc-3506	199	5	disorder	disorder	NOUN
dpc-3506	199	6	and	and	CCONJ
dpc-3506	199	7	can	can	AUX
dpc-3506	199	8	often	often	ADV
dpc-3506	199	9	be	be	AUX
dpc-3506	199	10	accompanied	accompany	VERB
dpc-3506	199	11	by	by	ADP
dpc-3506	199	12	various	various	ADJ
dpc-3506	199	13	systemic	systemic	ADJ
dpc-3506	199	14	,	,	PUNCT
dpc-3506	199	15	autoimmune	autoimmune	ADJ
dpc-3506	199	16	,	,	PUNCT
dpc-3506	199	17	and	and	CCONJ
dpc-3506	199	18	rheumatological	rheumatological	ADJ
dpc-3506	199	19	diseases	disease	NOUN
dpc-3506	199	20	.	.	PUNCT
dpc-3506	200	1	diseases	disease	NOUN
dpc-3506	200	2	such	such	ADJ
dpc-3506	200	3	as	as	ADP
dpc-3506	200	4	thyroid	thyroid	NOUN
dpc-3506	200	5	diseases	disease	NOUN
dpc-3506	200	6	and	and	CCONJ
dpc-3506	200	7	diabetes	diabete	NOUN
dpc-3506	200	8	play	play	VERB
dpc-3506	200	9	a	a	DET
dpc-3506	200	10	predisposing	predispose	VERB
dpc-3506	200	11	role	role	NOUN
dpc-3506	200	12	.	.	PUNCT
dpc-3506	201	1	the	the	DET
dpc-3506	201	2	presence	presence	NOUN
dpc-3506	201	3	of	of	ADP
dpc-3506	201	4	accompanying	accompany	VERB
dpc-3506	201	5	autoimmune	autoimmune	ADJ
dpc-3506	201	6	systemic	systemic	ADJ
dpc-3506	201	7	disease	disease	NOUN
dpc-3506	201	8	differs	differ	VERB
dpc-3506	201	9	between	between	ADP
dpc-3506	201	10	1%-4.9	1%-4.9	NUM
dpc-3506	201	11	%	%	NOUN
dpc-3506	201	12	[	[	X
dpc-3506	201	13	6,17,18,20,25	6,17,18,20,25	NUM
dpc-3506	201	14	]	]	PUNCT
dpc-3506	201	15	.	.	PUNCT
dpc-3506	202	1	in	in	ADP
dpc-3506	202	2	some	some	DET
dpc-3506	202	3	studies	study	NOUN
dpc-3506	202	4	,	,	PUNCT
dpc-3506	202	5	the	the	DET
dpc-3506	202	6	association	association	NOUN
dpc-3506	202	7	of	of	ADP
dpc-3506	202	8	autoimmune	autoimmune	ADJ
dpc-3506	202	9	diseases	disease	NOUN
dpc-3506	202	10	is	be	AUX
dpc-3506	202	11	up	up	ADP
dpc-3506	202	12	to	to	PART
dpc-3506	202	13	17	17	NUM
dpc-3506	202	14	%	%	NOUN
dpc-3506	202	15	[	[	X
dpc-3506	202	16	6,14,20,21	6,14,20,21	NUM
dpc-3506	202	17	]	]	SYM
dpc-3506	202	18	.	.	PUNCT
dpc-3506	203	1	saracino	saracino	PROPN
dpc-3506	203	2	et	et	PROPN
dpc-3506	203	3	al	al	PROPN
dpc-3506	203	4	found	find	VERB
dpc-3506	203	5	autoimmune	autoimmune	ADJ
dpc-3506	203	6	disease	disease	NOUN
dpc-3506	203	7	comorbidity	comorbidity	NOUN
dpc-3506	203	8	as	as	ADP
dpc-3506	203	9	11.3	11.3	NUM
dpc-3506	203	10	%	%	NOUN
dpc-3506	203	11	in	in	ADP
dpc-3506	203	12	general	general	ADJ
dpc-3506	203	13	,	,	PUNCT
dpc-3506	203	14	15.5	15.5	NUM
dpc-3506	203	15	%	%	NOUN
dpc-3506	203	16	for	for	ADP
dpc-3506	203	17	aols	aol	NOUN
dpc-3506	203	18	and	and	CCONJ
dpc-3506	203	19	8.0	8.0	NUM
dpc-3506	203	20	%	%	NOUN
dpc-3506	203	21	for	for	ADP
dpc-3506	203	22	pols	pol	NOUN
dpc-3506	203	23	[	[	X
dpc-3506	203	24	18	18	NUM
dpc-3506	203	25	]	]	PUNCT
dpc-3506	203	26	.	.	PUNCT
dpc-3506	204	1	in	in	ADP
dpc-3506	204	2	our	our	PRON
dpc-3506	204	3	study	study	NOUN
dpc-3506	204	4	,	,	PUNCT
dpc-3506	204	5	the	the	DET
dpc-3506	204	6	rate	rate	NOUN
dpc-3506	204	7	of	of	ADP
dpc-3506	204	8	comorbid	comorbid	NOUN
dpc-3506	204	9	diseases	disease	NOUN
dpc-3506	204	10	was	be	AUX
dpc-3506	204	11	similar	similar	ADJ
dpc-3506	204	12	to	to	ADP
dpc-3506	204	13	other	other	ADJ
dpc-3506	204	14	studies	study	NOUN
dpc-3506	204	15	[	[	X
dpc-3506	204	16	19,26	19,26	NUM
dpc-3506	204	17	]	]	PUNCT
dpc-3506	204	18	.	.	PUNCT
dpc-3506	205	1	eleven	eleven	NUM
dpc-3506	205	2	patients	patient	NOUN
dpc-3506	205	3	had	have	VERB
dpc-3506	205	4	comorbid	comorbid	NOUN
dpc-3506	205	5	autoimmune	autoimmune	ADJ
dpc-3506	205	6	skin	skin	NOUN
dpc-3506	205	7	disease	disease	NOUN
dpc-3506	205	8	.	.	PUNCT
dpc-3506	206	1	these	these	DET
dpc-3506	206	2	diseases	disease	NOUN
dpc-3506	206	3	were	be	AUX
dpc-3506	206	4	only	only	ADV
dpc-3506	206	5	in	in	ADP
dpc-3506	206	6	the	the	DET
dpc-3506	206	7	adult	adult	NOUN
dpc-3506	206	8	-	-	PUNCT
dpc-3506	206	9	onset	onset	NOUN
dpc-3506	206	10	group	group	NOUN
dpc-3506	206	11	.	.	PUNCT
dpc-3506	207	1	comorbid	comorbid	NOUN
dpc-3506	207	2	diseases	disease	NOUN
dpc-3506	207	3	increase	increase	VERB
dpc-3506	207	4	with	with	ADP
dpc-3506	207	5	age	age	NOUN
dpc-3506	207	6	[	[	X
dpc-3506	207	7	11	11	NUM
dpc-3506	207	8	]	]	PUNCT
dpc-3506	207	9	.	.	PUNCT
dpc-3506	208	1	furthermore	furthermore	ADV
dpc-3506	208	2	,	,	PUNCT
dpc-3506	208	3	in	in	ADP
dpc-3506	208	4	our	our	PRON
dpc-3506	208	5	cases	case	NOUN
dpc-3506	208	6	,	,	PUNCT
dpc-3506	208	7	iron	iron	NOUN
dpc-3506	208	8	deficiency	deficiency	NOUN
dpc-3506	208	9	was	be	AUX
dpc-3506	208	10	found	find	VERB
dpc-3506	208	11	in	in	ADP
dpc-3506	208	12	25.7	25.7	NUM
dpc-3506	208	13	%	%	NOUN
dpc-3506	208	14	of	of	ADP
dpc-3506	208	15	the	the	DET
dpc-3506	208	16	women	woman	NOUN
dpc-3506	208	17	.	.	PUNCT
dpc-3506	209	1	low	low	ADJ
dpc-3506	209	2	hb	hb	PROPN
dpc-3506	209	3	levels	level	NOUN
dpc-3506	209	4	may	may	AUX
dpc-3506	209	5	be	be	AUX
dpc-3506	209	6	a	a	DET
dpc-3506	209	7	sign	sign	NOUN
dpc-3506	209	8	of	of	ADP
dpc-3506	209	9	an	an	DET
dpc-3506	209	10	additional	additional	ADJ
dpc-3506	209	11	comorbid	comorbid	NOUN
dpc-3506	209	12	disease	disease	NOUN
dpc-3506	209	13	.	.	PUNCT
dpc-3506	210	1	in	in	ADP
dpc-3506	210	2	the	the	DET
dpc-3506	210	3	present	present	ADJ
dpc-3506	210	4	study	study	NOUN
dpc-3506	210	5	,	,	PUNCT
dpc-3506	210	6	the	the	DET
dpc-3506	210	7	rate	rate	NOUN
dpc-3506	210	8	of	of	ADP
dpc-3506	210	9	vit	vit	ADJ
dpc-3506	210	10	b12	b12	NOUN
dpc-3506	210	11	deficiency	deficiency	NOUN
dpc-3506	210	12	anemia	anemia	NOUN
dpc-3506	210	13	was	be	AUX
dpc-3506	210	14	9.8	9.8	NUM
dpc-3506	210	15	%	%	NOUN
dpc-3506	210	16	,	,	PUNCT
dpc-3506	210	17	and	and	CCONJ
dpc-3506	210	18	the	the	DET
dpc-3506	210	19	rate	rate	NOUN
dpc-3506	210	20	of	of	ADP
dpc-3506	210	21	vit	vit	ADJ
dpc-3506	210	22	d	d	NOUN
dpc-3506	210	23	deficiency	deficiency	NOUN
dpc-3506	210	24	was	be	AUX
dpc-3506	210	25	20.8	20.8	NUM
dpc-3506	210	26	%	%	NOUN
dpc-3506	210	27	.	.	PUNCT
dpc-3506	211	1	the	the	DET
dpc-3506	211	2	most	most	ADV
dpc-3506	211	3	comprehensive	comprehensive	ADJ
dpc-3506	211	4	multi	multi	ADJ
dpc-3506	211	5	-	-	ADJ
dpc-3506	211	6	centred	centred	ADJ
dpc-3506	211	7	study	study	NOUN
dpc-3506	211	8	so	so	ADV
dpc-3506	211	9	far	far	ADV
dpc-3506	211	10	was	be	AUX
dpc-3506	211	11	conducted	conduct	VERB
dpc-3506	211	12	by	by	ADP
dpc-3506	211	13	zulian	zulian	PROPN
dpc-3506	211	14	et	et	PROPN
dpc-3506	211	15	al	al	PROPN
dpc-3506	211	16	with	with	ADP
dpc-3506	211	17	750	750	NUM
dpc-3506	211	18	patients	patient	NOUN
dpc-3506	211	19	with	with	ADP
dpc-3506	211	20	juvenile	juvenile	ADJ
dpc-3506	211	21	8	8	NUM
dpc-3506	211	22	original	original	ADJ
dpc-3506	211	23	article	article	NOUN
dpc-3506	211	24	|	|	ADV
dpc-3506	211	25	dermatol	dermatol	ADJ
dpc-3506	211	26	pract	pract	NOUN
dpc-3506	211	27	concept	concept	NOUN
dpc-3506	211	28	.	.	PUNCT
dpc-3506	212	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	212	2	anomalies	anomaly	NOUN
dpc-3506	212	3	.	.	PUNCT
dpc-3506	213	1	that	that	SCONJ
dpc-3506	213	2	why	why	SCONJ
dpc-3506	213	3	patients	patient	NOUN
dpc-3506	213	4	with	with	ADP
dpc-3506	213	5	adult	adult	NOUN
dpc-3506	213	6	and	and	CCONJ
dpc-3506	213	7	pediatric	pediatric	ADJ
dpc-3506	213	8	onset	onset	NOUN
dpc-3506	213	9	morphea	morphea	PROPN
dpc-3506	213	10	require	require	VERB
dpc-3506	213	11	different	different	ADJ
dpc-3506	213	12	management	management	NOUN
dpc-3506	213	13	and	and	CCONJ
dpc-3506	213	14	treatment	treatment	NOUN
dpc-3506	213	15	strategies	strategy	NOUN
dpc-3506	213	16	.	.	PUNCT
dpc-3506	214	1	additionally	additionally	ADV
dpc-3506	214	2	,	,	PUNCT
dpc-3506	214	3	clinicians	clinician	NOUN
dpc-3506	214	4	should	should	AUX
dpc-3506	214	5	be	be	AUX
dpc-3506	214	6	aware	aware	ADJ
dpc-3506	214	7	of	of	ADP
dpc-3506	214	8	the	the	DET
dpc-3506	214	9	extracutaneous	extracutaneous	ADJ
dpc-3506	214	10	disease	disease	NOUN
dpc-3506	214	11	and	and	CCONJ
dpc-3506	214	12	anomalies	anomaly	NOUN
dpc-3506	214	13	that	that	PRON
dpc-3506	214	14	may	may	AUX
dpc-3506	214	15	accompany	accompany	VERB
dpc-3506	214	16	morphea	morphea	PROPN
dpc-3506	214	17	and	and	CCONJ
dpc-3506	214	18	patients	patient	NOUN
dpc-3506	214	19	should	should	AUX
dpc-3506	214	20	be	be	AUX
dpc-3506	214	21	examined	examine	VERB
dpc-3506	214	22	accordingly	accordingly	ADV
dpc-3506	214	23	.	.	PUNCT
dpc-3506	215	1	the	the	DET
dpc-3506	215	2	retrospective	retrospective	ADJ
dpc-3506	215	3	nature	nature	NOUN
dpc-3506	215	4	,	,	PUNCT
dpc-3506	215	5	inability	inability	NOUN
dpc-3506	215	6	to	to	PART
dpc-3506	215	7	create	create	VERB
dpc-3506	215	8	a	a	DET
dpc-3506	215	9	morphea	morphea	ADJ
dpc-3506	215	10	severity	severity	NOUN
dpc-3506	215	11	scale	scale	NOUN
dpc-3506	215	12	,	,	PUNCT
dpc-3506	215	13	and	and	CCONJ
dpc-3506	215	14	the	the	DET
dpc-3506	215	15	lack	lack	NOUN
dpc-3506	215	16	of	of	ADP
dpc-3506	215	17	standardization	standardization	NOUN
dpc-3506	215	18	in	in	ADP
dpc-3506	215	19	the	the	DET
dpc-3506	215	20	treatment	treatment	NOUN
dpc-3506	215	21	administered	administer	VERB
dpc-3506	215	22	for	for	ADP
dpc-3506	215	23	different	different	ADJ
dpc-3506	215	24	types	type	NOUN
dpc-3506	215	25	of	of	ADP
dpc-3506	215	26	morphea	morphea	NOUN
dpc-3506	215	27	are	be	AUX
dpc-3506	215	28	the	the	DET
dpc-3506	215	29	limitations	limitation	NOUN
dpc-3506	215	30	of	of	ADP
dpc-3506	215	31	our	our	PRON
dpc-3506	215	32	study	study	NOUN
dpc-3506	215	33	.	.	PUNCT
dpc-3506	216	1	multi	multi	ADJ
dpc-3506	216	2	-	-	ADJ
dpc-3506	216	3	centered	center	VERB
dpc-3506	216	4	,	,	PUNCT
dpc-3506	216	5	more	more	ADV
dpc-3506	216	6	comprehensive	comprehensive	ADJ
dpc-3506	216	7	and	and	CCONJ
dpc-3506	216	8	prospective	prospective	ADJ
dpc-3506	216	9	studies	study	NOUN
dpc-3506	216	10	are	be	AUX
dpc-3506	216	11	required	require	VERB
dpc-3506	216	12	to	to	PART
dpc-3506	216	13	obtain	obtain	VERB
dpc-3506	216	14	more	more	ADV
dpc-3506	216	15	accurate	accurate	ADJ
dpc-3506	216	16	data	datum	NOUN
dpc-3506	216	17	.	.	PUNCT
dpc-3506	217	1	references	reference	NOUN
dpc-3506	217	2	1	1	NUM
dpc-3506	217	3	.	.	PUNCT
dpc-3506	217	4	abbas	abbas	PROPN
dpc-3506	217	5	l	l	PROPN
dpc-3506	217	6	,	,	PUNCT
dpc-3506	217	7	joseph	joseph	PROPN
dpc-3506	217	8	a	a	PROPN
dpc-3506	217	9	,	,	PUNCT
dpc-3506	217	10	kunzler	kunzler	PROPN
dpc-3506	217	11	e	e	NOUN
dpc-3506	217	12	,	,	PUNCT
dpc-3506	217	13	jacobe	jacobe	PROPN
dpc-3506	217	14	ht	ht	PROPN
dpc-3506	217	15	.	.	PUNCT
dpc-3506	217	16	morphea	morphea	PROPN
dpc-3506	217	17	:	:	PUNCT
dpc-3506	217	18	progress	progress	NOUN
dpc-3506	217	19	to	to	ADP
dpc-3506	217	20	date	date	NOUN
dpc-3506	217	21	and	and	CCONJ
dpc-3506	217	22	the	the	DET
dpc-3506	217	23	road	road	NOUN
dpc-3506	217	24	ahead	ahead	ADV
dpc-3506	217	25	.	.	PUNCT
dpc-3506	218	1	ann	ann	PROPN
dpc-3506	218	2	transl	transl	PROPN
dpc-3506	218	3	med	med	PROPN
dpc-3506	218	4	.	.	PUNCT
dpc-3506	219	1	2021;9(5):437	2021;9(5):437	X
dpc-3506	219	2	.	.	X
dpc-3506	219	3	doi	doi	NOUN
dpc-3506	219	4	:	:	PUNCT
dpc-3506	219	5	10.21037	10.21037	NUM
dpc-3506	219	6	/	/	SYM
dpc-3506	219	7	atm-20	atm-20	NOUN
dpc-3506	219	8	-	-	PUNCT
dpc-3506	219	9	6222	6222	NUM
dpc-3506	219	10	.	.	PUNCT
dpc-3506	220	1	pmid	pmid	NOUN
dpc-3506	220	2	:	:	PUNCT
dpc-3506	220	3	33842658	33842658	NUM
dpc-3506	220	4	.	.	PUNCT
dpc-3506	221	1	pmcid	pmcid	NOUN
dpc-3506	221	2	:	:	PUNCT
dpc-3506	221	3	pmc8033330	pmc8033330	NOUN
dpc-3506	221	4	.	.	PUNCT
dpc-3506	222	1	2	2	X
dpc-3506	222	2	.	.	X
dpc-3506	222	3	fett	fett	PROPN
dpc-3506	222	4	n	n	CCONJ
dpc-3506	222	5	,	,	PUNCT
dpc-3506	222	6	werth	werth	PROPN
dpc-3506	222	7	vp	vp	PROPN
dpc-3506	222	8	.	.	PUNCT
dpc-3506	222	9	update	update	NOUN
dpc-3506	222	10	on	on	ADP
dpc-3506	222	11	morphea	morphea	PROPN
dpc-3506	222	12	:	:	PUNCT
dpc-3506	222	13	part	part	PROPN
dpc-3506	222	14	i.	i.	PROPN
dpc-3506	222	15	epidemiology	epidemiology	PROPN
dpc-3506	222	16	,	,	PUNCT
dpc-3506	222	17	clinical	clinical	ADJ
dpc-3506	222	18	presentation	presentation	NOUN
dpc-3506	222	19	,	,	PUNCT
dpc-3506	222	20	and	and	CCONJ
dpc-3506	222	21	pathogenesis	pathogenesis	NOUN
dpc-3506	222	22	.	.	PUNCT
dpc-3506	223	1	j	j	PROPN
dpc-3506	223	2	am	be	AUX
dpc-3506	223	3	acad	acad	ADJ
dpc-3506	223	4	dermatol	dermatol	NOUN
dpc-3506	223	5	.	.	PUNCT
dpc-3506	224	1	2011;64(2):217	2011;64(2):217	NUM
dpc-3506	224	2	-	-	SYM
dpc-3506	224	3	228	228	NUM
dpc-3506	224	4	.	.	PUNCT
dpc-3506	225	1	doi:10.1016	doi:10.1016	PROPN
dpc-3506	225	2	/	/	SYM
dpc-3506	225	3	j.jaad.2010.05.045	j.jaad.2010.05.045	PROPN
dpc-3506	225	4	.	.	PUNCT
dpc-3506	226	1	pmid.21238823	pmid.21238823	X
dpc-3506	226	2	.	.	NOUN
dpc-3506	226	3	3	3	NUM
dpc-3506	226	4	.	.	X
dpc-3506	226	5	khamaganova	khamaganova	PROPN
dpc-3506	226	6	i.	i.	PROPN
dpc-3506	226	7	localized	localize	VERB
dpc-3506	226	8	scleroderma	scleroderma	NOUN
dpc-3506	226	9	predisposing	predispose	VERB
dpc-3506	226	10	and	and	CCONJ
dpc-3506	226	11	triggering	trigger	VERB
dpc-3506	226	12	factors	factor	NOUN
dpc-3506	226	13	.	.	PUNCT
dpc-3506	227	1	the	the	DET
dpc-3506	227	2	open	open	ADJ
dpc-3506	227	3	dermatology	dermatology	NOUN
dpc-3506	227	4	journal.2017;1:11	journal.2017;1:11	PROPN
dpc-3506	227	5	.	.	PUNCT
dpc-3506	228	1	doi:10	doi:10	PROPN
dpc-3506	228	2	.	.	PUNCT
dpc-3506	229	1	2174/1874372201711010001	2174/1874372201711010001	NUM
dpc-3506	229	2	.	.	PUNCT
dpc-3506	230	1	4	4	X
dpc-3506	230	2	.	.	X
dpc-3506	230	3	bielsa	bielsa	VERB
dpc-3506	230	4	marsol	marsol	PROPN
dpc-3506	230	5	i.	i.	PROPN
dpc-3506	230	6	update	update	PROPN
dpc-3506	230	7	on	on	ADP
dpc-3506	230	8	the	the	DET
dpc-3506	230	9	classification	classification	NOUN
dpc-3506	230	10	and	and	CCONJ
dpc-3506	230	11	treatment	treatment	NOUN
dpc-3506	230	12	of	of	ADP
dpc-3506	230	13	localized	localized	ADJ
dpc-3506	230	14	scleroderma	scleroderma	NOUN
dpc-3506	230	15	.	.	PUNCT
dpc-3506	231	1	actas	actas	PROPN
dpc-3506	231	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-3506	231	3	.	.	PUNCT
dpc-3506	232	1	2013;104(8):654	2013;104(8):654	NUM
dpc-3506	232	2	-	-	SYM
dpc-3506	232	3	666	666	NUM
dpc-3506	232	4	.	.	PUNCT
dpc-3506	232	5	doi	doi	NOUN
dpc-3506	232	6	:	:	PUNCT
dpc-3506	232	7	10.1016	10.1016	NUM
dpc-3506	232	8	/	/	SYM
dpc-3506	232	9	j.adengl.2012	j.adengl.2012	PROPN
dpc-3506	232	10	.	.	PUNCT
dpc-3506	233	1	pmid	pmid	NOUN
dpc-3506	233	2	23948159	23948159	NUM
dpc-3506	233	3	.	.	PUNCT
dpc-3506	234	1	5	5	X
dpc-3506	234	2	.	.	X
dpc-3506	234	3	peterson	peterson	PROPN
dpc-3506	234	4	ls	ls	PROPN
dpc-3506	234	5	,	,	PUNCT
dpc-3506	234	6	nelson	nelson	PROPN
dpc-3506	234	7	am	am	PROPN
dpc-3506	234	8	,	,	PUNCT
dpc-3506	234	9	su	su	PROPN
dpc-3506	234	10	wp	wp	PROPN
dpc-3506	234	11	,	,	PUNCT
dpc-3506	234	12	mason	mason	PROPN
dpc-3506	234	13	t	t	PROPN
dpc-3506	234	14	,	,	PUNCT
dpc-3506	234	15	o’fallon	o’fallon	PROPN
dpc-3506	234	16	wm	wm	PROPN
dpc-3506	234	17	,	,	PUNCT
dpc-3506	234	18	gabriel	gabriel	PROPN
dpc-3506	234	19	 	 	SPACE
dpc-3506	234	20	se	se	PROPN
dpc-3506	234	21	.	.	PUNCT
dpc-3506	235	1	the	the	DET
dpc-3506	235	2	epidemiology	epidemiology	NOUN
dpc-3506	235	3	of	of	ADP
dpc-3506	235	4	morphea	morphea	PROPN
dpc-3506	235	5	(	(	PUNCT
dpc-3506	235	6	localized	localized	ADJ
dpc-3506	235	7	scleroderma	scleroderma	NOUN
dpc-3506	235	8	)	)	PUNCT
dpc-3506	235	9	in	in	ADP
dpc-3506	235	10	olmsted	olmsted	PROPN
dpc-3506	235	11	county	county	PROPN
dpc-3506	235	12	1960	1960	NUM
dpc-3506	235	13	-	-	SYM
dpc-3506	235	14	1993	1993	NUM
dpc-3506	235	15	.	.	PUNCT
dpc-3506	236	1	j	j	PROPN
dpc-3506	236	2	rheumatol	rheumatol	NOUN
dpc-3506	236	3	.	.	PUNCT
dpc-3506	237	1	1997;24(1):73	1997;24(1):73	NUM
dpc-3506	237	2	-	-	SYM
dpc-3506	237	3	80	80	NUM
dpc-3506	237	4	.	.	PUNCT
dpc-3506	238	1	pmid	pmid	NOUN
dpc-3506	238	2	:	:	PUNCT
dpc-3506	238	3	9002014	9002014	NUM
dpc-3506	238	4	.	.	PUNCT
dpc-3506	239	1	6	6	X
dpc-3506	239	2	.	.	X
dpc-3506	239	3	leitenberger	leitenberg	ADJ
dpc-3506	239	4	jj	jj	PROPN
dpc-3506	239	5	,	,	PUNCT
dpc-3506	239	6	cayce	cayce	PROPN
dpc-3506	239	7	rl	rl	PROPN
dpc-3506	239	8	,	,	PUNCT
dpc-3506	239	9	haley	haley	NOUN
dpc-3506	239	10	rw	rw	PROPN
dpc-3506	239	11	,	,	PUNCT
dpc-3506	239	12	adams	adams	PROPN
dpc-3506	239	13	-	-	PUNCT
dpc-3506	239	14	huet	huet	PROPN
dpc-3506	239	15	b	b	PROPN
dpc-3506	239	16	,	,	PUNCT
dpc-3506	239	17	bergstresser	bergstresser	NOUN
dpc-3506	239	18	pr	pr	NOUN
dpc-3506	239	19	,	,	PUNCT
dpc-3506	239	20	jacobe	jacobe	PROPN
dpc-3506	239	21	ht	ht	PROPN
dpc-3506	239	22	.	.	PUNCT
dpc-3506	239	23	distinct	distinct	ADJ
dpc-3506	239	24	autoimmune	autoimmune	ADJ
dpc-3506	239	25	syndromes	syndrome	NOUN
dpc-3506	239	26	in	in	ADP
dpc-3506	239	27	morphea	morphea	PROPN
dpc-3506	239	28	:	:	PUNCT
dpc-3506	239	29	a	a	DET
dpc-3506	239	30	review	review	NOUN
dpc-3506	239	31	of	of	ADP
dpc-3506	239	32	245	245	NUM
dpc-3506	239	33	adult	adult	NOUN
dpc-3506	239	34	and	and	CCONJ
dpc-3506	239	35	pediatric	pediatric	ADJ
dpc-3506	239	36	cases	case	NOUN
dpc-3506	239	37	.	.	PUNCT
dpc-3506	240	1	arch	arch	ADJ
dpc-3506	240	2	dermatol	dermatol	NOUN
dpc-3506	240	3	.	.	PUNCT
dpc-3506	241	1	2009;145(5):545	2009;145(5):545	NUM
dpc-3506	241	2	-	-	SYM
dpc-3506	241	3	550	550	NUM
dpc-3506	241	4	.	.	PUNCT
dpc-3506	242	1	doi	doi	NOUN
dpc-3506	242	2	:	:	PUNCT
dpc-3506	242	3	10.1001	10.1001	NUM
dpc-3506	242	4	/	/	SYM
dpc-3506	242	5	archdermatol.2009.79	archdermatol.2009.79	PROPN
dpc-3506	242	6	.	.	PUNCT
dpc-3506	243	1	pmid	pmid	NOUN
dpc-3506	243	2	:	:	PUNCT
dpc-3506	243	3	19451498	19451498	NUM
dpc-3506	243	4	.	.	PUNCT
dpc-3506	244	1	7	7	X
dpc-3506	244	2	.	.	X
dpc-3506	244	3	careta	careta	PROPN
dpc-3506	244	4	mf	mf	PROPN
dpc-3506	244	5	,	,	PUNCT
dpc-3506	244	6	romiti	romiti	PROPN
dpc-3506	244	7	r.	r.	PROPN
dpc-3506	244	8	localized	localize	VERB
dpc-3506	244	9	scleroderma	scleroderma	NOUN
dpc-3506	244	10	:	:	PUNCT
dpc-3506	244	11	clinical	clinical	ADJ
dpc-3506	244	12	spectrumand	spectrumand	NOUN
dpc-3506	244	13	therapeutic	therapeutic	ADJ
dpc-3506	244	14	update	update	NOUN
dpc-3506	244	15	.	.	PUNCT
dpc-3506	245	1	an	an	DET
dpc-3506	245	2	bras	bras	NOUN
dpc-3506	245	3	dermatol	dermatol	NOUN
dpc-3506	245	4	.	.	PUNCT
dpc-3506	246	1	2015;90(1):62	2015;90(1):62	NUM
dpc-3506	246	2	-	-	SYM
dpc-3506	246	3	73	73	NUM
dpc-3506	246	4	.	.	PUNCT
dpc-3506	247	1	doi:10.1590	doi:10.1590	ADJ
dpc-3506	247	2	/	/	SYM
dpc-3506	247	3	abd1806	abd1806	NOUN
dpc-3506	247	4	-	-	PUNCT
dpc-3506	247	5	4841.20152890	4841.20152890	NOUN
dpc-3506	247	6	.	.	PUNCT
dpc-3506	248	1	pmid	pmid	NOUN
dpc-3506	248	2	:	:	PUNCT
dpc-3506	248	3	25672301	25672301	NUM
dpc-3506	248	4	.	.	PUNCT
dpc-3506	249	1	8	8	X
dpc-3506	249	2	.	.	X
dpc-3506	249	3	laxer	laxer	PROPN
dpc-3506	249	4	rm	rm	PROPN
dpc-3506	249	5	,	,	PUNCT
dpc-3506	249	6	zulian	zulian	PROPN
dpc-3506	249	7	f.	f.	PROPN
dpc-3506	249	8	localized	localize	VERB
dpc-3506	249	9	scleroderma	scleroderma	NOUN
dpc-3506	249	10	.	.	PUNCT
dpc-3506	250	1	curr	curr	PROPN
dpc-3506	250	2	opin	opin	NOUN
dpc-3506	250	3	rheumatol.2006;18(6):606	rheumatol.2006;18(6):606	PROPN
dpc-3506	250	4	-	-	SYM
dpc-3506	250	5	613	613	NUM
dpc-3506	250	6	.	.	PUNCT
dpc-3506	250	7	doi:10.1097/01.bor.000245727	doi:10.1097/01.bor.000245727	PROPN
dpc-3506	250	8	.40630.c3	.40630.c3	PROPN
dpc-3506	250	9	.	.	PUNCT
dpc-3506	251	1	pmid	pmid	NOUN
dpc-3506	251	2	:	:	PUNCT
dpc-3506	251	3	17053506	17053506	NUM
dpc-3506	251	4	.	.	PUNCT
dpc-3506	252	1	9	9	X
dpc-3506	252	2	.	.	X
dpc-3506	252	3	bulur	bulur	PROPN
dpc-3506	252	4	i	i	PROPN
dpc-3506	252	5	,	,	PUNCT
dpc-3506	252	6	erdoğan	erdoğan	VERB
dpc-3506	252	7	hk	hk	PROPN
dpc-3506	252	8	,	,	PUNCT
dpc-3506	252	9	karapınar	karapınar	PROPN
dpc-3506	252	10	t	t	PROPN
dpc-3506	252	11	,	,	PUNCT
dpc-3506	252	12	saracoglu	saracoglu	PROPN
dpc-3506	252	13	zn	zn	PROPN
dpc-3506	252	14	.	.	PUNCT
dpc-3506	252	15	morphea	morphea	PROPN
dpc-3506	252	16	in	in	ADP
dpc-3506	252	17	middle	middle	PROPN
dpc-3506	252	18	anatolia	anatolia	PROPN
dpc-3506	252	19	,	,	PUNCT
dpc-3506	252	20	turkey	turkey	PROPN
dpc-3506	252	21	:	:	PUNCT
dpc-3506	252	22	a	a	DET
dpc-3506	252	23	5	5	NUM
dpc-3506	252	24	-	-	PUNCT
dpc-3506	252	25	year	year	NOUN
dpc-3506	252	26	single	single	ADJ
dpc-3506	252	27	-	-	PUNCT
dpc-3506	252	28	center	center	NOUN
dpc-3506	252	29	experience	experience	NOUN
dpc-3506	252	30	.	.	PUNCT
dpc-3506	253	1	postepy	postepy	PROPN
dpc-3506	253	2	allegol	allegol	NOUN
dpc-3506	253	3	.	.	PUNCT
dpc-3506	254	1	2017;34(4):334	2017;34(4):334	NUM
dpc-3506	254	2	-	-	SYM
dpc-3506	254	3	338	338	NUM
dpc-3506	254	4	.	.	PUNCT
dpc-3506	255	1	pmid:28951708	pmid:28951708	NOUN
dpc-3506	255	2	.	.	PUNCT
dpc-3506	256	1	doi	doi	PROPN
dpc-3506	256	2	.	.	PUNCT
dpc-3506	256	3	org/10.51114	org/10.51114	PROPN
dpc-3506	256	4	/	/	SYM
dpc-3506	256	5	ada.2017.69313	ada.2017.69313	PROPN
dpc-3506	256	6	.	.	PROPN
dpc-3506	257	1	10	10	NUM
dpc-3506	257	2	.	.	PUNCT
dpc-3506	258	1	parlak	parlak	PROPN
dpc-3506	258	2	n	n	CCONJ
dpc-3506	258	3	,	,	PUNCT
dpc-3506	258	4	akay	akay	PROPN
dpc-3506	258	5	bn	bn	NOUN
dpc-3506	258	6	,	,	PUNCT
dpc-3506	258	7	şanlı	şanlı	NOUN
dpc-3506	258	8	he	he	PRON
dpc-3506	258	9	,	,	PUNCT
dpc-3506	258	10	akyol	akyol	NOUN
dpc-3506	258	11	a.	a.	PROPN
dpc-3506	258	12	hastalarda	hastalarda	PROPN
dpc-3506	258	13	klinik	klinik	PROPN
dpc-3506	258	14	özellikler	özellikler	PROPN
dpc-3506	258	15	,	,	PUNCT
dpc-3506	258	16	laboratuvar	laboratuvar	NOUN
dpc-3506	258	17	bulguları	bulguları	NOUN
dpc-3506	258	18	,	,	PUNCT
dpc-3506	258	19	seçilen	seçilen	PROPN
dpc-3506	258	20	tedavi	tedavi	NOUN
dpc-3506	258	21	yöntemi	yöntemi	PROPN
dpc-3506	258	22	ve	ve	PROPN
dpc-3506	258	23	takip	takip	PROPN
dpc-3506	258	24	sonuçları	sonuçları	NOUN
dpc-3506	258	25	[	[	X
dpc-3506	258	26	the	the	DET
dpc-3506	258	27	clinical	clinical	ADJ
dpc-3506	258	28	features	feature	NOUN
dpc-3506	258	29	,	,	PUNCT
dpc-3506	258	30	laboratoryfindings	laboratoryfinding	NOUN
dpc-3506	258	31	,	,	PUNCT
dpc-3506	258	32	treatment	treatment	NOUN
dpc-3506	258	33	and	and	CCONJ
dpc-3506	258	34	follow	follow	VERB
dpc-3506	258	35	-	-	PUNCT
dpc-3506	258	36	up	up	ADP
dpc-3506	258	37	results	result	NOUN
dpc-3506	258	38	of	of	ADP
dpc-3506	258	39	patients	patient	NOUN
dpc-3506	258	40	with	with	ADP
dpc-3506	258	41	morphea	morphea	PROPN
dpc-3506	258	42	]	]	PUNCT
dpc-3506	258	43	.	.	PUNCT
dpc-3506	259	1	turkderm	turkderm	ADJ
dpc-3506	259	2	.	.	PUNCT
dpc-3506	260	1	2013;47(4):209	2013;47(4):209	NUM
dpc-3506	260	2	-	-	PUNCT
dpc-3506	260	3	213	213	NUM
dpc-3506	260	4	.	.	PUNCT
dpc-3506	261	1	doi:104274	doi:104274	PROPN
dpc-3506	261	2	/	/	SYM
dpc-3506	261	3	turkderm.05657	turkderm.05657	PROPN
dpc-3506	261	4	.	.	PROPN
dpc-3506	262	1	11	11	NUM
dpc-3506	262	2	.	.	PUNCT
dpc-3506	263	1	condie	condie	PROPN
dpc-3506	263	2	d	d	PROPN
dpc-3506	263	3	,	,	PUNCT
dpc-3506	263	4	grabell	grabell	VERB
dpc-3506	263	5	d	d	PROPN
dpc-3506	263	6	,	,	PUNCT
dpc-3506	263	7	jacobe	jacobe	PROPN
dpc-3506	263	8	h.	h.	PROPN
dpc-3506	263	9	comparison	comparison	NOUN
dpc-3506	263	10	of	of	ADP
dpc-3506	263	11	outcomes	outcome	NOUN
dpc-3506	263	12	in	in	ADP
dpc-3506	263	13	adults	adult	NOUN
dpc-3506	263	14	with	with	ADP
dpc-3506	263	15	pediatric	pediatric	ADJ
dpc-3506	263	16	-	-	PUNCT
dpc-3506	263	17	onset	onset	NOUN
dpc-3506	263	18	morphea	morphea	NOUN
dpc-3506	263	19	and	and	CCONJ
dpc-3506	263	20	those	those	PRON
dpc-3506	263	21	with	with	ADP
dpc-3506	263	22	adult	adult	NOUN
dpc-3506	263	23	-	-	PUNCT
dpc-3506	263	24	onset	onset	NOUN
dpc-3506	263	25	morphea	morphea	NOUN
dpc-3506	263	26	:	:	PUNCT
dpc-3506	263	27	a	a	DET
dpc-3506	263	28	cross	cross	ADJ
dpc-3506	263	29	-	-	ADJ
dpc-3506	263	30	sectional	sectional	ADJ
dpc-3506	263	31	study	study	NOUN
dpc-3506	263	32	from	from	ADP
dpc-3506	263	33	the	the	DET
dpc-3506	263	34	morphea	morphea	NOUN
dpc-3506	263	35	in	in	ADP
dpc-3506	263	36	adults	adult	NOUN
dpc-3506	263	37	and	and	CCONJ
dpc-3506	263	38	children	child	NOUN
dpc-3506	263	39	cohort	cohort	VERB
dpc-3506	263	40	.	.	PUNCT
dpc-3506	264	1	arthritis	arthritis	NOUN
dpc-3506	264	2	rheumatol	rheumatol	NOUN
dpc-3506	264	3	.	.	PUNCT
dpc-3506	265	1	2014;66(12):3496504	2014;66(12):3496504	X
dpc-3506	265	2	.	.	PUNCT
dpc-3506	266	1	doi	doi	NOUN
dpc-3506	266	2	:	:	PUNCT
dpc-3506	266	3	10.1002	10.1002	NUM
dpc-3506	266	4	/	/	SYM
dpc-3506	266	5	art.38853	art.38853	NOUN
dpc-3506	266	6	.	.	PUNCT
dpc-3506	267	1	pmid	pmid	NOUN
dpc-3506	267	2	:	:	PUNCT
dpc-3506	267	3	25156342	25156342	NUM
dpc-3506	267	4	.	.	PUNCT
dpc-3506	268	1	pmcid	pmcid	NOUN
dpc-3506	268	2	:	:	PUNCT
dpc-3506	268	3	pmc4245331	pmc4245331	ADJ
dpc-3506	268	4	.	.	PUNCT
dpc-3506	269	1	the	the	DET
dpc-3506	269	2	treatment	treatment	NOUN
dpc-3506	269	3	is	be	AUX
dpc-3506	269	4	to	to	PART
dpc-3506	269	5	stop	stop	VERB
dpc-3506	269	6	the	the	DET
dpc-3506	269	7	disease	disease	NOUN
dpc-3506	269	8	from	from	ADP
dpc-3506	269	9	progressing	progress	VERB
dpc-3506	269	10	at	at	ADP
dpc-3506	269	11	an	an	DET
dpc-3506	269	12	early	early	ADJ
dpc-3506	269	13	stage	stage	NOUN
dpc-3506	269	14	in	in	ADP
dpc-3506	269	15	order	order	NOUN
dpc-3506	269	16	to	to	PART
dpc-3506	269	17	avoid	avoid	VERB
dpc-3506	269	18	functional	functional	ADJ
dpc-3506	269	19	and	and	CCONJ
dpc-3506	269	20	cosmetic	cosmetic	ADJ
dpc-3506	269	21	complications	complication	NOUN
dpc-3506	269	22	.	.	PUNCT
dpc-3506	270	1	treatment	treatment	NOUN
dpc-3506	270	2	options	option	NOUN
dpc-3506	270	3	were	be	AUX
dpc-3506	270	4	assessed	assess	VERB
dpc-3506	270	5	according	accord	VERB
dpc-3506	270	6	to	to	ADP
dpc-3506	270	7	the	the	DET
dpc-3506	270	8	subtype	subtype	NOUN
dpc-3506	270	9	of	of	ADP
dpc-3506	270	10	the	the	DET
dpc-3506	270	11	disease	disease	NOUN
dpc-3506	270	12	,	,	PUNCT
dpc-3506	270	13	the	the	DET
dpc-3506	270	14	extent	extent	NOUN
dpc-3506	270	15	of	of	ADP
dpc-3506	270	16	involvement	involvement	NOUN
dpc-3506	270	17	,	,	PUNCT
dpc-3506	270	18	the	the	DET
dpc-3506	270	19	level	level	NOUN
dpc-3506	270	20	of	of	ADP
dpc-3506	270	21	activation	activation	NOUN
dpc-3506	270	22	and	and	CCONJ
dpc-3506	270	23	the	the	DET
dpc-3506	270	24	presence	presence	NOUN
dpc-3506	270	25	of	of	ADP
dpc-3506	270	26	complications	complication	NOUN
dpc-3506	270	27	[	[	X
dpc-3506	270	28	27,36	27,36	NUM
dpc-3506	270	29	]	]	PUNCT
dpc-3506	270	30	.	.	PUNCT
dpc-3506	271	1	while	while	SCONJ
dpc-3506	271	2	some	some	DET
dpc-3506	271	3	studies	study	NOUN
dpc-3506	271	4	report	report	VERB
dpc-3506	271	5	that	that	SCONJ
dpc-3506	271	6	topical	topical	ADJ
dpc-3506	271	7	treatment	treatment	NOUN
dpc-3506	271	8	was	be	AUX
dpc-3506	271	9	administered	administer	VERB
dpc-3506	271	10	at	at	ADP
dpc-3506	271	11	a	a	DET
dpc-3506	271	12	rate	rate	NOUN
dpc-3506	271	13	of	of	ADP
dpc-3506	271	14	45.9	45.9	NUM
dpc-3506	271	15	%	%	NOUN
dpc-3506	271	16	,	,	PUNCT
dpc-3506	271	17	in	in	ADP
dpc-3506	271	18	this	this	DET
dpc-3506	271	19	study	study	NOUN
dpc-3506	271	20	,	,	PUNCT
dpc-3506	271	21	topical	topical	ADJ
dpc-3506	271	22	agents	agent	NOUN
dpc-3506	271	23	were	be	AUX
dpc-3506	271	24	preferred	prefer	VERB
dpc-3506	271	25	as	as	ADP
dpc-3506	271	26	the	the	DET
dpc-3506	271	27	first	first	ADJ
dpc-3506	271	28	line	line	NOUN
dpc-3506	271	29	in	in	ADP
dpc-3506	271	30	65.6	65.6	NUM
dpc-3506	271	31	%	%	NOUN
dpc-3506	271	32	(	(	PUNCT
dpc-3506	271	33	n	n	NOUN
dpc-3506	271	34	=	=	SYM
dpc-3506	271	35	120	120	NUM
dpc-3506	271	36	)	)	PUNCT
dpc-3506	271	37	of	of	ADP
dpc-3506	271	38	both	both	DET
dpc-3506	271	39	groups	group	NOUN
dpc-3506	271	40	[	[	X
dpc-3506	271	41	18	18	NUM
dpc-3506	271	42	]	]	PUNCT
dpc-3506	271	43	.	.	PUNCT
dpc-3506	272	1	in	in	ADP
dpc-3506	272	2	our	our	PRON
dpc-3506	272	3	study	study	NOUN
dpc-3506	272	4	,	,	PUNCT
dpc-3506	272	5	patients	patient	NOUN
dpc-3506	272	6	with	with	ADP
dpc-3506	272	7	limited	limited	ADJ
dpc-3506	272	8	plaque	plaque	NOUN
dpc-3506	272	9	-	-	PUNCT
dpc-3506	272	10	type	type	NOUN
dpc-3506	272	11	lesions	lesion	NOUN
dpc-3506	272	12	were	be	AUX
dpc-3506	272	13	treated	treat	VERB
dpc-3506	272	14	with	with	ADP
dpc-3506	272	15	topical	topical	ADJ
dpc-3506	272	16	corticosteroids	corticosteroid	NOUN
dpc-3506	272	17	,	,	PUNCT
dpc-3506	272	18	calcipotriol	calcipotriol	NOUN
dpc-3506	272	19	,	,	PUNCT
dpc-3506	272	20	calcipotriol	calcipotriol	NOUN
dpc-3506	272	21	+	+	CCONJ
dpc-3506	272	22	steroid	steroid	NOUN
dpc-3506	272	23	combination	combination	NOUN
dpc-3506	272	24	,	,	PUNCT
dpc-3506	272	25	tacrolimus	tacrolimus	NOUN
dpc-3506	272	26	and	and	CCONJ
dpc-3506	272	27	pimecrolimus	pimecrolimus	VERB
dpc-3506	272	28	.	.	PUNCT
dpc-3506	273	1	this	this	DET
dpc-3506	273	2	rate	rate	NOUN
dpc-3506	273	3	was	be	AUX
dpc-3506	273	4	found	find	VERB
dpc-3506	273	5	to	to	PART
dpc-3506	273	6	be	be	AUX
dpc-3506	273	7	65.6	65.6	NUM
dpc-3506	273	8	%	%	NOUN
dpc-3506	273	9	(	(	PUNCT
dpc-3506	273	10	n	n	NOUN
dpc-3506	273	11	=	=	SYM
dpc-3506	273	12	120	120	NUM
dpc-3506	273	13	)	)	PUNCT
dpc-3506	273	14	in	in	ADP
dpc-3506	273	15	general	general	ADJ
dpc-3506	273	16	,	,	PUNCT
dpc-3506	273	17	62	62	NUM
dpc-3506	273	18	%	%	NOUN
dpc-3506	273	19	in	in	ADP
dpc-3506	273	20	aols	aol	NOUN
dpc-3506	273	21	,	,	PUNCT
dpc-3506	273	22	and	and	CCONJ
dpc-3506	273	23	75.6	75.6	NUM
dpc-3506	273	24	%	%	NOUN
dpc-3506	273	25	in	in	ADP
dpc-3506	273	26	pols	pol	NOUN
dpc-3506	273	27	.	.	PUNCT
dpc-3506	274	1	even	even	ADV
dpc-3506	274	2	if	if	SCONJ
dpc-3506	274	3	topical	topical	ADJ
dpc-3506	274	4	medications	medication	NOUN
dpc-3506	274	5	alone	alone	ADV
dpc-3506	274	6	are	be	AUX
dpc-3506	274	7	effective	effective	ADJ
dpc-3506	274	8	in	in	ADP
dpc-3506	274	9	treating	treat	VERB
dpc-3506	274	10	plaques	plaque	NOUN
dpc-3506	274	11	,	,	PUNCT
dpc-3506	274	12	they	they	PRON
dpc-3506	274	13	are	be	AUX
dpc-3506	274	14	unable	unable	ADJ
dpc-3506	274	15	to	to	PART
dpc-3506	274	16	suppress	suppress	VERB
dpc-3506	274	17	disease	disease	NOUN
dpc-3506	274	18	activity	activity	NOUN
dpc-3506	274	19	.	.	PUNCT
dpc-3506	275	1	therefore	therefore	ADV
dpc-3506	275	2	,	,	PUNCT
dpc-3506	275	3	they	they	PRON
dpc-3506	275	4	are	be	AUX
dpc-3506	275	5	not	not	PART
dpc-3506	275	6	advised	advise	VERB
dpc-3506	275	7	to	to	PART
dpc-3506	275	8	be	be	AUX
dpc-3506	275	9	used	use	VERB
dpc-3506	275	10	alone	alone	ADV
dpc-3506	275	11	in	in	ADP
dpc-3506	275	12	the	the	DET
dpc-3506	275	13	treatment	treatment	NOUN
dpc-3506	275	14	of	of	ADP
dpc-3506	275	15	severe	severe	ADJ
dpc-3506	275	16	,	,	PUNCT
dpc-3506	275	17	functionally	functionally	ADV
dpc-3506	275	18	disruptive	disruptive	ADJ
dpc-3506	275	19	,	,	PUNCT
dpc-3506	275	20	and	and	CCONJ
dpc-3506	275	21	progressive	progressive	ADJ
dpc-3506	275	22	diseases	disease	NOUN
dpc-3506	275	23	[	[	X
dpc-3506	275	24	36	36	NUM
dpc-3506	275	25	]	]	PUNCT
dpc-3506	275	26	.	.	PUNCT
dpc-3506	276	1	mtx	mtx	NOUN
dpc-3506	276	2	,	,	PUNCT
dpc-3506	276	3	phototherapy	phototherapy	NOUN
dpc-3506	276	4	,	,	PUNCT
dpc-3506	276	5	systemic	systemic	ADJ
dpc-3506	276	6	steroids	steroid	NOUN
dpc-3506	276	7	,	,	PUNCT
dpc-3506	276	8	and	and	CCONJ
dpc-3506	276	9	additional	additional	ADJ
dpc-3506	276	10	systemic	systemic	ADJ
dpc-3506	276	11	immunosuppressants	immunosuppressant	NOUN
dpc-3506	276	12	should	should	AUX
dpc-3506	276	13	be	be	AUX
dpc-3506	276	14	added	add	VERB
dpc-3506	276	15	to	to	PART
dpc-3506	276	16	prevent	prevent	VERB
dpc-3506	276	17	future	future	ADJ
dpc-3506	276	18	complications	complication	NOUN
dpc-3506	276	19	in	in	ADP
dpc-3506	276	20	linear	linear	PROPN
dpc-3506	276	21	,	,	PUNCT
dpc-3506	276	22	generalized	generalized	ADJ
dpc-3506	276	23	,	,	PUNCT
dpc-3506	276	24	and	and	CCONJ
dpc-3506	276	25	mixed	mixed	ADJ
dpc-3506	276	26	morphea	morphea	ADJ
dpc-3506	276	27	types	type	NOUN
dpc-3506	277	1	[	[	X
dpc-3506	277	2	7,27,36,37	7,27,36,37	X
dpc-3506	277	3	]	]	X
dpc-3506	277	4	.	.	PUNCT
dpc-3506	278	1	generalized-	generalized-	PROPN
dpc-3506	278	2	,	,	PUNCT
dpc-3506	278	3	mixed-	mixed-	ADJ
dpc-3506	278	4	,	,	PUNCT
dpc-3506	278	5	and	and	CCONJ
dpc-3506	278	6	linear	linear	ADJ
dpc-3506	278	7	-	-	PUNCT
dpc-3506	278	8	type	type	NOUN
dpc-3506	278	9	patients	patient	NOUN
dpc-3506	278	10	in	in	ADP
dpc-3506	278	11	this	this	DET
dpc-3506	278	12	study	study	NOUN
dpc-3506	278	13	,	,	PUNCT
dpc-3506	278	14	who	who	PRON
dpc-3506	278	15	represented	represent	VERB
dpc-3506	278	16	about	about	ADP
dpc-3506	278	17	half	half	NOUN
dpc-3506	278	18	of	of	ADP
dpc-3506	278	19	the	the	DET
dpc-3506	278	20	cases	case	NOUN
dpc-3506	278	21	for	for	ADP
dpc-3506	278	22	comparable	comparable	ADJ
dpc-3506	278	23	reasons	reason	NOUN
dpc-3506	278	24	,	,	PUNCT
dpc-3506	278	25	were	be	AUX
dpc-3506	278	26	treated	treat	VERB
dpc-3506	278	27	systemically	systemically	ADV
dpc-3506	278	28	.	.	PUNCT
dpc-3506	279	1	mtx	mtx	NOUN
dpc-3506	279	2	(	(	PUNCT
dpc-3506	279	3	54.6	54.6	NUM
dpc-3506	279	4	%	%	NOUN
dpc-3506	279	5	)	)	PUNCT
dpc-3506	279	6	was	be	AUX
dpc-3506	279	7	the	the	DET
dpc-3506	279	8	most	most	ADV
dpc-3506	279	9	frequently	frequently	ADV
dpc-3506	279	10	used	use	VERB
dpc-3506	279	11	systemic	systemic	ADJ
dpc-3506	279	12	treatment	treatment	NOUN
dpc-3506	279	13	in	in	ADP
dpc-3506	279	14	both	both	DET
dpc-3506	279	15	groups	group	NOUN
dpc-3506	279	16	and	and	CCONJ
dpc-3506	279	17	systemic	systemic	ADJ
dpc-3506	279	18	steroids	steroid	NOUN
dpc-3506	279	19	were	be	AUX
dpc-3506	279	20	preferred	prefer	VERB
dpc-3506	279	21	only	only	ADV
dpc-3506	279	22	in	in	ADP
dpc-3506	279	23	aols	aol	NOUN
dpc-3506	279	24	.	.	PUNCT
dpc-3506	280	1	majority	majority	NOUN
dpc-3506	280	2	of	of	ADP
dpc-3506	280	3	authors	author	NOUN
dpc-3506	280	4	suggest	suggest	VERB
dpc-3506	280	5	aggressive	aggressive	ADJ
dpc-3506	280	6	treatments	treatment	NOUN
dpc-3506	280	7	for	for	ADP
dpc-3506	280	8	morphea	morphea	ADJ
dpc-3506	280	9	types	type	NOUN
dpc-3506	280	10	such	such	ADJ
dpc-3506	280	11	as	as	ADP
dpc-3506	280	12	linear	linear	ADJ
dpc-3506	280	13	,	,	PUNCT
dpc-3506	280	14	generalized	generalized	ADJ
dpc-3506	280	15	morphea	morphea	NOUN
dpc-3506	280	16	which	which	PRON
dpc-3506	280	17	cause	cause	VERB
dpc-3506	280	18	deformity	deformity	NOUN
dpc-3506	280	19	[	[	X
dpc-3506	280	20	36	36	NUM
dpc-3506	280	21	]	]	PUNCT
dpc-3506	280	22	.	.	PUNCT
dpc-3506	281	1	in	in	ADP
dpc-3506	281	2	various	various	ADJ
dpc-3506	281	3	studies	study	NOUN
dpc-3506	281	4	,	,	PUNCT
dpc-3506	281	5	it	it	PRON
dpc-3506	281	6	has	have	AUX
dpc-3506	281	7	been	be	AUX
dpc-3506	281	8	demonstrated	demonstrate	VERB
dpc-3506	281	9	that	that	SCONJ
dpc-3506	281	10	mtx	mtx	NOUN
dpc-3506	281	11	and	and	CCONJ
dpc-3506	281	12	mmf	mmf	NOUN
dpc-3506	281	13	are	be	AUX
dpc-3506	281	14	effective	effective	ADJ
dpc-3506	281	15	treatment	treatment	NOUN
dpc-3506	281	16	options	option	NOUN
dpc-3506	281	17	in	in	ADP
dpc-3506	281	18	resistant	resistant	ADJ
dpc-3506	281	19	cases	case	NOUN
dpc-3506	281	20	[	[	X
dpc-3506	281	21	15,36	15,36	NUM
dpc-3506	281	22	]	]	PUNCT
dpc-3506	281	23	.	.	PUNCT
dpc-3506	282	1	it	it	PRON
dpc-3506	282	2	has	have	AUX
dpc-3506	282	3	been	be	AUX
dpc-3506	282	4	reported	report	VERB
dpc-3506	282	5	in	in	ADP
dpc-3506	282	6	various	various	ADJ
dpc-3506	282	7	studies	study	NOUN
dpc-3506	282	8	that	that	SCONJ
dpc-3506	282	9	children	child	NOUN
dpc-3506	282	10	were	be	AUX
dpc-3506	282	11	administered	administer	VERB
dpc-3506	282	12	mtx	mtx	NOUN
dpc-3506	282	13	at	at	ADP
dpc-3506	282	14	rates	rate	NOUN
dpc-3506	282	15	of	of	ADP
dpc-3506	282	16	17.8%–42	17.8%–42	NUM
dpc-3506	282	17	%	%	NOUN
dpc-3506	283	1	[	[	X
dpc-3506	283	2	24,37	24,37	X
dpc-3506	283	3	]	]	X
dpc-3506	283	4	.	.	PUNCT
dpc-3506	284	1	in	in	ADP
dpc-3506	284	2	this	this	DET
dpc-3506	284	3	study	study	NOUN
dpc-3506	284	4	,	,	PUNCT
dpc-3506	284	5	mtx	mtx	NOUN
dpc-3506	284	6	treatment	treatment	NOUN
dpc-3506	284	7	was	be	AUX
dpc-3506	284	8	given	give	VERB
dpc-3506	284	9	at	at	ADP
dpc-3506	284	10	a	a	DET
dpc-3506	284	11	rate	rate	NOUN
dpc-3506	284	12	of	of	ADP
dpc-3506	284	13	27.3	27.3	NUM
dpc-3506	284	14	%	%	NOUN
dpc-3506	284	15	(	(	PUNCT
dpc-3506	284	16	n	n	NOUN
dpc-3506	284	17	=	=	SYM
dpc-3506	284	18	50	50	NUM
dpc-3506	284	19	)	)	PUNCT
dpc-3506	284	20	in	in	ADP
dpc-3506	284	21	general	general	ADJ
dpc-3506	284	22	,	,	PUNCT
dpc-3506	284	23	27.5	27.5	NUM
dpc-3506	284	24	%	%	NOUN
dpc-3506	284	25	in	in	ADP
dpc-3506	284	26	aols	aol	NOUN
dpc-3506	284	27	and	and	CCONJ
dpc-3506	284	28	26.8	26.8	NUM
dpc-3506	284	29	%	%	NOUN
dpc-3506	284	30	in	in	ADP
dpc-3506	284	31	pols	pol	NOUN
dpc-3506	284	32	.	.	PUNCT
dpc-3506	285	1	litaiem	litaiem	ADJ
dpc-3506	285	2	et	et	PROPN
dpc-3506	285	3	al	al	PROPN
dpc-3506	285	4	administered	administer	VERB
dpc-3506	285	5	a	a	DET
dpc-3506	285	6	combination	combination	NOUN
dpc-3506	285	7	of	of	ADP
dpc-3506	285	8	mtx	mtx	NOUN
dpc-3506	285	9	and	and	CCONJ
dpc-3506	285	10	steroids	steroid	NOUN
dpc-3506	285	11	to	to	ADP
dpc-3506	285	12	28	28	NUM
dpc-3506	285	13	%	%	NOUN
dpc-3506	285	14	of	of	ADP
dpc-3506	285	15	patients	patient	NOUN
dpc-3506	285	16	.	.	PUNCT
dpc-3506	286	1	in	in	ADP
dpc-3506	286	2	this	this	DET
dpc-3506	286	3	study	study	NOUN
dpc-3506	286	4	,	,	PUNCT
dpc-3506	286	5	this	this	DET
dpc-3506	286	6	combined	combine	VERB
dpc-3506	286	7	treatment	treatment	NOUN
dpc-3506	286	8	rate	rate	NOUN
dpc-3506	286	9	was	be	AUX
dpc-3506	286	10	8.5	8.5	NUM
dpc-3506	286	11	%	%	NOUN
dpc-3506	286	12	[	[	X
dpc-3506	286	13	38	38	NUM
dpc-3506	286	14	]	]	PUNCT
dpc-3506	286	15	.	.	PUNCT
dpc-3506	287	1	the	the	DET
dpc-3506	287	2	authors	author	NOUN
dpc-3506	287	3	of	of	ADP
dpc-3506	287	4	some	some	DET
dpc-3506	287	5	studies	study	NOUN
dpc-3506	287	6	reported	report	VERB
dpc-3506	287	7	positive	positive	ADJ
dpc-3506	287	8	outcomes	outcome	NOUN
dpc-3506	287	9	for	for	ADP
dpc-3506	287	10	patients	patient	NOUN
dpc-3506	287	11	who	who	PRON
dpc-3506	287	12	received	receive	VERB
dpc-3506	287	13	colchicine	colchicine	NOUN
dpc-3506	287	14	[	[	X
dpc-3506	287	15	39,40	39,40	NUM
dpc-3506	287	16	]	]	PUNCT
dpc-3506	287	17	.	.	PUNCT
dpc-3506	288	1	in	in	ADP
dpc-3506	288	2	this	this	DET
dpc-3506	288	3	study	study	NOUN
dpc-3506	288	4	,	,	PUNCT
dpc-3506	288	5	colchicine	colchicine	PROPN
dpc-3506	288	6	was	be	AUX
dpc-3506	288	7	generally	generally	ADV
dpc-3506	288	8	given	give	VERB
dpc-3506	288	9	at	at	ADP
dpc-3506	288	10	a	a	DET
dpc-3506	288	11	rate	rate	NOUN
dpc-3506	288	12	of	of	ADP
dpc-3506	288	13	16.9	16.9	NUM
dpc-3506	288	14	%	%	NOUN
dpc-3506	288	15	(	(	PUNCT
dpc-3506	288	16	n	n	NOUN
dpc-3506	288	17	=	=	NUM
dpc-3506	288	18	31	31	NUM
dpc-3506	288	19	)	)	PUNCT
dpc-3506	288	20	.	.	PUNCT
dpc-3506	289	1	according	accord	VERB
dpc-3506	289	2	to	to	ADP
dpc-3506	289	3	some	some	DET
dpc-3506	289	4	researchers	researcher	NOUN
dpc-3506	289	5	,	,	PUNCT
dpc-3506	289	6	treatment	treatment	NOUN
dpc-3506	289	7	of	of	ADP
dpc-3506	289	8	plaque	plaque	NOUN
dpc-3506	289	9	-	-	PUNCT
dpc-3506	289	10	type	type	NOUN
dpc-3506	289	11	morphea	morphea	NOUN
dpc-3506	289	12	is	be	AUX
dpc-3506	289	13	unnecessary	unnecessary	ADJ
dpc-3506	289	14	because	because	SCONJ
dpc-3506	289	15	lesions	lesion	NOUN
dpc-3506	289	16	will	will	AUX
dpc-3506	289	17	naturally	naturally	ADV
dpc-3506	289	18	regress	regress	VERB
dpc-3506	289	19	in	in	ADP
dpc-3506	289	20	three	three	NUM
dpc-3506	289	21	to	to	PART
dpc-3506	289	22	five	five	NUM
dpc-3506	289	23	years	year	NOUN
dpc-3506	290	1	[	[	X
dpc-3506	290	2	25,27,36	25,27,36	NUM
dpc-3506	290	3	]	]	PUNCT
dpc-3506	290	4	.	.	PUNCT
dpc-3506	291	1	zulian	zulian	PROPN
dpc-3506	291	2	et	et	PROPN
dpc-3506	291	3	al	al	PROPN
dpc-3506	291	4	showed	show	VERB
dpc-3506	291	5	that	that	SCONJ
dpc-3506	291	6	17	17	NUM
dpc-3506	291	7	%	%	NOUN
dpc-3506	291	8	(	(	PUNCT
dpc-3506	291	9	n	n	NOUN
dpc-3506	291	10	=	=	SYM
dpc-3506	291	11	128	128	NUM
dpc-3506	291	12	)	)	PUNCT
dpc-3506	291	13	of	of	ADP
dpc-3506	291	14	the	the	DET
dpc-3506	291	15	patients	patient	NOUN
dpc-3506	291	16	did	do	AUX
dpc-3506	291	17	not	not	PART
dpc-3506	291	18	receive	receive	VERB
dpc-3506	291	19	any	any	DET
dpc-3506	291	20	treatment	treatment	NOUN
dpc-3506	291	21	  	  	SPACE
dpc-3506	292	1	[	[	X
dpc-3506	292	2	25	25	NUM
dpc-3506	292	3	]	]	PUNCT
dpc-3506	292	4	.	.	PUNCT
dpc-3506	293	1	fifteen	fifteen	NUM
dpc-3506	293	2	percent	percent	NOUN
dpc-3506	293	3	of	of	ADP
dpc-3506	293	4	the	the	DET
dpc-3506	293	5	patients	patient	NOUN
dpc-3506	293	6	in	in	ADP
dpc-3506	293	7	this	this	DET
dpc-3506	293	8	study	study	NOUN
dpc-3506	293	9	did	do	AUX
dpc-3506	293	10	not	not	PART
dpc-3506	293	11	require	require	VERB
dpc-3506	293	12	treatment	treatment	NOUN
dpc-3506	293	13	.	.	PUNCT
dpc-3506	294	1	treatments	treatment	NOUN
dpc-3506	294	2	administered	administer	VERB
dpc-3506	294	3	provided	provide	VERB
dpc-3506	294	4	partial	partial	ADJ
dpc-3506	294	5	recovery	recovery	NOUN
dpc-3506	294	6	in	in	ADP
dpc-3506	294	7	the	the	DET
dpc-3506	294	8	majority	majority	NOUN
dpc-3506	294	9	of	of	ADP
dpc-3506	294	10	the	the	DET
dpc-3506	294	11	patients	patient	NOUN
dpc-3506	294	12	.	.	PUNCT
dpc-3506	295	1	full	full	ADJ
dpc-3506	295	2	recovery	recovery	NOUN
dpc-3506	295	3	rate	rate	NOUN
dpc-3506	295	4	was	be	AUX
dpc-3506	295	5	25.4	25.4	NUM
dpc-3506	295	6	%	%	NOUN
dpc-3506	295	7	for	for	ADP
dpc-3506	295	8	the	the	DET
dpc-3506	295	9	aols	aol	NOUN
dpc-3506	295	10	patients	patient	NOUN
dpc-3506	295	11	and	and	CCONJ
dpc-3506	295	12	29.3	29.3	NUM
dpc-3506	295	13	%	%	NOUN
dpc-3506	295	14	for	for	ADP
dpc-3506	295	15	the	the	DET
dpc-3506	295	16	pols	pol	NOUN
dpc-3506	295	17	patients	patient	NOUN
dpc-3506	295	18	.	.	PUNCT
dpc-3506	296	1	adult	adult	NOUN
dpc-3506	296	2	and	and	CCONJ
dpc-3506	296	3	pediatric	pediatric	ADJ
dpc-3506	296	4	onset	onset	NOUN
dpc-3506	296	5	morphea	morphea	NOUN
dpc-3506	296	6	have	have	VERB
dpc-3506	296	7	different	different	ADJ
dpc-3506	296	8	disease	disease	NOUN
dpc-3506	296	9	characteristics	characteristic	NOUN
dpc-3506	296	10	,	,	PUNCT
dpc-3506	296	11	different	different	ADJ
dpc-3506	296	12	systemic	systemic	ADJ
dpc-3506	296	13	associations	association	NOUN
dpc-3506	296	14	and	and	CCONJ
dpc-3506	296	15	laboratory	laboratory	NOUN
dpc-3506	296	16	original	original	ADJ
dpc-3506	296	17	article	article	NOUN
dpc-3506	296	18	|	|	ADV
dpc-3506	296	19	dermatol	dermatol	ADJ
dpc-3506	296	20	pract	pract	NOUN
dpc-3506	296	21	concept	concept	NOUN
dpc-3506	296	22	.	.	PUNCT
dpc-3506	297	1	2024;14(1):e2024023	2024;14(1):e2024023	NUM
dpc-3506	297	2	9	9	NUM
dpc-3506	297	3	dermatol	dermatol	NOUN
dpc-3506	297	4	.	.	PUNCT
dpc-3506	298	1	2010;146(9):1044–1045	2010;146(9):1044–1045	X
dpc-3506	298	2	.	.	PUNCT
dpc-3506	299	1	doi	doi	NOUN
dpc-3506	299	2	:	:	PUNCT
dpc-3506	299	3	10.1001	10.1001	NUM
dpc-3506	299	4	/	/	SYM
dpc-3506	299	5	archdermatol	archdermatol	NOUN
dpc-3506	299	6	.2010.239	.2010.239	NOUN
dpc-3506	299	7	.	.	PUNCT
dpc-3506	300	1	pmid	pmid	NOUN
dpc-3506	300	2	:	:	PUNCT
dpc-3506	300	3	20855712	20855712	NUM
dpc-3506	300	4	.	.	PUNCT
dpc-3506	301	1	pmcid	pmcid	ADJ
dpc-3506	301	2	:	:	PUNCT
dpc-3506	301	3	pmc2945300	pmc2945300	NOUN
dpc-3506	301	4	.	.	PUNCT
dpc-3506	302	1	27	27	NUM
dpc-3506	302	2	.	.	PUNCT
dpc-3506	303	1	florez	florez	PROPN
dpc-3506	303	2	-	-	PUNCT
dpc-3506	303	3	pollack	pollack	PROPN
dpc-3506	303	4	s	s	PROPN
dpc-3506	303	5	,	,	PUNCT
dpc-3506	303	6	kunzler	kunzler	PROPN
dpc-3506	303	7	e	e	NOUN
dpc-3506	303	8	,	,	PUNCT
dpc-3506	303	9	jacobe	jacobe	PROPN
dpc-3506	303	10	ht	ht	PROPN
dpc-3506	303	11	.	.	PUNCT
dpc-3506	303	12	morphea	morphea	PROPN
dpc-3506	303	13	:	:	PUNCT
dpc-3506	303	14	current	current	ADJ
dpc-3506	303	15	concepts	concept	NOUN
dpc-3506	303	16	.	.	PUNCT
dpc-3506	303	17	 	 	SPACE
dpc-3506	303	18	clin	clin	PROPN
dpc-3506	303	19	dermatol	dermatol	NOUN
dpc-3506	303	20	.	.	PUNCT
dpc-3506	303	21	 	 	SPACE
dpc-3506	303	22	2018;36:475–486	2018;36:475–486	PROPN
dpc-3506	303	23	.	.	PUNCT
dpc-3506	303	24	 	 	SPACE
dpc-3506	303	25	doi	doi	NOUN
dpc-3506	303	26	:	:	PUNCT
dpc-3506	303	27	10.1016	10.1016	NUM
dpc-3506	303	28	/	/	SYM
dpc-3506	303	29	j.clindermatol.2018.04.005	j.clindermatol.2018.04.005	PROPN
dpc-3506	303	30	.	.	PUNCT
dpc-3506	304	1	pmid	pmid	NOUN
dpc-3506	304	2	:	:	PUNCT
dpc-3506	304	3	30047431	30047431	NUM
dpc-3506	304	4	.	.	PUNCT
dpc-3506	305	1	28	28	NUM
dpc-3506	305	2	.	.	PUNCT
dpc-3506	306	1	falanga	falanga	PROPN
dpc-3506	306	2	v	v	NOUN
dpc-3506	306	3	,	,	PUNCT
dpc-3506	306	4	medsger	medsger	NOUN
dpc-3506	306	5	ta	ta	PROPN
dpc-3506	306	6	jr	jr	PROPN
dpc-3506	306	7	,	,	PUNCT
dpc-3506	306	8	reichlin	reichlin	PROPN
dpc-3506	306	9	m	m	PROPN
dpc-3506	306	10	,	,	PUNCT
dpc-3506	306	11	rodnan	rodnan	PROPN
dpc-3506	306	12	gp	gp	NOUN
dpc-3506	306	13	.	.	PUNCT
dpc-3506	307	1	linear	linear	PROPN
dpc-3506	307	2	scleroderma	scleroderma	NOUN
dpc-3506	307	3	.	.	PUNCT
dpc-3506	308	1	clinical	clinical	ADJ
dpc-3506	308	2	spectrum	spectrum	NOUN
dpc-3506	308	3	,	,	PUNCT
dpc-3506	308	4	prognosis	prognosis	NOUN
dpc-3506	308	5	,	,	PUNCT
dpc-3506	308	6	and	and	CCONJ
dpc-3506	308	7	laboratory	laboratory	NOUN
dpc-3506	308	8	abnormalities	abnormality	NOUN
dpc-3506	308	9	.	.	PUNCT
dpc-3506	309	1	ann	ann	PROPN
dpc-3506	309	2	intern	intern	PROPN
dpc-3506	309	3	med	me	VERB
dpc-3506	309	4	.	.	PUNCT
dpc-3506	310	1	1986;104(6):849	1986;104(6):849	NUM
dpc-3506	310	2	-	-	SYM
dpc-3506	310	3	857	857	NUM
dpc-3506	310	4	.	.	PUNCT
dpc-3506	311	1	doi	doi	NOUN
dpc-3506	311	2	:	:	PUNCT
dpc-3506	311	3	10.7326/0003	10.7326/0003	NUM
dpc-3506	311	4	-	-	PUNCT
dpc-3506	311	5	4819	4819	NUM
dpc-3506	311	6	-	-	PUNCT
dpc-3506	311	7	104	104	NUM
dpc-3506	311	8	-	-	PUNCT
dpc-3506	311	9	6	6	NUM
dpc-3506	311	10	-	-	PUNCT
dpc-3506	311	11	849	849	NUM
dpc-3506	311	12	.	.	PUNCT
dpc-3506	312	1	pmid	pmid	NOUN
dpc-3506	312	2	:	:	PUNCT
dpc-3506	312	3	3486617	3486617	NUM
dpc-3506	312	4	.	.	PUNCT
dpc-3506	313	1	29	29	NUM
dpc-3506	313	2	.	.	PUNCT
dpc-3506	314	1	sato	sato	PROPN
dpc-3506	314	2	s	s	PROPN
dpc-3506	314	3	,	,	PUNCT
dpc-3506	314	4	fujimoto	fujimoto	PROPN
dpc-3506	314	5	m	m	PROPN
dpc-3506	314	6	,	,	PUNCT
dpc-3506	314	7	ihn	ihn	PROPN
dpc-3506	314	8	h	h	PROPN
dpc-3506	314	9	,	,	PUNCT
dpc-3506	314	10	kikuchi	kikuchi	PROPN
dpc-3506	314	11	k	k	PROPN
dpc-3506	314	12	,	,	PUNCT
dpc-3506	314	13	takehara	takehara	PROPN
dpc-3506	314	14	k.	k.	PROPN
dpc-3506	314	15	clinical	clinical	PROPN
dpc-3506	314	16	characteristics	characteristic	NOUN
dpc-3506	314	17	associated	associate	VERB
dpc-3506	314	18	with	with	ADP
dpc-3506	314	19	antihistone	antihistone	PROPN
dpc-3506	314	20	antibodies	antibodie	VERB
dpc-3506	314	21	in	in	ADP
dpc-3506	314	22	patients	patient	NOUN
dpc-3506	314	23	with	with	ADP
dpc-3506	314	24	localized	localized	ADJ
dpc-3506	314	25	scleroderma	scleroderma	NOUN
dpc-3506	314	26	.	.	PUNCT
dpc-3506	315	1	j	j	PROPN
dpc-3506	315	2	am	be	AUX
dpc-3506	315	3	acad	acad	ADJ
dpc-3506	315	4	dermatol	dermatol	NOUN
dpc-3506	315	5	.	.	PUNCT
dpc-3506	316	1	1994;31(4):567	1994;31(4):567	NUM
dpc-3506	316	2	-	-	SYM
dpc-3506	316	3	571	571	NUM
dpc-3506	316	4	.	.	PUNCT
dpc-3506	317	1	doi	doi	NOUN
dpc-3506	317	2	:	:	PUNCT
dpc-3506	317	3	10.1016	10.1016	NUM
dpc-3506	317	4	/	/	SYM
dpc-3506	317	5	s0190	s0190	VERB
dpc-3506	317	6	-	-	PUNCT
dpc-3506	317	7	9622(94)70217	9622(94)70217	NUM
dpc-3506	317	8	-	-	PUNCT
dpc-3506	317	9	9	9	NUM
dpc-3506	317	10	.	.	PUNCT
dpc-3506	318	1	pmid	pmid	NOUN
dpc-3506	318	2	:	:	PUNCT
dpc-3506	318	3	8089281	8089281	NUM
dpc-3506	318	4	.	.	PUNCT
dpc-3506	319	1	30	30	NUM
dpc-3506	319	2	.	.	PUNCT
dpc-3506	320	1	arkachaisri	arkachaisri	PROPN
dpc-3506	320	2	t	t	PROPN
dpc-3506	320	3	,	,	PUNCT
dpc-3506	320	4	fertig	fertig	X
dpc-3506	320	5	n	n	CCONJ
dpc-3506	320	6	,	,	PUNCT
dpc-3506	320	7	pino	pino	PROPN
dpc-3506	320	8	s	s	PROPN
dpc-3506	320	9	,	,	PUNCT
dpc-3506	320	10	medsger	medsger	NOUN
dpc-3506	320	11	ta	ta	PROPN
dpc-3506	320	12	.	.	PUNCT
dpc-3506	321	1	serum	serum	NOUN
dpc-3506	321	2	autoantibodies	autoantibody	NOUN
dpc-3506	321	3	and	and	CCONJ
dpc-3506	321	4	their	their	PRON
dpc-3506	321	5	clinical	clinical	ADJ
dpc-3506	321	6	associations	association	NOUN
dpc-3506	321	7	in	in	ADP
dpc-3506	321	8	patients	patient	NOUN
dpc-3506	321	9	with	with	ADP
dpc-3506	321	10	childhoodand	childhoodand	NOUN
dpc-3506	321	11	adult	adult	NOUN
dpc-3506	321	12	-	-	PUNCT
dpc-3506	321	13	onset	onset	VERB
dpc-3506	321	14	linear	linear	NOUN
dpc-3506	321	15	scleroderma	scleroderma	NOUN
dpc-3506	321	16	.	.	PUNCT
dpc-3506	322	1	a	a	DET
dpc-3506	322	2	single	single	ADJ
dpc-3506	322	3	-	-	PUNCT
dpc-3506	322	4	center	center	NOUN
dpc-3506	322	5	study	study	NOUN
dpc-3506	322	6	.	.	PUNCT
dpc-3506	323	1	j	j	PROPN
dpc-3506	323	2	rheumatol	rheumatol	NOUN
dpc-3506	323	3	.	.	PUNCT
dpc-3506	324	1	2008;35:2439	2008;35:2439	NUM
dpc-3506	324	2	-	-	SYM
dpc-3506	324	3	44	44	NUM
dpc-3506	324	4	.	.	PUNCT
dpc-3506	325	1	doi	doi	NOUN
dpc-3506	325	2	:	:	PUNCT
dpc-3506	325	3	10.3899	10.3899	NUM
dpc-3506	325	4	/	/	SYM
dpc-3506	325	5	jrheum.080098	jrheum.080098	PROPN
dpc-3506	325	6	.	.	PUNCT
dpc-3506	326	1	pmid	pmid	NOUN
dpc-3506	326	2	:	:	PUNCT
dpc-3506	326	3	19004036	19004036	NUM
dpc-3506	326	4	.	.	PUNCT
dpc-3506	327	1	31	31	NUM
dpc-3506	327	2	.	.	PUNCT
dpc-3506	328	1	khatri	khatri	PROPN
dpc-3506	328	2	s	s	PROPN
dpc-3506	328	3	,	,	PUNCT
dpc-3506	328	4	torok	torok	PROPN
dpc-3506	328	5	ks	ks	PROPN
dpc-3506	328	6	,	,	PUNCT
dpc-3506	328	7	mirizio	mirizio	PROPN
dpc-3506	328	8	e	e	PROPN
dpc-3506	328	9	,	,	PUNCT
dpc-3506	328	10	liu	liu	PROPN
dpc-3506	328	11	c	c	PROPN
dpc-3506	328	12	,	,	PUNCT
dpc-3506	328	13	astakhova	astakhova	PROPN
dpc-3506	328	14	k.	k.	PROPN
dpc-3506	328	15	autoantibodies	autoantibodies	PROPN
dpc-3506	328	16	in	in	ADP
dpc-3506	328	17	morphea	morphea	PROPN
dpc-3506	328	18	:	:	PUNCT
dpc-3506	328	19	an	an	DET
dpc-3506	328	20	update	update	NOUN
dpc-3506	328	21	.	.	PUNCT
dpc-3506	329	1	front	front	ADJ
dpc-3506	329	2	immunol	immunol	NOUN
dpc-3506	329	3	.	.	PUNCT
dpc-3506	330	1	2019(9);10:1487	2019(9);10:1487	X
dpc-3506	330	2	.	.	PUNCT
dpc-3506	331	1	doi	doi	NOUN
dpc-3506	331	2	:	:	PUNCT
dpc-3506	331	3	10.3389	10.3389	NUM
dpc-3506	331	4	/	/	SYM
dpc-3506	331	5	fimmu.2019.01487	fimmu.2019.01487	NOUN
dpc-3506	331	6	.	.	PUNCT
dpc-3506	332	1	pmid	pmid	NOUN
dpc-3506	332	2	:	:	PUNCT
dpc-3506	332	3	31354701	31354701	NUM
dpc-3506	332	4	.	.	PUNCT
dpc-3506	333	1	pmcid	pmcid	NOUN
dpc-3506	333	2	:	:	PUNCT
dpc-3506	333	3	pmc6634257	pmc6634257	NOUN
dpc-3506	333	4	.	.	PUNCT
dpc-3506	334	1	32	32	NUM
dpc-3506	334	2	.	.	PUNCT
dpc-3506	335	1	knobler	knobler	PROPN
dpc-3506	335	2	r	r	PROPN
dpc-3506	335	3	,	,	PUNCT
dpc-3506	335	4	moinzadeh	moinzadeh	NOUN
dpc-3506	335	5	p	p	X
dpc-3506	335	6	,	,	PUNCT
dpc-3506	335	7	hunzelmann	hunzelmann	PROPN
dpc-3506	335	8	n	n	SYM
dpc-3506	335	9	,	,	PUNCT
dpc-3506	335	10	et	et	PROPN
dpc-3506	335	11	al	al	PROPN
dpc-3506	335	12	.	.	PUNCT
dpc-3506	335	13	european	european	PROPN
dpc-3506	335	14	dermatology	dermatology	PROPN
dpc-3506	335	15	forum	forum	PROPN
dpc-3506	335	16	s1	s1	NOUN
dpc-3506	335	17	-	-	PUNCT
dpc-3506	335	18	guideline	guideline	NOUN
dpc-3506	335	19	on	on	ADP
dpc-3506	335	20	the	the	DET
dpc-3506	335	21	diagnosis	diagnosis	NOUN
dpc-3506	335	22	and	and	CCONJ
dpc-3506	335	23	treatment	treatment	NOUN
dpc-3506	335	24	of	of	ADP
dpc-3506	335	25	sclerosing	sclerose	VERB
dpc-3506	335	26	diseases	disease	NOUN
dpc-3506	335	27	of	of	ADP
dpc-3506	335	28	the	the	DET
dpc-3506	335	29	skin	skin	NOUN
dpc-3506	335	30	,	,	PUNCT
dpc-3506	335	31	part	part	NOUN
dpc-3506	335	32	1	1	NUM
dpc-3506	335	33	:	:	PUNCT
dpc-3506	335	34	localized	localized	ADJ
dpc-3506	335	35	scleroderma	scleroderma	NOUN
dpc-3506	335	36	,	,	PUNCT
dpc-3506	335	37	systemic	systemic	ADJ
dpc-3506	335	38	sclerosis	sclerosis	NOUN
dpc-3506	335	39	and	and	CCONJ
dpc-3506	335	40	overlap	overlap	NOUN
dpc-3506	335	41	syndromes	syndrome	NOUN
dpc-3506	335	42	.	.	PUNCT
dpc-3506	336	1	j	j	PROPN
dpc-3506	336	2	eur	eur	PROPN
dpc-3506	336	3	acad	acad	PROPN
dpc-3506	336	4	dermatology	dermatology	NOUN
dpc-3506	336	5	venereol	venereol	NOUN
dpc-3506	336	6	.	.	PUNCT
dpc-3506	337	1	2017;31(9):1401	2017;31(9):1401	NUM
dpc-3506	337	2	-	-	SYM
dpc-3506	337	3	1424	1424	NUM
dpc-3506	337	4	.	.	PUNCT
dpc-3506	338	1	doi	doi	NOUN
dpc-3506	338	2	:	:	PUNCT
dpc-3506	338	3	10.1111	10.1111	NUM
dpc-3506	338	4	/	/	SYM
dpc-3506	338	5	jdv.14458	jdv.14458	PROPN
dpc-3506	338	6	.	.	PUNCT
dpc-3506	339	1	mid	mid	ADJ
dpc-3506	339	2	:	:	PUNCT
dpc-3506	339	3	28792092	28792092	NUM
dpc-3506	339	4	.	.	PUNCT
dpc-3506	340	1	33	33	NUM
dpc-3506	340	2	.	.	PUNCT
dpc-3506	341	1	woo	woo	VERB
dpc-3506	341	2	ty	ty	PRON
dpc-3506	341	3	,	,	PUNCT
dpc-3506	341	4	rasmussen	rasmussen	PROPN
dpc-3506	341	5	je	je	PROPN
dpc-3506	341	6	.	.	PROPN
dpc-3506	342	1	juvenile	juvenile	ADJ
dpc-3506	342	2	linear	linear	ADJ
dpc-3506	342	3	scleroderma	scleroderma	NOUN
dpc-3506	342	4	associated	associate	VERB
dpc-3506	342	5	with	with	ADP
dpc-3506	342	6	serologic	serologic	ADJ
dpc-3506	342	7	abnormalities	abnormality	NOUN
dpc-3506	342	8	arch	arch	ADJ
dpc-3506	342	9	dermatol	dermatol	NOUN
dpc-3506	342	10	.	.	PUNCT
dpc-3506	343	1	1985;121(11):14031405	1985;121(11):14031405	X
dpc-3506	343	2	.	.	PUNCT
dpc-3506	344	1	pmid	pmid	NOUN
dpc-3506	344	2	:	:	PUNCT
dpc-3506	344	3	3876808	3876808	NUM
dpc-3506	344	4	34	34	NUM
dpc-3506	344	5	.	.	PUNCT
dpc-3506	345	1	dharamsi	dharamsi	PROPN
dpc-3506	345	2	jw	jw	PROPN
dpc-3506	345	3	,	,	PUNCT
dpc-3506	345	4	victor	victor	PROPN
dpc-3506	345	5	s	s	PROPN
dpc-3506	345	6	,	,	PUNCT
dpc-3506	345	7	aguwa	aguwa	ADJ
dpc-3506	345	8	n	n	CCONJ
dpc-3506	345	9	,	,	PUNCT
dpc-3506	345	10	et	et	PROPN
dpc-3506	345	11	al	al	PROPN
dpc-3506	345	12	.	.	PROPN
dpc-3506	345	13	morphea	morphea	PROPN
dpc-3506	345	14	in	in	ADP
dpc-3506	345	15	adults	adult	NOUN
dpc-3506	345	16	and	and	CCONJ
dpc-3506	345	17	children	child	NOUN
dpc-3506	345	18	cohort	cohort	VERB
dpc-3506	345	19	iii	iii	PROPN
dpc-3506	345	20	:	:	PUNCT
dpc-3506	345	21	nested	nested	ADJ
dpc-3506	345	22	case	case	NOUN
dpc-3506	345	23	-	-	PUNCT
dpc-3506	345	24	control	control	NOUN
dpc-3506	345	25	study	study	NOUN
dpc-3506	345	26	:	:	PUNCT
dpc-3506	345	27	the	the	DET
dpc-3506	345	28	clinical	clinical	ADJ
dpc-3506	345	29	significance	significance	NOUN
dpc-3506	345	30	of	of	ADP
dpc-3506	345	31	autoantibodies	autoantibody	NOUN
dpc-3506	345	32	in	in	ADP
dpc-3506	345	33	morphea	morphea	PROPN
dpc-3506	345	34	.	.	PUNCT
dpc-3506	346	1	jama	jama	PROPN
dpc-3506	346	2	dermatol	dermatol	NOUN
dpc-3506	346	3	.	.	PUNCT
dpc-3506	347	1	2013	2013	NUM
dpc-3506	347	2	;	;	PUNCT
dpc-3506	347	3	149(10):1159–65	149(10):1159–65	NUM
dpc-3506	347	4	.	.	PUNCT
dpc-3506	348	1	doi	doi	NOUN
dpc-3506	348	2	:	:	PUNCT
dpc-3506	348	3	10.1001	10.1001	NUM
dpc-3506	348	4	/	/	SYM
dpc-3506	348	5	jamadermatol.2013.4207	jamadermatol.2013.4207	PROPN
dpc-3506	348	6	.	.	PUNCT
dpc-3506	349	1	pmid	pmid	NOUN
dpc-3506	349	2	:	:	PUNCT
dpc-3506	349	3	23925398	23925398	NUM
dpc-3506	349	4	.	.	PUNCT
dpc-3506	350	1	pmcid	pmcid	NOUN
dpc-3506	350	2	:	:	PUNCT
dpc-3506	350	3	pmc4153681	pmc4153681	VERB
dpc-3506	350	4	.	.	PUNCT
dpc-3506	351	1	35	35	NUM
dpc-3506	351	2	.	.	PUNCT
dpc-3506	352	1	alimova	alimova	PROPN
dpc-3506	352	2	e	e	PROPN
dpc-3506	352	3	,	,	PUNCT
dpc-3506	352	4	farhi	farhi	NOUN
dpc-3506	352	5	d	d	NOUN
dpc-3506	352	6	,	,	PUNCT
dpc-3506	352	7	plantier	plantier	NOUN
dpc-3506	352	8	f	f	PROPN
dpc-3506	352	9	,	,	PUNCT
dpc-3506	352	10	et	et	PROPN
dpc-3506	352	11	al	al	PROPN
dpc-3506	352	12	.	.	PROPN
dpc-3506	352	13	morphea	morphea	PROPN
dpc-3506	352	14	(	(	PUNCT
dpc-3506	352	15	localizedscleroderma	localizedscleroderma	NOUN
dpc-3506	352	16	):	):	PUNCT
dpc-3506	352	17	baseline	baseline	NOUN
dpc-3506	352	18	body	body	NOUN
dpc-3506	352	19	surface	surface	NOUN
dpc-3506	352	20	involvement	involvement	NOUN
dpc-3506	352	21	and	and	CCONJ
dpc-3506	352	22	antinuclear	antinuclear	ADJ
dpc-3506	352	23	antibody	antibody	NOUN
dpc-3506	352	24	may	may	AUX
dpc-3506	352	25	have	have	VERB
dpc-3506	352	26	a	a	DET
dpc-3506	352	27	prognostic	prognostic	ADJ
dpc-3506	352	28	value	value	NOUN
dpc-3506	352	29	.	.	PUNCT
dpc-3506	353	1	clin	clin	PROPN
dpc-3506	353	2	exp	exp	PROPN
dpc-3506	353	3	dermatol.2009;34(7):e491	dermatol.2009;34(7):e491	PROPN
dpc-3506	353	4	-	-	PUNCT
dpc-3506	353	5	e492	e492	PROPN
dpc-3506	353	6	.	.	PUNCT
dpc-3506	354	1	doi	doi	NOUN
dpc-3506	354	2	:	:	PUNCT
dpc-3506	354	3	10.1111	10.1111	NUM
dpc-3506	354	4	/	/	SYM
dpc-3506	354	5	j.1365	j.1365	NOUN
dpc-3506	354	6	-	-	PUNCT
dpc-3506	354	7	2230.2009	2230.2009	NUM
dpc-3506	354	8	.03557.x	.03557.x	NOUN
dpc-3506	354	9	.	.	PUNCT
dpc-3506	355	1	pmid:19747327	pmid:19747327	NOUN
dpc-3506	355	2	.	.	PROPN
dpc-3506	356	1	36	36	NUM
dpc-3506	356	2	.	.	PUNCT
dpc-3506	357	1	fett	fett	PROPN
dpc-3506	357	2	n	n	CCONJ
dpc-3506	357	3	,	,	PUNCT
dpc-3506	357	4	werth	werth	PROPN
dpc-3506	357	5	vp	vp	PROPN
dpc-3506	357	6	.	.	PUNCT
dpc-3506	357	7	update	update	NOUN
dpc-3506	357	8	on	on	ADP
dpc-3506	357	9	morphea	morphea	PROPN
dpc-3506	357	10	:	:	PUNCT
dpc-3506	357	11	part	part	PROPN
dpc-3506	357	12	ii	ii	PROPN
dpc-3506	357	13	.	.	PROPN
dpc-3506	358	1	outcome	outcome	NOUN
dpc-3506	358	2	measuresand	measuresand	NOUN
dpc-3506	358	3	treatment	treatment	NOUN
dpc-3506	358	4	.	.	PUNCT
dpc-3506	359	1	j	j	PROPN
dpc-3506	359	2	am	be	AUX
dpc-3506	359	3	acad	acad	ADJ
dpc-3506	359	4	dermatol	dermatol	NOUN
dpc-3506	359	5	.	.	PUNCT
dpc-3506	360	1	2011;64(2):231	2011;64(2):231	NUM
dpc-3506	360	2	-	-	PUNCT
dpc-3506	360	3	242	242	NUM
dpc-3506	360	4	.	.	PUNCT
dpc-3506	361	1	doi	doi	NOUN
dpc-3506	361	2	:	:	PUNCT
dpc-3506	361	3	10.1016	10.1016	NUM
dpc-3506	361	4	/	/	SYM
dpc-3506	361	5	j.jaad.2010.05.046	j.jaad.2010.05.046	PROPN
dpc-3506	361	6	.	.	PUNCT
dpc-3506	362	1	pmid:-21238824	pmid:-21238824	NOUN
dpc-3506	362	2	.	.	PROPN
dpc-3506	362	3	37	37	NUM
dpc-3506	362	4	.	.	PUNCT
dpc-3506	363	1	zulian	zulian	PROPN
dpc-3506	363	2	f	f	NOUN
dpc-3506	363	3	,	,	PUNCT
dpc-3506	363	4	vallongo	vallongo	NOUN
dpc-3506	363	5	c	c	NOUN
dpc-3506	363	6	,	,	PUNCT
dpc-3506	363	7	patrizi	patrizi	NOUN
dpc-3506	363	8	a	a	PRON
dpc-3506	363	9	,	,	PUNCT
dpc-3506	363	10	et	et	PROPN
dpc-3506	363	11	al	al	PROPN
dpc-3506	363	12	.	.	PUNCT
dpc-3506	364	1	a	a	DET
dpc-3506	364	2	long	long	ADJ
dpc-3506	364	3	-	-	PUNCT
dpc-3506	364	4	term	term	NOUN
dpc-3506	364	5	follow	follow	NOUN
dpc-3506	364	6	-	-	PUNCT
dpc-3506	364	7	up	up	ADP
dpc-3506	364	8	study	study	NOUN
dpc-3506	364	9	of	of	ADP
dpc-3506	364	10	methotrexate	methotrexate	NOUN
dpc-3506	364	11	in	in	ADP
dpc-3506	364	12	juvenile	juvenile	ADJ
dpc-3506	364	13	localized	localized	ADJ
dpc-3506	364	14	scleroderma	scleroderma	NOUN
dpc-3506	364	15	(	(	PUNCT
dpc-3506	364	16	morphea	morphea	NUM
dpc-3506	364	17	)	)	PUNCT
dpc-3506	364	18	.	.	PUNCT
dpc-3506	365	1	j	j	PROPN
dpc-3506	365	2	  	  	SPACE
dpc-3506	365	3	am	be	AUX
dpc-3506	365	4	acad	acad	NOUN
dpc-3506	365	5	dermatol.2012;67(6):1151	dermatol.2012;67(6):1151	PROPN
dpc-3506	365	6	-	-	PUNCT
dpc-3506	365	7	1156	1156	NUM
dpc-3506	365	8	.	.	PUNCT
dpc-3506	366	1	doi	doi	NOUN
dpc-3506	366	2	:	:	PUNCT
dpc-3506	366	3	10.1016	10.1016	NUM
dpc-3506	366	4	/	/	SYM
dpc-3506	366	5	j.	j.	PROPN
dpc-3506	366	6	jaad.2012.03.036	jaad.2012.03.036	PROPN
dpc-3506	366	7	.	.	PUNCT
dpc-3506	367	1	pmid	pmid	PROPN
dpc-3506	367	2	:	:	PUNCT
dpc-3506	367	3	22657157	22657157	NUM
dpc-3506	367	4	.	.	PUNCT
dpc-3506	368	1	38	38	NUM
dpc-3506	368	2	.	.	PUNCT
dpc-3506	369	1	litaiem	litaiem	PROPN
dpc-3506	369	2	n	n	CCONJ
dpc-3506	369	3	,	,	PUNCT
dpc-3506	369	4	bacha	bacha	PROPN
dpc-3506	369	5	t	t	PROPN
dpc-3506	369	6	,	,	PUNCT
dpc-3506	369	7	drissi	drissi	PROPN
dpc-3506	369	8	h	h	PROPN
dpc-3506	369	9	,	,	PUNCT
dpc-3506	369	10	zeglaoui	zeglaoui	PROPN
dpc-3506	369	11	f.	f.	PROPN
dpc-3506	370	1	an	an	DET
dpc-3506	370	2	evaluation	evaluation	NOUN
dpc-3506	370	3	of	of	ADP
dpc-3506	370	4	long	long	ADJ
dpc-3506	370	5	-	-	PUNCT
dpc-3506	370	6	term	term	NOUN
dpc-3506	370	7	outcomes	outcome	NOUN
dpc-3506	370	8	and	and	CCONJ
dpc-3506	370	9	recurrence	recurrence	NOUN
dpc-3506	370	10	rates	rate	NOUN
dpc-3506	370	11	in	in	ADP
dpc-3506	370	12	patients	patient	NOUN
dpc-3506	370	13	with	with	ADP
dpc-3506	370	14	morphea	morphea	PROPN
dpc-3506	370	15	.	.	PUNCT
dpc-3506	371	1	int	int	PROPN
dpc-3506	371	2	j	j	PROPN
dpc-3506	371	3	dermatol	dermatol	NOUN
dpc-3506	371	4	.	.	PUNCT
dpc-3506	372	1	2019;58(4):e90	2019;58(4):e90	NUM
dpc-3506	372	2	-	-	PUNCT
dpc-3506	372	3	e92	e92	NOUN
dpc-3506	372	4	.	.	PUNCT
dpc-3506	373	1	doi	doi	NOUN
dpc-3506	373	2	:	:	PUNCT
dpc-3506	373	3	10.1111/	10.1111/	NUM
dpc-3506	373	4	ijd.14401	ijd.14401	PROPN
dpc-3506	373	5	..	..	PROPN
dpc-3506	373	6	pmid	pmid	PROPN
dpc-3506	373	7	:	:	PUNCT
dpc-3506	373	8	30710337	30710337	NUM
dpc-3506	373	9	.	.	PUNCT
dpc-3506	374	1	39	39	NUM
dpc-3506	374	2	.	.	PUNCT
dpc-3506	375	1	el	el	NOUN
dpc-3506	375	2	-	-	PUNCT
dpc-3506	375	3	sakka	sakka	NOUN
dpc-3506	375	4	ai	ai	VERB
dpc-3506	375	5	,	,	PUNCT
dpc-3506	375	6	bakircioglu	bakircioglu	VERB
dpc-3506	375	7	me	i	PRON
dpc-3506	375	8	,	,	PUNCT
dpc-3506	375	9	bhatnagar	bhatnagar	NOUN
dpc-3506	375	10	rs	rs	NOUN
dpc-3506	375	11	,	,	PUNCT
dpc-3506	375	12	yen	yen	NOUN
dpc-3506	375	13	ts	ts	NOUN
dpc-3506	375	14	,	,	PUNCT
dpc-3506	375	15	dahiya	dahiya	NOUN
dpc-3506	375	16	r	r	NOUN
dpc-3506	375	17	,	,	PUNCT
dpc-3506	375	18	lue	lue	NOUN
dpc-3506	375	19	tf	tf	PROPN
dpc-3506	375	20	.	.	PUNCT
dpc-3506	376	1	the	the	DET
dpc-3506	376	2	effects	effect	NOUN
dpc-3506	376	3	of	of	ADP
dpc-3506	376	4	colchicine	colchicine	NOUN
dpc-3506	376	5	on	on	ADP
dpc-3506	376	6	a	a	DET
dpc-3506	376	7	peyronie’s	peyronie’s	ADJ
dpc-3506	376	8	-	-	PUNCT
dpc-3506	376	9	like	like	ADJ
dpc-3506	376	10	condition	condition	NOUN
dpc-3506	376	11	in	in	ADP
dpc-3506	376	12	an	an	DET
dpc-3506	376	13	animal	animal	NOUN
dpc-3506	376	14	model	model	NOUN
dpc-3506	376	15	.	.	PUNCT
dpc-3506	377	1	j	j	PROPN
dpc-3506	377	2	urol	urol	PROPN
dpc-3506	377	3	.	.	PUNCT
dpc-3506	378	1	1999;161(6):1980	1999;161(6):1980	NUM
dpc-3506	378	2	-	-	SYM
dpc-3506	378	3	1983	1983	NUM
dpc-3506	378	4	.	.	PUNCT
dpc-3506	379	1	pmid	pmid	NOUN
dpc-3506	379	2	:	:	PUNCT
dpc-3506	379	3	10332485	10332485	NUM
dpc-3506	379	4	.	.	PUNCT
dpc-3506	380	1	40	40	NUM
dpc-3506	380	2	.	.	PUNCT
dpc-3506	381	1	noh	noh	PROPN
dpc-3506	381	2	jw	jw	PROPN
dpc-3506	381	3	,	,	PUNCT
dpc-3506	381	4	kim	kim	PROPN
dpc-3506	381	5	j	j	PROPN
dpc-3506	381	6	,	,	PUNCT
dpc-3506	381	7	kim	kim	PROPN
dpc-3506	381	8	jw	jw	PROPN
dpc-3506	381	9	.	.	PROPN
dpc-3506	381	10	localized	localize	VERB
dpc-3506	381	11	scleroderma	scleroderma	NOUN
dpc-3506	381	12	:	:	PUNCT
dpc-3506	381	13	a	a	DET
dpc-3506	381	14	clinical	clinical	ADJ
dpc-3506	381	15	study	study	NOUN
dpc-3506	381	16	at	at	ADP
dpc-3506	381	17	a	a	DET
dpc-3506	381	18	single	single	ADJ
dpc-3506	381	19	center	center	NOUN
dpc-3506	381	20	in	in	ADP
dpc-3506	381	21	korea	korea	PROPN
dpc-3506	381	22	.	.	PUNCT
dpc-3506	382	1	int	int	PROPN
dpc-3506	382	2	j	j	PROPN
dpc-3506	382	3	rheum	rheum	PROPN
dpc-3506	382	4	dis	dis	PROPN
dpc-3506	382	5	.	.	PUNCT
dpc-3506	383	1	2013;16(4):437	2013;16(4):437	NUM
dpc-3506	383	2	-	-	SYM
dpc-3506	383	3	441	441	NUM
dpc-3506	383	4	.	.	PUNCT
dpc-3506	383	5	doi	doi	NOUN
dpc-3506	383	6	:	:	PUNCT
dpc-3506	383	7	10.1111/1756	10.1111/1756	NUM
dpc-3506	383	8	-	-	SYM
dpc-3506	383	9	185x.12080	185x.12080	NUM
dpc-3506	383	10	.	.	PUNCT
dpc-3506	384	1	pmid	pmid	NOUN
dpc-3506	384	2	:	:	PUNCT
dpc-3506	384	3	23992265	23992265	NUM
dpc-3506	384	4	.	.	PUNCT
dpc-3506	385	1	12	12	NUM
dpc-3506	385	2	.	.	PUNCT
dpc-3506	386	1	alhumidi	alhumidi	PROPN
dpc-3506	386	2	a	a	PRON
dpc-3506	386	3	,	,	PUNCT
dpc-3506	386	4	alanazi	alanazi	PROPN
dpc-3506	386	5	sm	sm	PROPN
dpc-3506	386	6	,	,	PUNCT
dpc-3506	386	7	alfaraidi	alfaraidi	PROPN
dpc-3506	386	8	m	m	PROPN
dpc-3506	386	9	,	,	PUNCT
dpc-3506	386	10	alshamlan	alshamlan	PROPN
dpc-3506	386	11	n	n	CCONJ
dpc-3506	386	12	,	,	PUNCT
dpc-3506	386	13	alanazi	alanazi	VERB
dpc-3506	386	14	a	a	PRON
dpc-3506	386	15	,	,	PUNCT
dpc-3506	386	16	khalil	khalil	PROPN
dpc-3506	386	17	r	r	NOUN
dpc-3506	386	18	et	et	PROPN
dpc-3506	386	19	al	al	PROPN
dpc-3506	386	20	.	.	PROPN
dpc-3506	386	21	morphea	morphea	PROPN
dpc-3506	386	22	in	in	ADP
dpc-3506	386	23	saudi	saudi	PROPN
dpc-3506	386	24	arabia	arabia	PROPN
dpc-3506	386	25	,	,	PUNCT
dpc-3506	386	26	a	a	DET
dpc-3506	386	27	clinical	clinical	ADJ
dpc-3506	386	28	study	study	NOUN
dpc-3506	386	29	of	of	ADP
dpc-3506	386	30	64	64	NUM
dpc-3506	386	31	patients	patient	NOUN
dpc-3506	386	32	.	.	PUNCT
dpc-3506	387	1	clin	clin	PROPN
dpc-3506	387	2	res	re	NOUN
dpc-3506	387	3	dermatol	dermatol	NOUN
dpc-3506	387	4	open	open	ADJ
dpc-3506	387	5	access	access	NOUN
dpc-3506	387	6	.	.	PUNCT
dpc-3506	388	1	2017;4(4):1	2017;4(4):1	PROPN
dpc-3506	388	2	-	-	PUNCT
dpc-3506	388	3	7	7	PROPN
dpc-3506	388	4	.	.	PUNCT
dpc-3506	388	5	doi	doi	NOUN
dpc-3506	388	6	:	:	PUNCT
dpc-3506	388	7	10.15226/2378	10.15226/2378	NUM
dpc-3506	388	8	-	-	SYM
dpc-3506	388	9	1726/4/4/00167	1726/4/4/00167	NUM
dpc-3506	388	10	.	.	PROPN
dpc-3506	388	11	13	13	NUM
dpc-3506	388	12	.	.	PUNCT
dpc-3506	389	1	zulian	zulian	PROPN
dpc-3506	389	2	f	f	NOUN
dpc-3506	389	3	,	,	PUNCT
dpc-3506	389	4	athreya	athreya	PROPN
dpc-3506	389	5	bh	bh	PROPN
dpc-3506	389	6	,	,	PUNCT
dpc-3506	389	7	laxer	laxer	PROPN
dpc-3506	389	8	r	r	NOUN
dpc-3506	389	9	,	,	PUNCT
dpc-3506	389	10	nelson	nelson	PROPN
dpc-3506	389	11	am	be	AUX
dpc-3506	389	12	.	.	PUNCT
dpc-3506	390	1	juvenile	juvenile	ADJ
dpc-3506	390	2	localized	localized	ADJ
dpc-3506	390	3	scleroderma	scleroderma	NOUN
dpc-3506	390	4	:	:	PUNCT
dpc-3506	390	5	clinical	clinical	ADJ
dpc-3506	390	6	and	and	CCONJ
dpc-3506	390	7	epidemiological	epidemiological	ADJ
dpc-3506	390	8	features	feature	NOUN
dpc-3506	390	9	in	in	ADP
dpc-3506	390	10	750	750	NUM
dpc-3506	390	11	children	child	NOUN
dpc-3506	390	12	.	.	PUNCT
dpc-3506	391	1	an	an	DET
dpc-3506	391	2	international	international	ADJ
dpc-3506	391	3	study	study	NOUN
dpc-3506	391	4	.	.	PUNCT
dpc-3506	392	1	rheumatology	rheumatology	NOUN
dpc-3506	392	2	(	(	PUNCT
dpc-3506	392	3	oxford	oxford	PROPN
dpc-3506	392	4	)	)	PUNCT
dpc-3506	392	5	.	.	PUNCT
dpc-3506	393	1	2006;45(5	2006;45(5	NUM
dpc-3506	393	2	):	):	PUNCT
dpc-3506	393	3	614	614	NUM
dpc-3506	393	4	-	-	SYM
dpc-3506	393	5	20	20	NUM
dpc-3506	393	6	.	.	PUNCT
dpc-3506	393	7	doi:10.1093	doi:10.1093	NOUN
dpc-3506	393	8	/	/	SYM
dpc-3506	393	9	rheumatology	rheumatology	PROPN
dpc-3506	393	10	/	/	SYM
dpc-3506	393	11	kei251	kei251	PROPN
dpc-3506	393	12	.	.	PUNCT
dpc-3506	394	1	pmid	pmid	NOUN
dpc-3506	394	2	:	:	PUNCT
dpc-3506	394	3	16368732	16368732	NUM
dpc-3506	394	4	.	.	PUNCT
dpc-3506	395	1	14	14	NUM
dpc-3506	395	2	.	.	PUNCT
dpc-3506	396	1	mertens	mertens	PROPN
dpc-3506	396	2	js	js	PROPN
dpc-3506	396	3	,	,	PUNCT
dpc-3506	396	4	seyger	seyger	NOUN
dpc-3506	396	5	mm	mm	PROPN
dpc-3506	396	6	,	,	PUNCT
dpc-3506	396	7	kievit	kievit	PROPN
dpc-3506	396	8	w	w	PROPN
dpc-3506	396	9	,	,	PUNCT
dpc-3506	396	10	et	et	PROPN
dpc-3506	396	11	al	al	PROPN
dpc-3506	396	12	.	.	PROPN
dpc-3506	396	13	disease	disease	NOUN
dpc-3506	396	14	recurrence	recurrence	NOUN
dpc-3506	396	15	in	in	ADP
dpc-3506	396	16	localized	localized	ADJ
dpc-3506	396	17	scleroderma	scleroderma	NOUN
dpc-3506	396	18	:	:	PUNCT
dpc-3506	396	19	a	a	DET
dpc-3506	396	20	retrospective	retrospective	ADJ
dpc-3506	396	21	analysis	analysis	NOUN
dpc-3506	396	22	of	of	ADP
dpc-3506	396	23	344	344	NUM
dpc-3506	396	24	patients	patient	NOUN
dpc-3506	396	25	with	with	ADP
dpc-3506	396	26	paediatricor	paediatricor	NOUN
dpc-3506	396	27	adult	adult	NOUN
dpc-3506	396	28	-	-	PUNCT
dpc-3506	396	29	onset	onset	NOUN
dpc-3506	396	30	disease	disease	NOUN
dpc-3506	396	31	.	.	PUNCT
dpc-3506	397	1	br	br	PROPN
dpc-3506	397	2	j	j	PROPN
dpc-3506	397	3	dermatol	dermatol	NOUN
dpc-3506	397	4	.	.	PUNCT
dpc-3506	398	1	2015;172(3	2015;172(3	NUM
dpc-3506	398	2	):	):	PUNCT
dpc-3506	398	3	722	722	NUM
dpc-3506	398	4	-	-	SYM
dpc-3506	398	5	728	728	NUM
dpc-3506	398	6	.	.	PUNCT
dpc-3506	399	1	doi	doi	NOUN
dpc-3506	399	2	:	:	PUNCT
dpc-3506	399	3	10.1111	10.1111	NUM
dpc-3506	399	4	/	/	SYM
dpc-3506	399	5	bjd.13514	bjd.13514	PROPN
dpc-3506	399	6	.	.	PUNCT
dpc-3506	400	1	pmid	pmid	NOUN
dpc-3506	400	2	:	:	PUNCT
dpc-3506	400	3	25381928	25381928	NUM
dpc-3506	400	4	.	.	PUNCT
dpc-3506	401	1	15	15	NUM
dpc-3506	401	2	.	.	PUNCT
dpc-3506	401	3	marzano	marzano	PROPN
dpc-3506	401	4	av	av	PROPN
dpc-3506	401	5	,	,	PUNCT
dpc-3506	401	6	menni	menni	NOUN
dpc-3506	401	7	s	s	PROPN
dpc-3506	401	8	,	,	PUNCT
dpc-3506	401	9	parodi	parodi	X
dpc-3506	401	10	a	a	NOUN
dpc-3506	401	11	,	,	PUNCT
dpc-3506	401	12	et	et	PROPN
dpc-3506	401	13	al	al	PROPN
dpc-3506	401	14	.	.	PROPN
dpc-3506	401	15	localized	localized	ADJ
dpc-3506	401	16	scleroderma	scleroderma	NOUN
dpc-3506	401	17	in	in	ADP
dpc-3506	401	18	adults	adult	NOUN
dpc-3506	401	19	and	and	CCONJ
dpc-3506	401	20	children	child	NOUN
dpc-3506	401	21	.	.	PUNCT
dpc-3506	402	1	clinical	clinical	ADJ
dpc-3506	402	2	and	and	CCONJ
dpc-3506	402	3	laboratory	laboratory	NOUN
dpc-3506	402	4	investigations	investigation	NOUN
dpc-3506	402	5	on	on	ADP
dpc-3506	402	6	239	239	NUM
dpc-3506	402	7	 	 	SPACE
dpc-3506	402	8	cases	case	NOUN
dpc-3506	402	9	.	.	PUNCT
dpc-3506	403	1	eur	eur	PROPN
dpc-3506	403	2	j	j	PROPN
dpc-3506	403	3	dermatol	dermatol	NOUN
dpc-3506	403	4	.	.	PUNCT
dpc-3506	404	1	2003;13(2):171	2003;13(2):171	NUM
dpc-3506	404	2	-	-	SYM
dpc-3506	404	3	176	176	NUM
dpc-3506	404	4	.	.	PUNCT
dpc-3506	405	1	pmid	pmid	NOUN
dpc-3506	405	2	:	:	PUNCT
dpc-3506	405	3	12695134	12695134	NUM
dpc-3506	405	4	.	.	PUNCT
dpc-3506	406	1	16	16	NUM
dpc-3506	406	2	.	.	PUNCT
dpc-3506	407	1	wu	wu	PROPN
dpc-3506	407	2	ey	ey	PROPN
dpc-3506	407	3	,	,	PUNCT
dpc-3506	407	4	li	li	PROPN
dpc-3506	407	5	sc	sc	PROPN
dpc-3506	407	6	,	,	PUNCT
dpc-3506	407	7	torok	torok	PROPN
dpc-3506	407	8	ks	ks	PROPN
dpc-3506	407	9	,	,	PUNCT
dpc-3506	407	10	et	et	PROPN
dpc-3506	407	11	al	al	PROPN
dpc-3506	407	12	.	.	PUNCT
dpc-3506	407	13	description	description	NOUN
dpc-3506	407	14	of	of	ADP
dpc-3506	407	15	the	the	DET
dpc-3506	407	16	juvenile	juvenile	ADJ
dpc-3506	407	17	localized	localized	ADJ
dpc-3506	407	18	scleroderma	scleroderma	NOUN
dpc-3506	407	19	subgroup	subgroup	NOUN
dpc-3506	407	20	of	of	ADP
dpc-3506	407	21	the	the	DET
dpc-3506	407	22	carra	carra	PROPN
dpc-3506	407	23	registry	registry	PROPN
dpc-3506	407	24	.	.	PUNCT
dpc-3506	408	1	arthritis	arthritis	NOUN
dpc-3506	408	2	rheumatol	rheumatol	NOUN
dpc-3506	408	3	(	(	PUNCT
dpc-3506	408	4	hoboken	hoboken	PROPN
dpc-3506	408	5	,	,	PUNCT
dpc-3506	408	6	nj	nj	PROPN
dpc-3506	408	7	)	)	PUNCT
dpc-3506	408	8	.	.	PUNCT
dpc-3506	409	1	2014	2014	NUM
dpc-3506	409	2	;	;	PUNCT
dpc-3506	410	1	66(suppl	66(suppl	NUM
dpc-3506	410	2	11):s43	11):s43	NUM
dpc-3506	410	3	–	–	PUNCT
dpc-3506	410	4	s44	s44	ADJ
dpc-3506	410	5	.	.	PUNCT
dpc-3506	410	6	doi:10.1002	doi:10.1002	NOUN
dpc-3506	410	7	/	/	SYM
dpc-3506	410	8	art.38444	art.38444	PROPN
dpc-3506	410	9	.	.	PROPN
dpc-3506	410	10	17	17	NUM
dpc-3506	410	11	.	.	PUNCT
dpc-3506	411	1	akbas	akbas	PROPN
dpc-3506	411	2	,	,	PUNCT
dpc-3506	411	3	;	;	PUNCT
dpc-3506	411	4	kılınç	kılınç	PROPN
dpc-3506	411	5	f.	f.	PROPN
dpc-3506	411	6	clinical	clinical	ADJ
dpc-3506	411	7	and	and	CCONJ
dpc-3506	411	8	demographic	demographic	ADJ
dpc-3506	411	9	characteristics	characteristic	NOUN
dpc-3506	411	10	of	of	ADP
dpc-3506	411	11	pediatric	pediatric	ADJ
dpc-3506	411	12	patients	patient	NOUN
dpc-3506	411	13	diagnosed	diagnose	VERB
dpc-3506	411	14	with	with	ADP
dpc-3506	411	15	localized	localized	ADJ
dpc-3506	411	16	scleroderma	scleroderma	NOUN
dpc-3506	411	17	:	:	PUNCT
dpc-3506	411	18	a	a	DET
dpc-3506	411	19	retrospective	retrospective	ADJ
dpc-3506	411	20	analysis	analysis	NOUN
dpc-3506	411	21	.	.	PUNCT
dpc-3506	411	22	 	 	SPACE
dpc-3506	412	1	türkiye	türkiye	PROPN
dpc-3506	412	2	çocuk	çocuk	PROPN
dpc-3506	412	3	hastalıkları	hastalıkları	PROPN
dpc-3506	412	4	dergisi	dergisi	PROPN
dpc-3506	412	5	.	.	PUNCT
dpc-3506	413	1	2022;16.1:25	2022;16.1:25	NUM
dpc-3506	413	2	-	-	SYM
dpc-3506	413	3	31	31	NUM
dpc-3506	413	4	.	.	PUNCT
dpc-3506	414	1	18	18	NUM
dpc-3506	414	2	.	.	PUNCT
dpc-3506	414	3	saracino	saracino	PROPN
dpc-3506	414	4	am	am	PROPN
dpc-3506	414	5	,	,	PUNCT
dpc-3506	414	6	george	george	PROPN
dpc-3506	414	7	c	c	PROPN
dpc-3506	414	8	,	,	PUNCT
dpc-3506	414	9	nihtyanova	nihtyanova	ADJ
dpc-3506	414	10	si	si	PROPN
dpc-3506	414	11	,	,	PUNCT
dpc-3506	414	12	denton	denton	PROPN
dpc-3506	414	13	cp	cp	PROPN
dpc-3506	414	14	.	.	PROPN
dpc-3506	414	15	comparing	compare	VERB
dpc-3506	414	16	paediatricand	paediatricand	NOUN
dpc-3506	414	17	adult	adult	NOUN
dpc-3506	414	18	-	-	PUNCT
dpc-3506	414	19	onset	onset	VERB
dpc-3506	414	20	linear	linear	ADJ
dpc-3506	414	21	morphoea	morphoea	NOUN
dpc-3506	414	22	in	in	ADP
dpc-3506	414	23	a	a	DET
dpc-3506	414	24	large	large	ADJ
dpc-3506	414	25	tertiary	tertiary	ADJ
dpc-3506	414	26	-	-	PUNCT
dpc-3506	414	27	referral	referral	ADJ
dpc-3506	414	28	scleroderma	scleroderma	NOUN
dpc-3506	414	29	centre	centre	NOUN
dpc-3506	414	30	.	.	PUNCT
dpc-3506	415	1	j	j	PROPN
dpc-3506	415	2	scleroderma	scleroderma	PROPN
dpc-3506	415	3	relat	relat	PROPN
dpc-3506	415	4	disord	disord	PROPN
dpc-3506	415	5	.	.	PUNCT
dpc-3506	416	1	2021;6(1):102	2021;6(1):102	NUM
dpc-3506	416	2	-	-	SYM
dpc-3506	416	3	108	108	NUM
dpc-3506	416	4	.	.	PUNCT
dpc-3506	417	1	doi	doi	NOUN
dpc-3506	417	2	:	:	PUNCT
dpc-3506	417	3	10.1177/2397198320925684	10.1177/2397198320925684	NUM
dpc-3506	417	4	.	.	PUNCT
dpc-3506	418	1	pmid	pmid	NOUN
dpc-3506	418	2	:	:	PUNCT
dpc-3506	418	3	35382251	35382251	NUM
dpc-3506	418	4	;	;	PUNCT
dpc-3506	418	5	19	19	NUM
dpc-3506	418	6	.	.	PUNCT
dpc-3506	419	1	kim	kim	PROPN
dpc-3506	419	2	j	j	PROPN
dpc-3506	419	3	,	,	PUNCT
dpc-3506	419	4	chung	chung	PROPN
dpc-3506	419	5	kb	kb	PROPN
dpc-3506	419	6	,	,	PUNCT
dpc-3506	419	7	lee	lee	PROPN
dpc-3506	419	8	yi	yi	PROPN
dpc-3506	419	9	,	,	PUNCT
dpc-3506	419	10	kim	kim	PROPN
dpc-3506	419	11	j	j	PROPN
dpc-3506	419	12	,	,	PUNCT
dpc-3506	419	13	lee	lee	PROPN
dpc-3506	419	14	jh	jh	PROPN
dpc-3506	419	15	.	.	PUNCT
dpc-3506	420	1	clinical	clinical	ADJ
dpc-3506	420	2	characteristics	characteristic	NOUN
dpc-3506	420	3	and	and	CCONJ
dpc-3506	420	4	histopathologic	histopathologic	ADJ
dpc-3506	420	5	changes	change	NOUN
dpc-3506	420	6	of	of	ADP
dpc-3506	420	7	morphea	morphea	NOUN
dpc-3506	420	8	:	:	PUNCT
dpc-3506	420	9	a	a	DET
dpc-3506	420	10	single	single	ADJ
dpc-3506	420	11	-	-	PUNCT
dpc-3506	420	12	center	center	NOUN
dpc-3506	420	13	,	,	PUNCT
dpc-3506	420	14	retrospective	retrospective	ADJ
dpc-3506	420	15	study	study	NOUN
dpc-3506	420	16	of	of	ADP
dpc-3506	420	17	137	137	NUM
dpc-3506	420	18	patients	patient	NOUN
dpc-3506	420	19	.	.	PUNCT
dpc-3506	421	1	j	j	PROPN
dpc-3506	421	2	am	be	AUX
dpc-3506	421	3	acad	acad	ADJ
dpc-3506	421	4	dermatol	dermatol	NOUN
dpc-3506	421	5	.	.	PUNCT
dpc-3506	422	1	2021;85(1):105	2021;85(1):105	NUM
dpc-3506	422	2	-	-	PUNCT
dpc-3506	422	3	113	113	NUM
dpc-3506	422	4	.	.	PUNCT
dpc-3506	423	1	doi	doi	NOUN
dpc-3506	423	2	:	:	PUNCT
dpc-3506	423	3	10.1016	10.1016	NUM
dpc-3506	423	4	/	/	SYM
dpc-3506	423	5	j.jaad.2020.11.006	j.jaad.2020.11.006	PROPN
dpc-3506	423	6	.	.	PUNCT
dpc-3506	424	1	pmid	pmid	NOUN
dpc-3506	424	2	:	:	PUNCT
dpc-3506	424	3	33188871	33188871	NUM
dpc-3506	424	4	.	.	PUNCT
dpc-3506	425	1	20	20	NUM
dpc-3506	425	2	.	.	X
dpc-3506	426	1	lis	lis	NOUN
dpc-3506	426	2	-	-	NOUN
dpc-3506	426	3	święty	święty	NOUN
dpc-3506	426	4	a	a	NOUN
dpc-3506	426	5	,	,	PUNCT
dpc-3506	426	6	skrzypek	skrzypek	PROPN
dpc-3506	426	7	-	-	PUNCT
dpc-3506	426	8	salamon	salamon	PROPN
dpc-3506	426	9	a	a	PRON
dpc-3506	426	10	,	,	PUNCT
dpc-3506	426	11	ranosz	ranosz	NOUN
dpc-3506	426	12	-	-	PUNCT
dpc-3506	426	13	janicka	janicka	NOUN
dpc-3506	426	14	i	i	PRON
dpc-3506	426	15	,	,	PUNCT
dpc-3506	426	16	brzezińska	brzezińska	PROPN
dpc-3506	426	17	-	-	PUNCT
dpc-3506	426	18	wcisło	wcisło	PROPN
dpc-3506	426	19	l.	l.	PROPN
dpc-3506	426	20	localized	localize	VERB
dpc-3506	426	21	scleroderma	scleroderma	NOUN
dpc-3506	426	22	:	:	PUNCT
dpc-3506	426	23	clinical	clinical	ADJ
dpc-3506	426	24	and	and	CCONJ
dpc-3506	426	25	epidemiological	epidemiological	ADJ
dpc-3506	426	26	features	feature	NOUN
dpc-3506	426	27	with	with	ADP
dpc-3506	426	28	emphasis	emphasis	NOUN
dpc-3506	426	29	on	on	ADP
dpc-3506	426	30	adulthoodversus	adulthoodversus	PROPN
dpc-3506	426	31	childhood	childhood	NOUN
dpc-3506	426	32	-	-	PUNCT
dpc-3506	426	33	onset	onset	NOUN
dpc-3506	426	34	disease	disease	NOUN
dpc-3506	426	35	differences	difference	NOUN
dpc-3506	426	36	.	.	PUNCT
dpc-3506	427	1	j	j	PROPN
dpc-3506	427	2	eur	eur	PROPN
dpc-3506	427	3	acad	acad	PROPN
dpc-3506	427	4	dermatolvenereol	dermatolvenereol	PROPN
dpc-3506	427	5	.	.	PUNCT
dpc-3506	428	1	2017;31(10):1595	2017;31(10):1595	NUM
dpc-3506	428	2	-	-	SYM
dpc-3506	428	3	603	603	NUM
dpc-3506	428	4	.	.	PUNCT
dpc-3506	429	1	doi	doi	NOUN
dpc-3506	429	2	:	:	PUNCT
dpc-3506	429	3	10.1111	10.1111	NUM
dpc-3506	429	4	/	/	SYM
dpc-3506	429	5	jdv.14197	jdv.14197	PROPN
dpc-3506	429	6	.	.	PUNCT
dpc-3506	430	1	pmid	pmid	NOUN
dpc-3506	430	2	:	:	PUNCT
dpc-3506	430	3	28271552	28271552	NUM
dpc-3506	430	4	.	.	PUNCT
dpc-3506	431	1	21	21	NUM
dpc-3506	431	2	.	.	PUNCT
dpc-3506	432	1	kunzler	kunzler	PROPN
dpc-3506	432	2	e	e	PROPN
dpc-3506	432	3	,	,	PUNCT
dpc-3506	432	4	florez	florez	PROPN
dpc-3506	432	5	-	-	PUNCT
dpc-3506	432	6	pollack	pollack	PROPN
dpc-3506	432	7	s	s	PROPN
dpc-3506	432	8	,	,	PUNCT
dpc-3506	432	9	teske	teske	ADJ
dpc-3506	432	10	n	n	SYM
dpc-3506	432	11	,	,	PUNCT
dpc-3506	432	12	o’brien	o’brien	PROPN
dpc-3506	432	13	j	j	PROPN
dpc-3506	432	14	,	,	PUNCT
dpc-3506	432	15	prasad	prasad	PROPN
dpc-3506	432	16	s	s	PROPN
dpc-3506	432	17	,	,	PUNCT
dpc-3506	432	18	jacobe	jacobe	PROPN
dpc-3506	432	19	h.	h.	PROPN
dpc-3506	432	20	linear	linear	PROPN
dpc-3506	432	21	morphea	morphea	PROPN
dpc-3506	432	22	:	:	PUNCT
dpc-3506	432	23	clinical	clinical	ADJ
dpc-3506	432	24	characteristics	characteristic	NOUN
dpc-3506	432	25	,	,	PUNCT
dpc-3506	432	26	disease	disease	NOUN
dpc-3506	432	27	course	course	NOUN
dpc-3506	432	28	,	,	PUNCT
dpc-3506	432	29	and	and	CCONJ
dpc-3506	432	30	treatment	treatment	NOUN
dpc-3506	432	31	of	of	ADP
dpc-3506	432	32	the	the	DET
dpc-3506	432	33	morphea	morphea	NOUN
dpc-3506	432	34	in	in	ADP
dpc-3506	432	35	adults	adult	NOUN
dpc-3506	432	36	and	and	CCONJ
dpc-3506	432	37	children	child	NOUN
dpc-3506	432	38	cohort	cohort	VERB
dpc-3506	432	39	.	.	PUNCT
dpc-3506	433	1	j	j	NOUN
dpc-3506	433	2	 	 	SPACE
dpc-3506	433	3	am	be	AUX
dpc-3506	433	4	acad	acad	ADJ
dpc-3506	433	5	dermatol	dermatol	NOUN
dpc-3506	433	6	.	.	PUNCT
dpc-3506	434	1	2019;80(6):1664	2019;80(6):1664	NUM
dpc-3506	434	2	-	-	SYM
dpc-3506	434	3	1670.e1	1670.e1	NUM
dpc-3506	434	4	.	.	PUNCT
dpc-3506	435	1	doi	doi	NOUN
dpc-3506	435	2	:	:	PUNCT
dpc-3506	435	3	10	10	NUM
dpc-3506	435	4	.	.	X
dpc-3506	436	1	1016	1016	NUM
dpc-3506	436	2	/	/	SYM
dpc-3506	436	3	j	j	PROPN
dpc-3506	436	4	.jaad.2019.01.050	.jaad.2019.01.050	PUNCT
dpc-3506	436	5	.	.	PUNCT
dpc-3506	437	1	22	22	NUM
dpc-3506	437	2	.	.	PUNCT
dpc-3506	438	1	d’amico	d’amico	PROPN
dpc-3506	438	2	e	e	PROPN
dpc-3506	438	3	,	,	PUNCT
dpc-3506	438	4	zanghì	zanghì	X
dpc-3506	438	5	a	a	X
dpc-3506	438	6	,	,	PUNCT
dpc-3506	438	7	romano	romano	NOUN
dpc-3506	438	8	a	a	PRON
dpc-3506	438	9	,	,	PUNCT
dpc-3506	438	10	sciandra	sciandra	PROPN
dpc-3506	438	11	m	m	PROPN
dpc-3506	438	12	,	,	PUNCT
dpc-3506	438	13	palumbo	palumbo	PROPN
dpc-3506	438	14	gam	gam	X
dpc-3506	438	15	,	,	PUNCT
dpc-3506	438	16	patti	patti	PROPN
dpc-3506	438	17	f.	f.	PROPN
dpc-3506	439	1	the	the	DET
dpc-3506	439	2	neutrophil	neutrophil	PROPN
dpc-3506	439	3	-	-	PUNCT
dpc-3506	439	4	to	to	ADP
dpc-3506	439	5	-	-	PUNCT
dpc-3506	439	6	lymphocyte	lymphocyte	ADJ
dpc-3506	439	7	ratio	ratio	NOUN
dpc-3506	439	8	is	be	AUX
dpc-3506	439	9	related	relate	VERB
dpc-3506	439	10	to	to	ADP
dpc-3506	439	11	disease	disease	NOUN
dpc-3506	439	12	activity	activity	NOUN
dpc-3506	439	13	in	in	ADP
dpc-3506	439	14	relapsing	relapse	VERB
dpc-3506	439	15	remitting	remit	VERB
dpc-3506	439	16	multiple	multiple	ADJ
dpc-3506	439	17	sclerosis	sclerosis	NOUN
dpc-3506	439	18	.	.	PUNCT
dpc-3506	440	1	cells	cell	NOUN
dpc-3506	440	2	.	.	PUNCT
dpc-3506	441	1	2019;8(10):1114	2019;8(10):1114	X
dpc-3506	441	2	.	.	PUNCT
dpc-3506	441	3	doi	doi	NOUN
dpc-3506	441	4	:	:	PUNCT
dpc-3506	441	5	10.3390	10.3390	NUM
dpc-3506	441	6	/	/	SYM
dpc-3506	441	7	cells8101114	cells8101114	NOUN
dpc-3506	441	8	.	.	PUNCT
dpc-3506	442	1	pmid	pmid	NOUN
dpc-3506	442	2	:	:	PUNCT
dpc-3506	442	3	31547008	31547008	NUM
dpc-3506	442	4	.	.	PUNCT
dpc-3506	443	1	pmcid	pmcid	ADJ
dpc-3506	443	2	:	:	PUNCT
dpc-3506	443	3	pmc6830321	pmc6830321	NOUN
dpc-3506	443	4	.	.	PUNCT
dpc-3506	444	1	23	23	NUM
dpc-3506	444	2	.	.	PUNCT
dpc-3506	445	1	arif	arif	PROPN
dpc-3506	445	2	t	t	PROPN
dpc-3506	445	3	,	,	PUNCT
dpc-3506	445	4	adil	adil	PROPN
dpc-3506	445	5	m	m	PROPN
dpc-3506	445	6	,	,	PUNCT
dpc-3506	445	7	amin	amin	PROPN
dpc-3506	445	8	ss	ss	PROPN
dpc-3506	445	9	,	,	PUNCT
dpc-3506	445	10	et	et	PROPN
dpc-3506	445	11	al	al	PROPN
dpc-3506	445	12	.	.	PUNCT
dpc-3506	446	1	clinico	clinico	ADJ
dpc-3506	446	2	-	-	PUNCT
dpc-3506	446	3	epidemiological	epidemiological	ADJ
dpc-3506	446	4	study	study	NOUN
dpc-3506	446	5	of	of	ADP
dpc-3506	446	6	morphea	morphea	PROPN
dpc-3506	446	7	from	from	ADP
dpc-3506	446	8	a	a	DET
dpc-3506	446	9	tertiary	tertiary	ADJ
dpc-3506	446	10	care	care	NOUN
dpc-3506	446	11	hospital	hospital	NOUN
dpc-3506	446	12	.	.	PUNCT
dpc-3506	447	1	curr	curr	PROPN
dpc-3506	447	2	rheumatol	rheumatol	PROPN
dpc-3506	447	3	rev	rev	VERB
dpc-3506	447	4	.	.	PUNCT
dpc-3506	448	1	2018;14(3):251	2018;14(3):251	NUM
dpc-3506	448	2	-	-	SYM
dpc-3506	448	3	254	254	NUM
dpc-3506	448	4	.	.	PUNCT
dpc-3506	449	1	doi	doi	NOUN
dpc-3506	449	2	:	:	PUNCT
dpc-3506	449	3	10.2174/157339711466618041011	10.2174/157339711466618041011	NUM
dpc-3506	449	4	5553	5553	NUM
dpc-3506	449	5	.	.	PUNCT
dpc-3506	450	1	pmid	pmid	NOUN
dpc-3506	450	2	:	:	PUNCT
dpc-3506	450	3	29637865	29637865	NUM
dpc-3506	450	4	.	.	PUNCT
dpc-3506	451	1	24	24	NUM
dpc-3506	451	2	.	.	PUNCT
dpc-3506	452	1	weber	weber	PROPN
dpc-3506	452	2	k.	k.	PROPN
dpc-3506	452	3	is	be	AUX
dpc-3506	452	4	juvenile	juvenile	ADJ
dpc-3506	452	5	localized	localized	ADJ
dpc-3506	452	6	scleroderma	scleroderma	NOUN
dpc-3506	452	7	related	relate	VERB
dpc-3506	452	8	to	to	ADP
dpc-3506	452	9	lyme	lyme	NOUN
dpc-3506	452	10	borreliozis	borreliozi	NOUN
dpc-3506	452	11	?	?	PUNCT
dpc-3506	453	1	j	j	PROPN
dpc-3506	453	2	am	be	AUX
dpc-3506	453	3	acad	acad	ADJ
dpc-3506	453	4	dermatol	dermatol	NOUN
dpc-3506	453	5	.	.	PUNCT
dpc-3506	454	1	2009;61(5):901	2009;61(5):901	NUM
dpc-3506	454	2	.	.	PUNCT
dpc-3506	455	1	doi:10.1016	doi:10.1016	PROPN
dpc-3506	455	2	/	/	SYM
dpc-3506	455	3	j.	j.	PROPN
dpc-3506	455	4	jaad.2009.05.022	jaad.2009.05.022	PROPN
dpc-3506	455	5	.	.	PUNCT
dpc-3506	455	6	pmid:19836648	pmid:19836648	NOUN
dpc-3506	455	7	.	.	PUNCT
dpc-3506	456	1	25	25	NUM
dpc-3506	456	2	.	.	PUNCT
dpc-3506	457	1	zulian	zulian	PROPN
dpc-3506	457	2	f	f	NOUN
dpc-3506	457	3	,	,	PUNCT
dpc-3506	457	4	vallongo	vallongo	NOUN
dpc-3506	457	5	c	c	AUX
dpc-3506	457	6	,	,	PUNCT
dpc-3506	457	7	woo	woo	VERB
dpc-3506	457	8	p	p	PRON
dpc-3506	457	9	,	,	PUNCT
dpc-3506	457	10	et	et	PROPN
dpc-3506	457	11	al	al	PROPN
dpc-3506	457	12	.	.	PROPN
dpc-3506	457	13	localized	localized	ADJ
dpc-3506	457	14	scleroderma	scleroderma	NOUN
dpc-3506	457	15	in	in	ADP
dpc-3506	457	16	childhood	childhood	NOUN
dpc-3506	457	17	is	be	AUX
dpc-3506	457	18	not	not	PART
dpc-3506	457	19	just	just	ADV
dpc-3506	457	20	a	a	DET
dpc-3506	457	21	skin	skin	NOUN
dpc-3506	457	22	disease	disease	NOUN
dpc-3506	457	23	.	.	PUNCT
dpc-3506	458	1	arthritis	arthritis	NOUN
dpc-3506	458	2	rheum	rheum	NOUN
dpc-3506	458	3	.	.	PUNCT
dpc-3506	459	1	2005;52(9):2873	2005;52(9):2873	NUM
dpc-3506	459	2	-	-	SYM
dpc-3506	459	3	2881	2881	NUM
dpc-3506	459	4	.	.	PUNCT
dpc-3506	460	1	pmid:16142730	pmid:16142730	X
dpc-3506	460	2	.	.	PROPN
dpc-3506	460	3	26	26	NUM
dpc-3506	460	4	.	.	PUNCT
dpc-3506	461	1	saxton	saxton	PROPN
dpc-3506	461	2	-	-	PUNCT
dpc-3506	461	3	daniels	daniels	PROPN
dpc-3506	461	4	s	s	PART
dpc-3506	461	5	,	,	PUNCT
dpc-3506	461	6	jacobe	jacobe	PROPN
dpc-3506	461	7	ht	ht	PROPN
dpc-3506	461	8	.	.	PUNCT
dpc-3506	462	1	an	an	DET
dpc-3506	462	2	evaluation	evaluation	NOUN
dpc-3506	462	3	of	of	ADP
dpc-3506	462	4	long	long	ADJ
dpc-3506	462	5	-	-	PUNCT
dpc-3506	462	6	term	term	NOUN
dpc-3506	462	7	outcomes	outcome	NOUN
dpc-3506	462	8	in	in	ADP
dpc-3506	462	9	adults	adult	NOUN
dpc-3506	462	10	with	with	ADP
dpc-3506	462	11	pediatric	pediatric	ADJ
dpc-3506	462	12	-	-	PUNCT
dpc-3506	462	13	onset	onset	NOUN
dpc-3506	462	14	morphea	morphea	NOUN
dpc-3506	462	15	.	.	PUNCT
dpc-3506	463	1	arch	arch	NOUN